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ABSTRACT 
Keturah Ruth Faurot: Botanical Dietary Supplement Use among Hispanic/Latino Adults in the Hispanic 
Community Health Study/Study of Latinos:   
Comparison of a Diet- vs. Medication-based Survey 
(Under the direction of Anna Maria Siega-Riz) 
Botanical supplement use is common in the United States, but its assessment is difficult among 
Hispanics/Latinos.    This report documents the prevalence of botanical and non-vitamin non-mineral 
(NVNM) supplement use over a 30-day recall period in a sample of Hispanics/Latinos in the US as 
measured with two instruments.  Dietary supplement assessment in the Hispanic Community Health 
Study/Study of Latinos included both a medication inventory and a nutrition-based dietary supplement 
interview, enabling a comparison of instruments across supplement categories.  Additional supplements 
were captured from 24-hour dietary recalls.  In addition, characteristics of botanical supplement users 
and their motivations for use were explored. 
The prevalence of dietary supplement use was substantially higher as measured in the dietary 
supplement interview as compared to the medication inventory:  for total dietary supplements (40 vs. 
26%, respectively), for NVNM supplements (25 vs. 13%), and botanicals (9 vs. 4%).  Concordance 
between the two measures was fair-moderate by Cohen’s Kappa (0.28 – 0.56).  Estimates were 
sensitive to inclusion of botanical teas captured exclusively from 24-hour dietary recalls with increases 
in botanical supplement prevalence from 7 to 15% with their addition.  After vitamins and minerals, the 
most prevalent supplement ingredients consumed were omega-3 fatty acids (9.7%), lutein (9.6%), and 
lycopene (10.5%).   
The prevalence of botanical supplement use varied across Hispanic/Latino background. 
Individuals with a self-reported Mexican, Central or South American background were more likely to 
use botanicals than individuals with a Dominican, Cuban, or Puerto Rican background.   Other 
characteristics associated with botanical supplement use included age, income, and adoption of 
healthy lifestyle behaviors. The association of education with botanical supplement use was stronger 
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for more rather than less acculturated individuals.   Motivations for supplement use included 
treatment/prevention of health conditions and appearance enhancements.   
Botanical use prevalence varied by Hispanic/Latino background, but characteristics of 
botanical supplement users across backgrounds were similar to those in the general US population as 
were the types of botanical supplements captured.  Results suggest that drivers of commercial 
botanical supplement consumption may not differ between Hispanics/Latinos and the non-Hispanic 
white population and indicate an interest in self-improvement.  Clearly needed are better dietary 
supplement assessment strategies and standardization of categorization.  
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CHAPTER 1:  INTRODUCTION AND SPECIFIC AIMS 
Botanical dietary supplement use among Hispanic/Latino Americans is common, particularly 
among those over the age of 60 where use exceeds that of non-Hispanics/Latinos [1-3]. Although little 
is known about factors associated with botanical supplement use among these rapidly growing 
populations, preliminary evidence suggests that, unlike for non-Hispanics/Latinos, acculturation and 
access to care may play a substantial role, although the direction of the associations is uncertain. 
Botanical dietary supplement use in older adults is of particular concern given the increased potential 
for interaction with prescription medications or substitution for appropriate conventional medical care 
[4]. Despite the risks, more than 65% of Hispanic/Latino botanical users report that their physicians 
never ask about their botanical supplement use [5] and less than 20% disclose their use [6, 7].  
Methodological issues specific to these populations need to be addressed in order to achieve 
valid prevalence estimates. For example, the way in which botanical supplement use has been assessed 
in the past may not be valid in a population where many botanical supplements are consumed as teas 
rather than as capsules or tablets, potentially leading to prevalence underestimates.  In the current 
literature, prevalence estimates are highly variable, ranging from 5 to 94%.  Possible selection bias and 
outcome misclassification hampers interpretation of available estimates. Requirements for accurate 
botanical supplement use prevalence estimates include: 1) a large sample (N>10,000) of 
Hispanics/Latinos; 2) sampling of multiple Latino cultural groups; 3) inclusion of recent immigrants; 
and 4) outcome assessments that include botanical supplement common among Hispanics/Latinos. 
The proposed analyses assess botanical supplement use among Hispanics utilizing both the 
medication inventory (4 week medication and supplement use) and the two 24-hour diet recalls (with a 
30-day dietary supplement interview) from the Hispanic Community Health Study/Study of Latinos 
(HCHS/SOL), a prospective cohort study designed to identify risk factors and disease prevalence among 
Hispanic/Latino populations within the US. HCHS/SOL has enrolled16,415 individuals  (aged 18 to 74) 
from four communities:  Miami, the Bronx, Chicago, and San Diego representing Hispanic/Latino groups 
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from Cuba, Puerto Rico, Mexico, the Dominican Republic, Central and South America. The double 
assessment (medication inventory plus dietary supplement interview with dietary recalls) could serve 
as a reference standard for calibrated estimates of botanical supplements and the prevalence of 
different types of botanical supplements across groups of Hispanic/Latino backgrounds.  Correlates of 
botanical supplement use will be examined, with special attention to factors that are found to differ 
by Hispanic/Latino background.  
Specific Aim 1:  Evaluate the prevalence of botanical supplement use in the HCHS/SOL cohort across 
assessment instruments 
a. Estimate the prevalence of botanical and non-vitamin, non-mineral dietary supplement use 
among Hispanics/Latinos as assessed at baseline by the:  
1) Medication inventory;  
2) Dietary supplement interview (with and without dietary recall data); and  
3) Combined medication inventory/dietary supplement interview 
 
b. Compare dietary supplement prevalence estimates based on the medication inventory with those 
of the dietary supplement interview (with and without dietary recall data) and the combined 
assessment across categories of supplements (any dietary supplement, NVNM supplements, any 
supplement with botanical components, primarily botanical supplements). 
 
Specific Aim 2:  Explore population characteristics associated with botanical supplement use among 
Hispanics/Latinos with particular attention to:  
a. Hispanic/Latino background, as defined by country of origin (Cuba, Puerto Rico, Dominican 
Republic, Mexico, Central, and South America);  
b.  Acculturation (Born in US, years in the U.S., Short Acculturation Scale for Hispanics);  
c. Access to healthcare (insurance status, perceived lack of access);  
d. Health indicators (medication use and perceived health);  
e. Health behaviors (non-smoking status, physical activity, adherence to healthy dietary 
guidelines); 
f. Demographics (age, gender, education, income); 
g. Geographic location in the United States. 
 
 
   Understanding botanical supplement use patterns is essential to protect the public from harm, 
but these patterns are poorly understood among Hispanics/Latinos, soon to be the largest ethnic 
minority in the US.  The HCHS/SOL cohort provides a unique opportunity to address some of the 
challenges inherent in measuring botanical supplement intakes among Hispanics/Latinos.  The sampling 
strategy of HCHS/SOL, ensuring representation of all Hispanic/Latino background groups and recent 
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immigrants, provides the basis for estimating patterns of botanical supplement use particular to 
Hispanics/Latinos.  In addition, HCHS/SOL is unique in its double assessments of botanical supplement 
use (dietary supplement interview with recall and medication inventory).  
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CHAPTER 2:  BACKGROUND  
2.1 Potential Risks of Botanical Dietary Supplement Use among Hispanics/Latinos 
 
The Dietary Supplement Health and Education Act of 1994 (DSHEA) defined the dietary supplement.  
 
TABLE 2.1.Definition of a dietary supplement under the Dietary Supplement Health and Education 
Act 
“A dietary supplement  
• Is a product (other than tobacco) that is intended to supplement the diet that bears or contains one or more 
of the following dietary ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid, a 
dietary substance for use by man to supplement the diet by increasing the total daily intake, or a 
concentrate, metabolite, constituent, extract, or combinations of these ingredients.   
• Is intended for ingestion in pill, capsule, tablet, or liquid form.   
• Is not represented for use as a conventional food or as the sole item of a meal or diet.   
• Is labeled as a "dietary supplement."   
• Includes products such as an approved new drug, certified antibiotic, or licensed biologic that was 
marketed as a dietary supplement or food before approval, certification, or license (unless the Secretary 
of Health and Human Services waives this provision).”  
 
Under DSHEA, botanical products, including teas, alcoholic extracts, capsules, and tablets, are 
regulated as dietary supplements, resulting in a lower level of government oversight of product safety 
as compared with pharmaceutical drugs.  Although recent amendments to DSHEA require that 
manufacturers follow current Good Manufacturing Practices and submit serious adverse events to the 
Food and Drug Administration (FDA), current regulations fall short of full public protection [8].  New 
research points to increasing reasons for concern about dietary supplement use as a mechanism for 
interactions with medications and this concern is highest with botanical supplement  [9, 10].    Product 
contamination, either intentional (e.g., addition of undeclared drugs) or accidental (e.g., formulation 
error or plant misidentification) is problematic [11].  Up to 30% of Mexican Americans have reported 
that they obtain both their botanical supplements and drugs from Mexico, increasing worries about 
product safety [6, 12, 13].   In addition, blood lead levels have been found to be higher among women 
using herbal products  [14]. 
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Botanical supplement use among Hispanics/Latinos is popular within the US especially among 
patient populations.  In fact, supplement use is higher among individuals with chronic conditions than 
those without [15] and individuals with chronic illness are more likely to take prescription medications 
concomitantly.  Concurrent use of supplements and medications approaches 25% in the general 
population and 75% among those 55-70 years old [16-18].   
 
Medication-botanical interactions are incompletely understood.  Of concern are both 
pharmacokinetic and pharmacodynamic interactions [9].  For example, St. John’s Wort induces 
Cytochrome P450 (CYP450) isoenzymes and reduces blood levels of antiviral medications in HIV, 
transplant-rejection suppressants, and oral contraceptives [19-21].  Unfortunately, the extent of 
CYP450 activity of many botanicals is yet unknown [9], especially those common among 
Hispanics/Latinos [22]. Concomitant use of anticoagulants and/or antiplatelet agents and botanical 
supplement is especially worrisome, given that multiple botanical agents possess antiplatelet activity 
[23].  For example, use of Ginkgo biloba with aspirin has resulted in cases of intracranial bleeding [20].  
Adverse effects associated with many botanical supplement common among Hispanics/Latinos are 
uncertain. Studies have documented episodes of hypoglycemia possibly associated with a combination 
of nopal and oral hypoglycemic agents [24].   Other studies identified multiple potential medication-
supplement interactions [25].  For example, chamomile (manzanilla), a popular botanical in several 
Hispanic/Latino populations, because of its effects on cytochrome P450 substrates, could interact with 
multiple commonly-used medications [5].   However, the clinical significance of many of these 
potential interactions is unknown [25]. 
In spite of the potential risks, rates of disclosure of botanical supplement use to physicians are 
low.  In the general population, about a third of supplement users report their use to health care 
providers; among Hispanics/Latinos disclosure rates vary from 7 to 66% with a median of 34.5% [5-7, 
26-38].  Seventy-five percent of studies reported disclosure rates less than 50%.  Disclosure rates are 
likely to be even lower among individuals who are marginalized and/or speak little English [39] .  
Moreover, in a chart review, only 15% of botanical supplement use was documented in the medical 
record [31]. Substitution for appropriate medical care may also put individuals at risk. Small studies 
suggest that botanical supplement use is greater among Hispanics/Latinos without insurance and with 
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low incomes [12, 40].  Underutilization of medical care, due to limited access or perceived 
discrimination [41], could strongly impact choices to use botanical supplements.   
2.2 Unique Patterns of Botanical Supplement Use in Hispanic/Latino Populations  
Hispanic/Latino populations encompass people from diverse cultural traditions with differences 
in dialects, primary language, and traditions [22].  In some Hispanic/Latino populations, attitudes and 
beliefs about the use of botanical medicines are part of a cultural belief system transmitted through 
female relatives [2, 22, 41-43].  Surveys and interviews with Hispanic/Latino immigrants report a belief 
that botanical remedies are safer than prescription drugs and consistent with family traditions [43, 44]. 
Medications are not eschewed, however; herbal teas are often consumed along with medications, 
especially among diabetics [41, 45]. In fact, conventional medical care and physician’s advice may be 
highly valued [40].  However, herbal remedies may be chosen because they are consistent with cultural 
practices and are cheaper and easier to obtain; in two studies, annual income was the strongest 
predictor of alternative medicine use (chiefly botanicals) [40, 45].   In other studies, in areas of the 
country far from traditional sources of botanicals, botanical supplement use may be less common 
because it is less available.  Hence, use patterns may be consistent with pragmatic self-care behaviors 
[2, 46-48].  Among Hispanics/Latinos, botanical supplement may be used for treatment of symptoms 
and minor illnesses, much in the same way other Americans try over-the-counter medications [49]. 
Unlike in the general population, factors related to botanical supplement use among 
Hispanics/Latinos are incompletely understood.  Education appears either to play a limited role or to 
vary across categories of acculturation [50, 51]. Moreover, the operational definition of acculturation 
itself is variable.  Studies that utilized acculturation scales disagreed on the importance of 
unidimensional as opposed to bidimensional theoretical models.  Unidimensional acculturation, 
typically measured with the Short Acculturation Scale for Hispanics/Latinos [52], characterizes 
orientation toward the new and initial cultures as occurring along a continuum; a person reporting 
Spanish-language activities and friends would receive a lower acculturation score on a unidimensional 
scale.  Bidimensional acculturation [53], on the other hand, assesses endorsements of aspects of both 
the US culture and the culture of origin [54, 55].   Most studies including acculturation as a covariate, 
 
 
7 
 
however, limit its definition to length of residence in the US and/or primary language [56, 57], the 
latter possibly conflated with employment opportunity and income rather than Hispanic/Latino identity 
[40].   
  Some studies report higher botanical supplement prevalence estimates among recent 
immigrants [5, 29, 58, 59], but others find no association between length of residence and the 
prevalence of botanical supplement use [33, 40, 56, 60].  Moreover, a closer examination of the studies 
suggests that overall prevalence may not differ much by acculturation, regardless of its measurement, 
but by the types of botanicals used.   In one study, botanical use patterns among those with higher US 
acculturation scores were more similar to that of the non-Hispanic white (NHW) sample than to less 
acculturated Hispanics/Latinos [29].  Similarly, in a small study of middle-aged Mexican American 
women, those who used botanical supplements common among Hispanics/Latinos scored higher on the 
Mexican orientation of the bidimensional acculturation scale as compared with women who used 
botanical supplements popular in the US culture [46].  In another, most participants did not know the 
English names for the botanical supplements they were using currently [5].  It should also be noted that 
the Spanish names for these herbs may vary from country to country. 
2.3 Overcoming Existing Methodological Barriers  
A botanical assessment instrument should have good test-retest reliability, be easy to 
administer, and, most importantly, contain extensive prompts, known to aid recall of over-the-counter 
products. In addition, prompts should include questions about botanical supplements meaningful to the 
target population.  In Hispanic/Latino populations, it is particularly important to inquire about herbal 
teas and those herbs common among Hispanics/Latinos, but uncommon among the general public.  
Despite its importance, outside of randomized trials, few US studies have assessed botanical 
supplement use in any population, and even fewer have employed comprehensive strategies. 
Assessment strategies in studies have varied; most cohort studies have relied on self-completed 
questionnaires [61-64] or telephone surveys [65], invariably requiring participants to choose from a list 
of botanical supplement.   Personal interviews with examination of products is considered a more 
comprehensive method and served as a criterion standard for a vitamin supplement validation study 
[66].  In addition to HCHS/SOL, the Hispanic Established Populations for the Epidemiologic Study of the 
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Elderly (EPESE) used this method.  In EPESE, participants were asked if they “had taken any folk 
medicine, herbs, or herbal remedy in the 2 weeks prior to the baseline interview” (p M715)[59], a 
strategy that improves upon the typical assessment.   
HCHS/SOL appears to be unique, however, in its double assessment of botanical supplements, 
requesting information on botanical supplements with both medication and dietary data.  Because 
some botanical dietary supplements are considered treatments, like medications, and others are more 
like preventatives, like vitamins, different supplements may be captured by alternative methodologies.  
In addition, different forms of botanical supplements may be captured better by one instrument than 
the other.  For example, in some Hispanic/Latino populations, medicinal plants are prepared as 
“liquadas” in a blender and many are prepared as teas.  Hence, it would be important to assess the 
value of adding the dietary recall botanical supplement assessment to that of the medication 
questionnaire.  If the overlap between instruments is small and the prevalence of botanical supplement 
use increases substantially with the double assessment, this strategy could become the new criterion 
standard, at least in Hispanic/Latino populations.   
Unfortunately, despite these careful assessment procedures, HCHS/SOL may yet be 
underestimating botanical supplement use.    Usual assessment of botanical supplements via tablets 
and capsules limit the ability to accurately characterize botanical supplement use among 
Hispanics/Latinos because, as a matter of cultural practice, many Hispanics/Latinos consume botanical 
supplements in food-like forms. It is unclear whether or not participants will include herbal teas with 
their medications and the question about botanical supplements in the dietary recall targets products 
more common in the general population than among immigrant Hispanics/Latinos. A systematic review 
of prevalence of botanical supplement use documents wide variations in prevalence estimates,  
partially related to the nature of the assessment instruments; those that specifically target 
Hispanic/Latino populations and include the use of teas result in much higher prevalence estimates.  
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CHAPTER 3:  PRELIMINARY STUDIES 
3.1 Systematic Review of Botanical Supplement Prevalence among Hispanics/Latinos  
Establishing accurate prevalence estimates are critical:  underestimates could misrepresent the 
public health impact of botanical supplement use.  Prevalence estimates of botanical supplement use 
are often dependent on self-report measures, and, as such, vary by multiple factors.   
Methods  
To further elucidate factors associated with variations in prevalence among Hispanics/Latinos, 
a team of researchers (Gardiner, Filippelli, Faurot) conducted a systematic review of the available 
literature.  Our strategy included electronic database searches (CINAHL, EMBASE, Global Health, CAB 
Abstracts, and Medline) with keywords: herbal, herb, medicinal plant, botanical, and Hispanic or 
Latino along with a manual search of retrieved references. Only studies with at least 1% and at least 10 
Hispanics/Latinos were included with publication dates of 1998-2011. Information was extracted on 
study and sample characteristics, and rates of disclosures to clinicians.  The following were expected 
to have an impact on prevalence estimates: 1) the sampling strategy (convenience vs. probability); b) 
study size, including proportion of Hispanics/Latinos in the sample; c) the time period of the recall (< 
30 days vs. 12 months vs. “ever used”); d) characteristics of the population studied (patients vs. 
general public, older vs. younger adults, proportion of males); and e) region of the country (Mexican 
border states vs. other states vs. national samples). Other extracted data included variables not 
available in all of the studies such as measures of acculturation (percent of sample born in the US, 
years living in the US, and preferred language) and participant health status.  In addition, we 
documented the study definition of a botanical supplement.  This varied from  all “biologically-based”  
CAM therapies (including botanical supplements, other dietary supplements and special diets) to non-
vitamin non-mineral supplements (AKA  herbal and “natural” or “specialty” supplements), botanical 
supplements limited to commercial products, and botanical supplements inclusive of plus “home 
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remedies” and/or herbal teas).  We further identified possible sources of recall, selection, and 
information bias in the estimates (Appendix 1) based on the study designs.   
Results  
Study heterogeneity necessitated primarily descriptive analyses. To examine the impact of 
sample characteristics across studies, we limited our analysis to those studies with unique populations.  
If the study was based on the 2002 NHIS sample, we used the report with estimates for the entire 
population rather than estimates for subgroups, such as older adults or patients with diabetes.  Fifteen 
studies used duplicate data and were set aside [2, 16, 61, 67-76].  Of the remaining studies, eighteen 
were excluded because they were missing prevalence estimates for Hispanics/Latinos [13, 42, 47, 77-
90], seven included less than 10 Hispanics/Latinos [91-97], six were qualitative studies [41, 48, 98-
101], and four reported the use of BDS for treatment of a specific illness [102-105].  Use of botanical 
supplements for any indication (rather than for a specific disease) within samples of patients with 
various illnesses was retained.  Of the forty-two studies meeting these criteria, seven described the 
prevalence of the use of biologically-based therapies or dietary supplements including vitamins and 
minerals [10, 40, 46, 106-108].  In addition, one study reported of chamomile use [109]. Thirty-four 
studies had reasonably similar outcomes [3, 5-7, 27-37, 44, 59-61, 73, 110-123].  In these studies, 
botanical supplements were described as herbal medicines, herbal therapies, herbal products, or herbs 
for treatment or prevention of illness.  Some studies also included “herbal and home remedies” in the 
estimates.  TABLE 3.1 presents prevalence estimates separately for studies of botanical supplement 
use and over 1-2 weeks, over 6-12 months, and over 2 years or more.   
Of the 34 studies defining botanical supplements as herbal remedies or therapies, study size 
ranged from 23 to 29,990 with Hispanic/Latino sample sizes of 11 to 4,196.  Fifty percent of studies 
reported less than 500 subjects.  Seventy-one percent (n=24) of samples included non-Hispanics, 44% 
had a minority Hispanic/Latino sample, and 9% included fewer than 50 Hispanics/Latinos.  More than 
half (53%) of the studies were conducted within patient populations.  Studies among patients included 
those with cancer [35, 106, 117], HIV [116, 124], diabetes [31], osteoarthritis [29], menopause [37, 
123], surgical patients [7, 26], and pregnancy [27].   Regional studies included those from states along 
the Mexican border (TX, NM, AZ, CA:  53%) and those in other parts of the country (FL, NY, MA, IL).  
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Nineteen percent of the studies were representative of the national population.  BDS prevalence 
estimates among Hispanics/Latinos ranged from 4.7% (over 1 week) to 94% (use in past year).   
 
In regional samples, potentially biased by the sampling strategy, prevalence estimates were up 
to three times as high as in nationally-representative population surveys.  However, in nationally-
representative samples, ethnic minorities, especially recent immigrants, may be under-represented, 
especially among older age groups [113].  For example, among studies of individuals along the Mexican 
border over a 12 month period, prevalence estimates of botanical supplement use range from 21 to 94% 
[3, 6, 7, 28, 32, 34, 36, 60, 111, 118].   In contrast, prevalence estimates among Hispanics/Latinos in 
nationally-representative samples range over a similar time period range from 7 to 23% [30, 114, 115, 
119, 122, 123].   
 
 
 
 
 
FIGURE 3.1 
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TABLE 3.1.  Prevalence of the use of botanical supplements in studies Including 
Hispanics/Latinos 1998-2011 across characteristics of included studies 
 Prevalence of use of botanical supplements 
 n N Median 95% CI P
a 
Overall 32 95,523 42 21, 61  
Time period      
    Over ≤30 days 5 18,108 12 4.7 , 43 0.02 
    Over 6-12 months 18 75,050 31 19 , 59  
    Over 2+ years 9 5,365 50 37,  75  
Sample  type      
    Probability 11 82,002 19 8.9, 48 0.02 
    Convenience 21 14,521 49 35,  63  
Data collection method   
 
  
    Interview 20 74,401 27 12, 60 0.3 
    Written 12 22,122 46 21,  63  
Publication type      
    CAM journal 7 19, 500 28 12,  51 0.4 
    General  journal 25 77,023 43 19,  62  
Regional vs. national      
    Regional 25 16,496 50 35, 62 0.002 
    National 7 80,027 15 7.7, 22  
Sample population      
    General  public 16 88,578 20 10, 49 0.01 
    Patients 16 7,945 50 36, 65  
Target age of population   
 
  
    Adults ≥65 7 9,147 12 6.3, 50 0.02 
    Adults <65 25 87,376 47 27, 62  
Gender distribution   
 
  
    Majority males 8 5,034 51 19, 76 0.2 
    Majority females 24 91,489 36 18, 61  
Language of instrument   
 
  
    Spanish & English 19 16,701 47 28, 64 0.02 
     English only 13 78,822 17 9.1, 50  
Sample proportion of H-L      
    Majority H-L 15 8,142 42 29, 67 0.03 
    Minority H-L 17 88,381 21 12, 50  
Size of H-L sample      
    N < 250 17 8,060 52 42, 63 0.03 
    N ≥ 250 15 88,463 23 15, 37  
Botanicals common among  H-L    
    No 12 83,087 19 10, 49 0.02 
    Yes 20 13,436 49 29, 66  
Abbreviations:  H-L—Hispanics -Latinos; n= number of studies; N = sum of sample populations;  CI = confidence interval, calculated 
using binomial method; CAM = Complementary and alternative medicine.  a. p values are based on Kruskal-Wallis (or Mann-
Whitney U) rank nonparametric tests.  All analyses were conducted in Stata 12. 
 
Not surprisingly, because the language used to describe botanical supplements among 
Hispanics/Latinos differs from that of the general US public (including plant names, product 
formulations, and typical use patterns), assessment instruments designed for Hispanic/Latino 
populations produce higher prevalence estimates than those created for national samples. In some 
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studies, supplement definitions consisted of commercial products only; in others, information on any 
botanical substance (including herbal teas) used to prevent or treat a disease or illness was solicited.  
As teas are the most prevalent form of supplements consumed in many Hispanic/Latino populations 
[125], a botanical assessment instrument that excludes them will result in serious underestimates.  
Among the 11 studies of botanical supplement use over 12 months with instruments that target herbs 
common among Hispanics/Latinos, particularly herbal teas, prevalence of use among Hispanics/Latinos 
ranges from 18 to 94 % (weighted median 28%)[3, 6, 28, 32, 34, 36, 60, 111, 115, 124] while among 
those that do not target Hispanic/Latino herbs, the range is 7 to 55% (median 12%) [26, 30, 110, 114, 
118, 119, 122, 123]. 
TABLE 3.2.  Medicinal plants common among Hispanic/Latino populations in four  
areas of the US 
Texas/New Mexico   Florida 
English  Spanish   English Spanish 
Aloe Savila 
 
Aloe Savila 
Chamomile Manzanilla 
 
Chamomile Manzanilla 
Cornsilk Pelo de Elote 
 
Garlic  Ajo 
Damiana Damiana 
 
Ginger Jengibre 
Diabetil tea Te Diabetil 
 
Ginseng Ginseng 
Garlic Ajo 
 
Linden Tilo 
Lime (Linden) Tilo 
 
Star anise Anis estrella 
Mints Hierbabuena 
 
Valerian Valeriana 
Osha Hierba del cochino 
   Prickly pear Nopal 
   California  Illinois 
English Spanish  English Spanish 
Aloe Savila  Aloe Savila 
Cactus Nopal  Anise Anis estrella 
Cascara Cascara  Chamomile Manzanilla 
Chamomile Manzanilla  Cornsilk Pelo de Elote 
Ginseng Ginseng  Garlic Ajo 
Peppermint Hierbabuena  Ginseng Ginseng 
Rue Ruda  Herbal teas Te hierbas 
Wormwood Ajenjo  Mullein Gordolobo 
Flaxseed Semillas de lino  St. John's wort Hierba de San Juan 
Herbs in bold were reported in multiple studies.  Additional herbs reported among Mexican Americans include 
Bricklebush (Prodigiosa), Eucalyptus (Eucalipto), Loquat (Nispero), Milkberry (Perllila), Matarique (Matarique), 
Trumpet tree (Lapacho or Taheebo), Wormwood (Ajenjo), and Yellow Bells (Tronadora). 
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In the general population (2007 NHIS), of those who used botanical supplements over a period 
of 12 months, 75% had also used botanical supplements over the past 30 days (primary calculation).   
Other studies have documented similar patterns of regular use of supplements among users [126].  In 
contrast, “point prevalence” or prevalence of botanical supplement use over a week or two, across the 
studies in this sample, averages almost a quarter of the estimates of use over a period of several 
months.  This pattern may be related to the types of herbs most common within Hispanic/Latino 
populations, particularly among those who identify with traditional Mexican and Central American 
cultures [28, 29, 40].   In the general population, the most commonly used botanical supplements are 
those typically taken daily (e.g., glucosamine, ginseng, garlic, ginkgo, St. John’s Wort, saw 
palmetto)[2, 73, 127].   In contrast, among Hispanics/Latinos, the most common herbs are those used 
for intermittent treatment of symptoms (e.g., manzanilla, tila, hierba buena, savila).  Botanical 
supplements most common among Hispanic/Latino populations in the surveyed literature are listed in 
Table 2 [6, 7, 22, 40, 43, 113, 125, 128].    
Discussion 
The sample of studies was not restricted by any definition of study quality; no studies were 
free of bias, particularly selection bias.    Studies based on national probability samples were either 
hampered by an overall poor response rate [30, 129], did not report a response rate [104, 108, 119], or 
had a differential, lower response rate for Hispanics/Latinos [115].  In addition, studies utilizing the 
NHIS, based on the US census with data collection by census staff, may have excluded certain 
Hispanic/Latino populations, such as recent or undocumented immigrants.  Other probability samples 
used sampling frames biased toward individuals with higher incomes.  For example, an otherwise 
excellent study limited its sample to older women covered by a particular health plan [118] and 
another limited the sample to seniors with a Medicare supplement [79].  Similarly, studies that utilized 
telephone surveys exclude those without telephones [88, 107, 114].  Samples based on baseline clinical 
trial populations [18, 105] may also not have been representative of the target population [130].  
Studies using cohort follow-up samples [87, 123] may have suffered from bias due to differential loss to 
follow up.  Many convenience studies were likely to have been biased by differential non-response:  
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non-users of BDS may have been less likely to respond.  Most studies were unable to provide 
information on non-responders.  The two studies that did provide information on responders compared 
with the target population indicated that responders were more likely to be female and white [81] or 
better educated [89], characteristics associated with higher rates of botanical supplements use.  Some 
of the best studies with convenience samples, with close to 100% response rates are difficult to 
compare, due to the difference in their target populations.  One study was undertaken in a low-income 
clinic [60] and another in an ophthalmology specialty clinic [95]. 
Other potential sources of bias included recall and information bias.  The majority of the 
studies asked participants to recall their use of botanical supplements over a period of several months.  
It is unclear whether or not participant characteristics, such as poor health [34] or adverse pregnancy 
outcomes [27] may have resulted in differential recall.  Even in studies with a fairly short recall period, 
outcome misclassification is a real possibility.  However, in a study of participants in a clinical trial, 
kappa statistics comparing questionnaire to a medication interview ranged from 0.49 to 0.87 (fair to 
excellent) [18].    
Outcome misclassification is related not only to poor participant recall, but also to variable 
botanical supplement definitions.  Although we excluded studies of dietary supplements (including 
vitamins/minerals) and biologically-based therapies (including special diets) from our final analysis, we 
cannot be certain that questions about “herbal products” (e.g., Rivera, 2007) and “herbal remedies” 
(e.g., Burge, 2002) are the same.  In addition, some studies included non-herbal natural substances in 
their analysis (e.g., Greenlee, 2009) and others any plant-based product used to treat a symptom or 
illness (e.g., White, 2009). It is with trepidation that we presented any measures of central tendency, 
recognizing that we are aggregating outcomes that may be fundamentally different.   
In the general public, botanical supplement use is more prevalent among middle-aged persons, 
women, and those with chronic conditions [122, 127].  National samples have also predicted higher use 
of botanical supplements among older Hispanics/Latinos as compared with non-Hispanic whites, up to 
age 70 [131].   However, among Hispanics/Latinos in the selected samples, botanical supplement use in 
studies targeting older adults is somewhat lower than among younger adults.  Use within patient 
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populations is higher, but predominantly female populations do not necessarily have higher prevalence 
estimates.   
The language of the study instrument had an impact on estimates.  Not only do studies offered 
only in English exclude those who are less proficient in English, they also may result in 
misclassification.  In one study, most of the participants did not know the English name for over 90% of 
the herbal products in the study [5].  Regional studies, even those with probability sampling, reported 
much higher prevalence estimates than national studies.  The differentials are likely to be due to a 
combination of factors, including non-response bias in the convenience samples, and outcome 
differences (variations in how the questions are asked), in the national samples.   
3.2 Prevalence of Botanical Supplement Use among Hispanics/Latinos in a National Sample 
Despite the acknowledged heterogeneity among those categorized as “Hispanic/Latino”, little 
is known about the effect of country of origin on prevalence estimates.  Multiple studies reported 
prevalence estimates among specific US Hispanic/Latino populations (e.g., Mexican Americans in El 
Paso [50], Mexican and Central/South Americans in California [40, 60],  but prevalence by 
Hispanic/Latino country of origin has not been reported [22].  Curiously, although the 2007 NHIS 
contains data on Hispanic/Latino country of origin, studies utilizing this data have reported only 
aggregate Hispanic/Latino estimates. 
 Based on a review of the literature, the 2007 NHIS instrument was expected to capture the 
pattern of NVNM supplement use of the general population, rather than the pattern more common 
among Hispanic/Latino immigrant populations.  Hence the following hypotheses were entertained:   
1. Higher acculturation (as measured by immigrant status) would be associated with greater use of 
botanical supplements (including NVNM supplements) 
2. Higher education would be associated with greater use of botanical supplements 
3. Use of botanical/specialty supplements would be highest for the 45-64 year old age group 
4. Female gender would be associated with higher use of NVNM supplements 
5. Use of botanical supplements would be associated with greater access to health care as measured 
by insurance status and usual health care home 
6. Hispanics/Latinos with greater incomes would be more likely to use NVNM supplements 
7. Hispanics/Latinos would be less likely than individuals of other ethnicities to use NVNM 
supplements 
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Methods 
 In preparation for the current study the prevalence of dietary supplement use among 
participants in the 2007 National Health Interview Survey (NHIS) was assessed, including 
Hispanics/Latinos. NHIS is a national multistage probability sample administered annually since 
1957 by US Census interviewers to one sample adult per household.  Each year, the NHIS includes 
questions about a broad range of health indicators; every five years since 2002, the alternative 
health supplement is administered. The NHIS oversamples elderly minorities. 
 In the 2007 NHIS, according to the interview guide, participants are asked:  “People take 
herbs and non-vitamin supplements for a variety of reasons.  By herbal supplements we mean 
pills, capsules or tablets that have been labeled as a dietary supplement.   This does NOT 
include drinking herbal or green tea.  Have you EVER taken any herbal supplements listed on this 
card for yourself?”  Products on the list include the following supplements botanical as well as 
other non-vitamin, non-mineral  (NVNM) dietary supplements: black cohosh, chasteberry, comfrey, 
cranberry, Echinacea, ephedra, evening primrose, feverfew, flaxseed oil, garlic, ginkgo, ginseng, 
goldenseal, guarana, grape seed extract, green tea, EGCG, hawthorn, horny goat weed, kava, 
lecithin, lutein, lycopene, milk thistle, saw palmetto, senna, soy, St. John’s Wort, and valerian.   
 In our preliminary study, prevalence of NVNM (including botanical) supplement use was 
examined by age, gender, education, acculturation, and access to care variables (insurance) across 
racial and ethnic categories. To explore the independent influence of these variables for 
Hispanic/Latino versus non-Hispanic individuals, logistic regression models were constructed with 
botanical/NVNM supplement use as the outcome.   Further, prevalence estimates were examined by 
Hispanic/Latino country of origin:  Mexican, Cuban, Puerto Rican/Dominican and Central/South 
American.  Finally, the prevalence odds ratio was calculated for supplement use by Hispanic/Latino 
country of origin controlling for demographic factors.   
 In addition, because many of the studies reported high proportions of Hispanics/Latinos with 
less than a high school education and education may not have the same effect on botanical supplement 
use among Hispanics/Latinos, a logistic regression model was constructed stratifying on education.  
Thus, our initial full model included Hispanic/Latino ethnicity vs. non-Hispanic, four categories of age 
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(18-24, 25-44, 45-64, 65-85), three categories of education (<high school, high school graduate, at least 
some college), sex, insurance coverage (none vs. some), healthcare access (usual place for care vs. 
none) poverty status, and a Hispanic/Latino* education interaction term.  All analyses were conducted 
in Stata 12.1 with application of sampling weights (StataCorps, LLC).  Analyses of data for 
Hispanics/Latinos with different cultural backgrounds are, of necessity, exploratory; no current 
literature focuses on the differences in BSDS use patterns among American Hispanics/Latinos. 
Results  
 TABLE 3.3 presents the prevalence data across covariates of interest for Hispanics/Latinos 
as a group, compared with other racial/ethnic groups.  Models were examined for effect 
modification by education, poverty status, and both. The strongest model, both in terms of 
explanatory power and model fit was the model stratified on poverty status. Controlling for age, 
sex, education, and insurance/ health care access, and immigrant status Hispanics/Latinos with an 
income higher than the poverty line were less likely to use BSDS than non-Hispanics/Latinos with a 
prevalence odds ratio (POR) of 0.73 and 95% confidence interval (CI):  0.63, 0.86.  In contrast, 
Hispanics/Latinos with an income below the poverty line had about half the odds of botanical 
supplement use: POR 0.55 (0.38, 0.80).  Poverty was also associated with a lower likelihood of 
botanical supplement use among non-Hispanics/Latinos:  POR 0.82 (0.72, 0.95).    
 Those most likely to use botanical supplements had at least some post-high school 
education; less than a high school education was associated with one-third the likelihood of 
botanical supplement use  [POR 0.33 (0.28, 0.38)] while those with a high school diploma had about 
half the odds of BSDS use [POR 0.56 (0.51, 0.61)].   Women were slightly more likely to use 
botanical supplement than men: 1.24 (1.14, 1.35) and older individuals were more likely to use 
botanical supplement than younger ones.  Those without insurance were slightly more likely to use 
botanical supplement [POR 1.14 (1.00, 1.29)] and those without a usual place of care were slightly 
less likely to use botanical supplement than those with health care access: POR 0.88 (0.76, 1.00).  
Individuals born in the US were more likely to use botanical supplements than immigrants [POR 
1.36 (1.20, 1.54)].  Self-reported health (good to excellent vs. fair or poor) was not influential and 
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was removed from the models. The model c statistic was only fair at 0.65, suggesting that other 
factors predictive of botanical supplement use are unaccounted for in the analysis. 
TABLE 3.3.  Prevalence of botanical and NVNM supplement use in the US population in the 2007 
NHIS  
  
 White                
Non-Hispanic 
*n = 13,859 
African-American 
*n = 3,612 
Hispanic/Latino 
All races 
*n = 4,173 
Other† 
*n = 1,654 
Variable n % (se) † % (se) % (se) % (se) 
Overall 23385 21.0 (0.44) 10.1 (0.59) 9.71 (0.51) 18.8 (1.15) 
Age      
 18 - 24 2,494 16.4 (1.34) 7.19 (1.38) 3.55 (0.87) 15.4 (2.99) 
 25 - 44 8,538 19.5 (0.68) 10.7 (0.89) 9.75 (0.74) 16.7 (1.54) 
 45 - 64 7,503 24.3 (0.73) 11.0 (1.03) 13.0 (1.20) 18.7 (2.29) 
 65 + 4,581 19.7 (0.79) 9.27 (1.37) 10.5 (1.75) 27.9 (3.84) Gender     
 Male 10,373 18.6 (0.60) 10.0 (0.97) 9.86 (0.77) 17.8 (1.59) 
 Female 13,012 23.0 (0.56) 10.2 (0.70) 9.58 (0.70) 19.6 (1.62) Education     
 < HS 4,223 11.6 (0.88) 3.55 (0.76) 4.43 (0.52) 12.6 (2.79) 
   HS 6,519 16.7 (0.60) 7.92 (0.97) 8.81 (0.98) 17.0 (2.56) 
 >HS 12,383 24.9 (0.60) 14.5 (1.02) 16.5 (1.09) 20.7 (1.41) Insurance      
 None 4,043 21.2 (1.0) 9.32 (1.19) 7.31 (0.75) 16.1 (2.40) 
 Some 19,266 20.0(0.45) 10.4 (0.67) 11.0 (0.71) 19.5 (1.32) Usual place for healthcare    
 Yes 19,425 21.5 (0.42) 10.1 (0.56) 10.1 (0.59) 17.3 (1.32) 
 No 3,534 22.3 (1.20) 9.55 (1.41) 6.30 (0.77) 19.5 (2.92) Born in the US     
 Yes 18,810 21.0 (0.44) 10.2 (0.62) 13.6 (1.02) 23.6 (2.05) 
 No 4,557 20.2 (1.68) 10.0 (1.93) 7.12 (0.61) 14.2 (1.22) 
Total family income     
 <$20K 5,649 18.0 (0.81) 6.16 (0.69) 6.22 (0.76) 16.4 (2.24) 
 $20-39K 5,797 19.1 (0.81) 10.6 (1.06) 7.10 (0.91) 19.8 (2.56) 
 $40-59K 4,104 21.7 (0.96) 10.9 (1.58) 11.0 (1.23) 18.6 (2.75) 
 $60K+ 7,835 23.2 (0.68) 15.8 (1.47) 16.8 (1.50) 19.9 (1.71) 
  *n = sample, but percentages are weighted.  †Other race/ethnicities include Asian Americans and American Indians; NVNM= non-
vitamin, non-mineral 
 
 
  Among Hispanics/Latinos, individuals reporting a Central/South American 
background or mixed Hispanic/Latino background were more likely to use BSDS than those 
reporting a Mexican background (POR 1.48 CI: 1.03, 2.02 and 1.86 CI: 1.41, 2.47) (Table 3.4).  
Botanical supplement use was strongly associated with age; among Hispanics/Latinos, individuals in 
the 65-74 age groups had more than three times the odds (POR 3.45 CI: 1.91, 6.22) of botanical 
supplement use as those in the 18-24 age group.   Insurance status, US birthplace, and years in the 
US were not predictive of botanical supplement use and had little effect on estimates by 
Hispanic/Latino ethnicity. 
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TABLE 3.4.  Prevalence of botanical and NVNM supplement use among Hispanic/Latino 
populations in the 2007 NHIS  
  
 
Mexican 
American 
*n = 1,581 
 
Cuban 
American 
n = 187 
 
Puerto 
Rican 
n = 593 
Central/ 
South 
American 
n = 663 
Other 
Hispanic/ 
Latino‡ 
n = 1,149 
 
Non-
Hispanic 
n = 19,125 
Variable % (se) † % (se) % (se) % (se) % (se) % (se) 
Overall 6.3 (0.59) 9.6 (1.27) 9.4 (2.67) 10.1 (1.31) 11.5 (0.87) 18.8 (0.33) 
Age       
 18 - 24 3.0 (1.20) 0 5.0 (2.43) 2.6 (1.83) 4.1 (1.56) 14.4 (0.93) 
 25 - 44 6.7 (0.86) 11.4 (5.30) 8.9 (1.97) 11.0 (1.98) 12.8 (1.46) 17.0 (0.54) 
 45 - 64 7.1 (1.44) 11.5 (4.34) 13.7 (2.90) 11.1 (2.62) 14.5 (2.13) 21.5 (0.56) 
 65 - 85 6.8 (2.46) 6.7 (3.81) 8.4 (2.58) 12.8 (3.81) 12.4 (3.06) 18.9 (0.65) 
Gender       
 Male 5.3 (0.85) 9.4 (3.83) 14.7 (2.80) 9.4 (2.15) 11.0 (1.40) 17.4 (0.42) 
 Female 7.2 (0.88) 9.4 (3.27) 6.6 (1.19) 10.6 (1.68) 11.9 (1.28) 20.0 (0.46) 
Education       
 < HS 5.9 (1.16) 17.8 (6.19) 11.0 (2.07) 10.5 (2.15) 11.9 (1.50) 19.3 (0.60) 
 HS 7.9 (1.61) 9.5 (5.43) 7.0 (2.47) 3.5 (1.22) 13.8 (2.20) 18.4 (0.70) 
 >HS 6.1 (1.04) 4.7 (3.19) 8.7 (2.22) 11.8 (2.26) 9.2 (1.64) 18.7 (0.51) 
Insurance       
 None 6.4 (1.34) 10.0 (5.85) 9.8 (3.04) 5.2 (2.29) 11.5 (2.38) 18.7 (0.72) 
 Some 6.3 (0.66) 9.5 (2.77) 9.2 (1.27) 11.1 (1.51) 11.4 (1.02) 18.8 (0.36) 
Born in US       
 Yes 6.1 (0.64) 10.4 (3.15) 9.6 (1.32) 10.6 (1.43) 11.0 (1.00) 18.9 (0.36) 
 No 7.7 (1.76) 4.4 (4.29) 9.8 (3.80) 5.9 (2.35) 15.1 (3.24) 18.2 (0.76) 
Family income      
 <$20K 4.5 (1.01) 3.4 (2.70) 4.7 (1.46) 8.2 (1.90) 9.9 (1.96) 15.3 (0.62) 
 $20-39K 4.3 (0.85) 9.7(6.29) 11.0 (3.02) 4.8 (1.85) 11.1 (2.29) 17.8 (0.69) 
 $40-59K 10.1 (1.88) 5.3 (3.72) 12.5 (3.14) 15.8 (3.36) 9.32 (2.24) 20.1 (0.85) 
 $60K+ 11.0 (2.32) 26.6 (7.54) 19.3 (4.26)   22.4 (0.64) 
*n = number of participants in 2007 sample, not representative sample. †Frequencies are weighted. ‡Other Hispanic/Latino 
includes those reporting mixed ethnicity. 
 
 
Discussion 
 As expected, the results conform to patterns noted in prior nationally-representative 
studies of botanical and NVNM supplement use among US adults and are consistent with our 
expectations.  As the literature indicates higher use patterns among Hispanics/Latinos with medical 
conditions [59, 79, 89, 132] and among individuals who visit health care professionals [5], it is not 
surprising to find higher use among those with a health care home.  The literature is mixed with 
regard to the impact of insurance coverage.  Some studies suggest higher use among the insured 
[30], while other studies suggest the opposite [114, 133].  The current findings support a modest 
effect of access to care on use of botanical supplements common in the general US public.  
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 In this sample, consistent with prior studies in US populations, educational attainment was 
associated with greater botanical and NVNM supplement use [2].  Poverty was associated with 
lower botanical and NVNM supplement use and this effect was magnified for the Hispanics/Latinos 
in the sample. The association between income and the use of complementary and alternative 
medicine (CAM) has been documented in prior studies [35, 131, 134], but no study has examined 
these effects stratified by ethnicity.  NVNM supplement use, as assessed, was less common among 
individuals born outside the US, a finding consistent with prior studies of botanical and NVNM 
supplement use in national samples [135].  In regional samples, however, even those with 
probability samples, the CAM use (including botanical and NVNM supplement use) is often higher 
among immigrants [34].   
 It should be noted that the “herbal supplements listed on this card” in the NHIS botanical and 
NVNM supplement use assessment did not include most of the botanical supplements usual in 
Hispanic/Latino populations.  In addition, because both common botanical supplements among 
Hispanics/Latinos and herbal teas are specifically excluded from collection, the prevalence of NVNM 
use among Hispanics/Latinos in the NHIS analysis is likely to be substantially underestimated. The 2002 
NHIS Complementary and Alternative supplement included herbal teas (although did not specify most 
botanical supplements common among Hispanics/Latinos).   This may be the reason why the prevalence 
of botanical and NVNM use over 12 months among Hispanics/Latinos appears to have declined 
substantially, from about 18 % [30] in 2002 to less than 9% in 2007.     
3.3 Summary and Implications 
Understanding NVNM and botanical supplement use patterns is essential to protect the public 
from harm, but these patterns are poorly understood among Hispanics/Latinos, soon to be the largest 
ethnic minority in the US.  The HCHS/SOL cohort provides a unique opportunity to address some of the 
challenges inherent in measuring NVNM and botanical supplement intakes among Hispanics/Latinos.  
The  sampling strategy of HCHS/SOL, ensuring representation of Hispanic/Latino background groups 
and thorough assessment of both acculturation and access to care, provides the basis for estimating 
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patterns of NVNM and botanical supplement use particular to Hispanics/Latinos.  In addition, HCHS/SOL 
is unique in its double assessments of dietary supplement use. 
To our knowledge, this is the first study in a large representative sample to estimate the 
effects of Hispanic/Latino country of origin on the prevalence of botanical supplement use among 
Hispanics/Latinos.  In addition, because the assessment of Hispanic/Latino background is captured in 
HCHS/SOL, I will be the first to be able to assess the impact of varying Hispanic/Latino background 
groups.  Study measurements also enable us to examine not only the impact of country of origin and 
acculturation, but also income, education, and access to healthcare, all covariates that have been 
incompletely accounted for in previous work. Hence, the study will yield data of value to public health 
professionals in planning botanical supplement guidelines and education.   
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CHAPTER 4: RESEARCH DESIGN AND METHODS 
4.1 Overview of Study Design 
 The proposed study of botanical supplement use and patterns of use among 
Hispanics/Latinos utilized the baseline data of the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL), a prospective cohort study designed to identify risk factors and disease 
prevalence among Hispanic/Latino populations within four communities in the United States 
(Miami, Bronx, Chicago, and San Diego) representing immigrants from Cuba, Mexico, Puerto Rico, 
and Central/South America.  HCHS/SOL has completed enrollment of a representative sample of 
16,000 Hispanics/Latinos; including 10,000 individuals aged 45-74. Baseline data collection 
included a medical history and physical exam as well as assessments of acculturation, health 
behaviors, family structure, health care access, nutrition, and physical activity.  The HCHS/SOL 
cohort is the first to enroll an adequate sample of Hispanics/Latinos of different backgrounds to 
make possible a robust assessment of the prevalence of NVNM and botanical supplement use and its 
correlates in these populations. 
 
 
Eligibility  
All participants in the HCHS/SOL cohort were eligible to participate in the primary analysis.  
The HCHS/SOL sample was a stratified two-stage probability sample of 16,414 from the communities 
included; ensuring unbiased inferences [136].   
HCHS/SOL cohort sample selection, recruitment, and enrollment  
The source population for HCHS/SOL is that of non-institutionalized adults aged 18-74, either 
gender, of Hispanic or Latino origin residing in specific census tracts in the city of Chicago, Miami-Dade 
County, San Diego County, and the Bronx, NY.  HCHS/SOL investigators chose these communities to 
achieve a balanced recruitment of Hispanics/Latinos from across the US and countries of origin [137]. 
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Within the communities, they selected census tracts based on their proximity to the field center clinic 
(one in each of the four cities) and to achieve a broad demographic representation, additionally cross-
stratifying by high vs. low concentration of Hispanic/Latino residents and high vs. low SES [136]. To 
recruit individuals, a letter is sent to the selected household, individuals within the household are 
contacted and screened for eligibility (living in the household, age 18-74, able to attend a clinic visit, 
and not planning to move within 6 months)[136].  Screened individuals then attend a study visit at the 
field center clinic where they review/sign the consent documents and participate in study assessments. 
 
External validity   
The HCHS/SOL sampling strategy ensured generalizability to Hispanics/Latinos in the selected 
communities. However, because HCHS/SOL recruits only from urban areas and their surrounding 
counties, generalizability does not extend to all Hispanics/Latinos in the US.   
 
HCHS/SOL cohort quality control procedures   
The HCHS/SOL cohort staff consists of a central Coordinating Center and four Field Centers.  
Overall data collection procedures are presented in the Field Center Procedures Manual.  Procedures 
include steps for the following:  1) sampling and recruitment, 2) safety screening 3) scheduling study 
visits, 4) obtaining informed consent, 5) participant flow, and 6) administration of each element of 
data collection and management.  All HCHS/SOL field center technicians were fully trained and 
certified in the procedures, passing a training exercise with a score of at least 80%.  In addition, with 
the approval of the study participant, interviews were audio-recorded and randomly selected for 
reviewed by Field Center supervisors and Central Coordinating Center monitors.  Discrepancies were 
brought to the attention of the Quality Control Committee for corrective action.   
Medication inventory   
For the medication use inventory, participants in HCHS/SOL were asked to bring in all 
medications they had taken in the past four weeks, including herbal remedies, to their study 
appointment.  Upon their arrival at the appointment, a staff member captured product information 
with a barcode scanner.  The staff member copied down information for any product that did not 
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successfully scan, including the UPC/NDC code, name and strength.  Data was entered into a Medispan 
MDDB database with Micromedex and Lexicomp products in Spanish added. Coding success was close to 
100% for single-ingredient products and many botanical supplements are listed in the database.  If 
individuals did not bring their medications, staff attempted to obtain the medication information by 
telephone. 
Medications and other medicinal products were classified by their indication and drug classes.  
Misclassification could occur if the individual is taking a product for a different indication.  Botanical 
supplements not in the MDDB database were to have been recorded on the data form verbatim, usually 
in Spanish. These supplements required review and coding by trained healthcare professionals 
(physicians, pharmacists, physician assistants).  
Dietary Supplement Interview and Dietary Recall 
A second assessment of botanical supplements occurs with the dietary supplement interview.  
At the time of the visit to the field center clinic, clinic technicians interviewed participants about 
botanical supplements use over the 24 hours and 30 days prior to the study visit.  Dietary interviewers 
were to have had access to the medication inventory, but data sharing was said to be uncommon.   
With or without the medication inventory, dietary interviewers asked the interview questions about 
botanical use.   After dietary interviewers obtained the dietary information, through a 24-hour recall, 
they asked individuals ten questions about dietary supplement use, including one question about 
botanical supplements:  “Did you take any products containing one or more herbal or botanical 
ingredients like Echinacea, ginseng, ginkgo or St. John’s Wort?”  Next, they reviewed label information 
for any supplements brought to the interview.  Interviewers also asked participants how much of the 
product they took, how long they had taken it, and why they took the product.  The dietary 
interviewers inquired about use of herbal teas during the dietary recall, although this inquiry covered a 
24 hour period only.  A second dietary recall was conducted by telephone within 45 days of the first 
assessment.  During the second dietary recall, only supplement use over the past 24 hours was 
assessed. 
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Dietary interviewers entered data directly into the Dietary Supplement Assessment Module 
(DSAM) Nutrition Data System for Research database (NDSR).  Botanical supplements that did not match 
in the DSAM, were captured with information from the product label, listed as “Missing Dietary 
Supplement Products” and saved as DSAM User Products to be validated against outside resources.   
4.2 Categorization of Dietary Supplements 
Supplements reported in the medication inventory and the dietary supplement interviews were 
examined in detail.  The first step was to categorize supplements as botanical products, botanical-
containing products, or other non-vitamin, non-mineral dietary supplements in both the medication 
inventory and the dietary recall.  For this work, it was necessary to obtain label information for the 
dietary supplement products in both files.   
To categorize the dietary supplements, the Langual categorization system for dietary 
supplements as proposed by Saldanha, Dwyer et al. (2011) was adapted [138].  Coded product facets 
included product type (Facet A), physical form (Facet E, with collapsed categories), and ingredients 
(Facet H) (TABLE 4.1).   Coding using the Langual system moves from the broad to the specific.  
Hence, product types were coded with three levels.  The first identified the product as a prescription 
medication, dietary supplement, over-the-counter medication, or other (topical products).  The second 
level identified the dietary supplement products in 10 different categories:  vitamin, mineral, 
botanical, amino acid or protein, other supplement type, metabolite, combination product, unknown, 
homeopathic, or other.  The third level identifies the supplement components more specifically. 
Individual ingredients common in the dataset and of potential value to the goals of the Hispanic 
Community Health Study/Study of Latinos (HCHS/SOL) were captured.  Specifically, because HCHS/SOL 
focuses on tracking cardiovascular and metabolic outcomes, products containing supplements marketed 
for these outcomes (e.g., Coenzyme Q-10, Omega-3 fatty acids) or with reported concerns about 
adverse reactions (e.g., Glucosamine) were identified (TABLE 4.2).  
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TABLE 4.1.  Product characteristics coded in the medication inventory and dietary supplement 
interview data from HCHS/SOL 
Prod_type1 Prod_type2 Prod_type3 Phys_Form 
1 medication 
  
1. Tablet/caplet /capsule/soft gel/gummies 
2 DS 
  
2. Liquid (alcohol-based (tincture, tonic)  
3 OTC 1. Vitamin 
 
3. Liquid (water-based (syrup, liquadas) 
4 other 
 
1. single 4. Tea bags 
  
2. multiple vitamins 5. Other raw herb 
 
2. Mineral 
 
6. Other (Powders or Bars, etc.) 
  
1 single 7. Unknown 
  
2 multiple 8. other 
 
3. Herbal/botanical or herbal extract 
 
  
1 yeast 
 
  
2 algae 
 
  
3 fungus 
 
  
4 single botanical (added) 
 
  
5 multi-botanical (added) 
 
 
4. Amino acid/protein 
  1 single or multiple 
    
 
5. Other dietary substance to supplement the diet  
  
1. fiber 
 
  
2. enzymes 
 
  
3. probiotic bacteria 
 
  
4. other 
 
 
6. Metabolite, constituent, extract, isolate, or combination of any of these  
  
1. hormone precursors 
 
  
2. steroid precursors 
 
  
3. 7-dehydrocholesterol, phospholipids 
  
4. lutein, lycopene and similar (carotenoids) 
  
5. omega-3 fatty acids (fish oil, flax oil) 
  
6  omega 6 fatty acids  
  
7. Omega 3 & 6 fatty acids  
  
8. Co-Q10 
 
  
9. Glucosamine, Chondroitin, MSM (including Hyaluronic acid) 
  
10. other metabolite 
 
 
7. Combination of any of the above ingredients listed in 1– 6 above 
  
1. MVM x 
 
 
 2. Mineral(s) & botanical 
 
  
3. MVM & amino acids 
 
  
4. MVM & botanical 
 
  
5. MVM & fatty acids 
 
  
6. Vitamin(s) & botanical 
  
7. Vitamin(s) & fatty acids 
  
8. Other not listed above 
8. Unknown   
  88 unknown 88 unknown 
 9. Homeopathic 
  99 homeopathic  
 111 other 111 other 111 other 
Abbreviations:  Prod_type1 codes the broad product type:  medication (prescription), dietary supplement (DS), non-prescription 
medications, and other:  primarily  topical products (by definition, excluded as dietary supplements.  Prod_type2 narrows the 
description as per Saldanha (2012) and Prod_type3 provides an additional level of detail.  MVM=Multivitamins with minerals  
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TABLE 4.2.  Ingredients coded from product name data in the medication inventory and dietary 
supplement interview files 
Product Ingredients Product Ingredients 
Alpha-lipoic acid Mineral 
Amino acids Minerals 
Bioflavonoids (citrus bioflavonoids, soy isoflavones, 
quercetin, rutin) MSM 
Botanicals Multi-botanical 
Chondroitin Multi-vitamin 
Cod liver oil (coded as an omega-3) Omega-3 
Coenzyme Q-10 Omega-6 
Collagen (coded as a protein when separate) Omega-3-6-9 
Fiber Phospholipid 
Fungus Phytosterols 
Glucosamine Probiotic 
Homeopathic  (regardless of constituents) Propolis  ( bee pollen, propolis, royal jelly) 
Hormone precursor Protein 
Lipotropic Vitamin 
Lutein  
Lycopene  
Metabolite-other   
 
 
4.3 Outcome Definitions: Dietary Supplement Variables 
   The proposed descriptive analysis reported botanical supplement prevalence estimates as 
assessed by the medication history and by the dietary recall assessment, both separately and as an 
aggregate and with the inclusion of botanical teas (from the 24-hour dietary recall).   
Analyses were based on multiple definitions of botanical supplement use:  1) dietary 
supplement products alone, as captured in the dietary supplement interview, dietary products (with a 
few additional bulk botanicals) as captured in the medication inventory, and products from the dietary 
supplement interview plus dietary botanical teas and nopal as captured in the dietary recall.  The 
latter definition was inclusive of herbal teas and other herbal food-based products, such as liquadas, 
Herbalife-brand liquid supplements with botanicals, but excluded botanicals included in “energy 
drinks” (difficult to identify in this dataset).  The rationale for this added step was that some herbal 
teas (e.g., chamomile, estafiate) and herbal liquadas (e.g., aloe, nopal) have documented biologic 
activity, may have toxic properties, and may interact with medications [5, 83, 139]. 
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TABLE 4.3.  Primary dietary supplement variables  
Variable name Description Operalization 
rxwbot_any 
dywbot_any 
eiwbot_any 
dywbot24_any 
eiwbot24_any 
dywbotf_any 
eiwbotf_any 
Use of any product with a plant-based substance reportedly used for the 
prevention of disease or the treatment of symptoms, interim illnesses, or 
diseases.  Use by this definition was derived from the medication 
inventory (rx), dietary supplement  interview (dy) following the recall, the 
dietary supplement interview plus 24-hour (bot24) dietary recall data and 
combined medication inventory and dietary supplement interview data (ei).  
An additional variable assigned all fiber products to botanicals (botf). 
Any use (1) vs. 
no use (0) 
rxpbot_any 
dypbot_any 
eipbot_any 
 
Many products contain a mixture of ingredients.  Definitions were also 
created to capture products that were primarily botanicals with < 50% of 
the recommended daily allowance (RDA) for any listed vitamin or mineral.    
Use by this definition was derived from the medication inventory (rx),  the 
dietary supplement interview (dy), and either (ei).   
Any use (1) vs. 
no use (0) 
rxwnvnm_any 
dywnvnm_any 
eiwnvnm_any 
dywnvnm24_any 
eiwnvnm24_any 
Use of any non-vitamin, non-mineral dietary supplement, including 
botanicals.  Use by this definition was derived from the medication 
inventory (rx), dietary supplement  interview (dy) following the recall, the 
dietary supplement interview plus 24-hour (xxxx24) dietary recall data and 
combined medication inventory and dietary supplement interview data (ei). 
Any use (1) vs. 
no use (0) 
rxwpvnm_any 
dypnvnm_any 
eipnvnm_any 
 
Use of any dietary supplement that is primarily non-vitamin, non-mineral 
(with < 50% RDA of a vitamin or mineral). Use by this definition was 
derived from the medication inventory (rx), dietary supplement interview 
(dy) following the recall, the dietary supplement interview plus 24-hour 
(nvnm24) dietary recall data and combined medication inventory and 
dietary supplement interview data (ei).   
Any use (1) vs. 
no use (0) 
rxds_user 
dyds_user 
eids_user 
 
Identifies users of any dietary supplement, whether vitamin, mineral, 
botanical, or other NVNM. 
Any use (1) vs. 
no use (0) 
ingxxx variables Specific botanical and NVNM ingredients were captured from the DSAM, 
based on the dietary data alone. 
Any use (1) vs. 
no use (0) 
ffxxx variables Specific botanical ingredients (botanical teas, nopal) were captured from 
the 24-hour recalls 
Any use (1) vs. 
no use (0) 
DSAM=Dietary supplement assessment module of the NDSR 
 
Because standard definitions are lacking, prevalence estimates were calculated for all of the 
classifications of botanical supplements delineated in Table 4.3.  These include estimates based on 
both broad and narrow definitions of botanical supplement use:  1) including botanical teas; 2) 
including all fiber products; 3) including all NVNM products; 4) limiting to commercially-available 
botanical supplement products alone.    Distinctions were also made between products that contained 
a botanical or NVNM ingredient (such as a multivitamin, multi-mineral with ginseng or lutein) and 
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products that were primarily botanicals or NVNM that had incidental vitamin or mineral ingredients.   
Overall dietary supplement use was also captured.   
TABLE 4.4.  Additional dietary supplement variables 
Variable Name Description Operalization 
rxwbot_2plus 
dywbot_2plus 
eiwbot_2plus 
rxwbot24_2plus 
dywbot24_2plus 
eiwbot24_2plus 
eiwbotf_2plus 
 
Variables identify users of 2 or more products with botanical ingredients.  
Use by this definition was derived from the medication inventory (rx), 
dietary supplement  interview (dy) following the recall, the dietary 
supplement interview plus 24-hour (bot24) dietary recall data and 
combined medication inventory and dietary supplement interview data (ei).  
An additional variable assigned all fiber products to botanicals (botf). 
Any use (1) vs. 
no use (0) 
rxwnvnm_2plus 
dywnvnm_2plus 
eiwnvnm_2plus 
dywnvnm24_2plus 
eiwnvnm24_2plus 
 
Variables identify users of 2 or more products with botanical or other 
NVNM ingredients.  Use by this definition was derived from the medication 
inventory (rx), dietary supplement  interview (dy) following the recall, the 
dietary supplement interview plus 24-hour (nvnm24) dietary recall data 
and combined medication inventory and dietary supplement interview data 
(ei). 
Any use (1) vs. 
no use (0) 
rxds_3plus 
dyds_3plus 
eids_3plus 
 
Identifies users of 3 or more dietary supplements of any type, whether 
vitamin, mineral, botanical, or other NVNM. 
Any use (1) vs. 
no use (0) 
rxpowds_user 
dypowds_user 
eipowds_user 
Identifies users of powdered (or wafer) dietary supplements by the 
medication inventory, the dietary supplement interview, or both. 
Any use (1) vs. 
no use (0) 
rxliqds_user 
dyliqds_user 
eiliqds_user 
Identifies users of liquid (or teabag) dietary supplements by the 
medication inventory, the dietary supplement interview, or both. 
Any use (1) vs. 
no use (0) 
rxcaptabds_user 
dytabds_user 
eitabds_user 
Identifies users of tablet (or capsule) dietary supplements by the 
medication inventory, the dietary supplement interview, or both.  Any 
encapsulated product was classified in this category. 
Any use (1) vs. 
no use (0) 
 
Users of multiple botanical or NVNM supplements may constitute a different population than 
the occasional or casual user [86].   Hence, additional analyses assessed the prevalence of the multiple 
supplement user, defined as use of 3 or more dietary supplements and by 2 or more botanical or NVNM 
supplements.  To further characterize supplements, the physical form of the supplement was captured 
(tablet or capsule, liquids or teas, powders or wafers).  For all supplement types, a variable was 
created that identified the number of supplements each individual takes. 
Individual botanicals were extracted from the ingredient files associated with the dietary 
supplement interview. Hence, a person was classified as a user of the particular botanical if any of the 
products consumed contained that botanical.   
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Motivations for botanical supplement use 
In the dietary supplement interview, individuals were asked why they were taking a particular 
supplement.  These reasons for use of supplements were extracted from the dietary supplement 
interview files and categorized into reported use for 19 different conditions (anemia, allergy, low 
appetite, cancer, diabetes, eye health, indigestion, gynecological conditions, heart health, kidney 
disease, joint health, liver health, lipid abnormality, lung disease, pain, prostate problems, sexual 
problems, thyroid health, mental stress),  to supplement the diet, for prevention of health problems 
(bone health, immune system, healthy aging, general health, bowel health/digestion, mental clarity), 
and for nonspecific reasons.  In addition, some participants indicated that the supplement had been 
recommended by a healthcare provider or by a family member or friend. 
4.4 Covariate Assessments  
Hispanic/Latino background 
 The primary variable of interest is Hispanic/Latino background.  The literature reports very 
little data on any variation by background group. The variable is assessed in the Personal Information 
Questionnaire.  In addition to inquiries about their place of birth, participants were asked, “Which of 
the following best describes your Hispanic/Latino heritage?” Response choices include both citizen of 
country or heritage, e.g., Dominican or Dominican descent.  The proposed analysis variable will 
examine patterns of botanical supplement use by cultural background (Puerto Rican, Dominican, 
Cuban, Mexican, Central or South American or other Hispanic/Latino).  
Acculturation 
 A key variable is acculturation, assessed as in the HCHS/SOL Sociocultural Questionnaire.  The 
first 6 questions assess use of Spanish vs. English language, the second four address preferences for 
spending time with Hispanics/Latinos vs. non-Hispanics, and the third two items assess ethnic identity.  
The HCHS/SOL Sociocultural Questionnaire is based on the Short Acculturation Scale for Hispanics 
(SASH)[140], a 12-item scale validated with multiple Hispanic/Latino groups in California, Florida, and 
Wisconsin.  Three factors in the scale, Language Use, Media, and Ethnic Social Relations achieved 
internal consistencies (Cronbach’s α) of 0.90, 0.86, and 0.78.  The scale discriminated first and second 
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generation immigrants and was highly correlated with both length of residence in the US and subjective 
evaluation of acculturation (ρ = 0.70, 0.76).  This variable is usually dichotomized at ≤2.99 (less 
acculturated), >2.99 (more acculturated) as per scoring instructions[141].  However, because 
HCHS/SOL altered the scale, per study guidelines, it was used as a continuous variable with a range 
from 1 to 4.  Additional acculturation variables included years of US residence and birthplace within 
the US. 
Access to healthcare 
Current insurance status formed one variable:  any vs. no insurance.  A second variable will 
identify perceived lack of care access in the Health Care Use questionnaire, based on the question:  
“Have you been unable to get healthcare when you needed it? “  
Medication use   
Medication use was captured from the participant derived files.  This included any use of 
medications for target conditions:  cardiovascular disease, metabolic disease, lung disease and kidney 
disease.  For this analysis, use of medication was dichotomized to any use of target medications and no 
target medication use.   
Chronic disease  
The HCHS/SOL Medical History captured chronic medical illness, including hypertension, heart 
disease, diabetes, lung disease, and kidney disease, among others.  In botanical supplement literature, 
association or predictive models usually include a measure of chronic disease, most often the number 
of chronic conditions reported, (either as a continuous or a categorical variable) [2, 34, 126, 142].  The 
association between conditions captured in HCHS/SOL and botanical supplement use was explored.  A 
simple index was created assigning a value of 1 to any of the conditions captured in the participant-
derived files, except end-stage kidney disease.  Following the Charlson Index, this condition was given 
a value of 2 [143].  Associations with the derived index were based on a score of 0, 1 or 2.  
Perceived health   
In other studies of botanical supplement use, individuals with poor perceived health are more 
likely to consume botanical supplements than those who perceive their health as good [15].  It is 
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unknown whether or not these patterns apply to Hispanic/Latino populations.  In HCHS/SOL, perceived 
health is measured with the Medical Outcomes Study 12-item Short Form (SF-12), a common measure in 
health research validated in numerous populations [144].    To maintain consistency with other studies, 
the first question of the scale was used (“Compared with a year ago, how would you rate your current 
health” –excellent, very good, good, fair, poor).   It was categorized as very good to excellent, good, 
and fair to poor). 
Demographics, income, and education 
The HCHS/SOL cohort protocol included a thorough assessment of demographics and health 
behaviors. Demographics variables and their derivation and potential categories are listed in 
TABLE4.3.  Prior studies have documented a consistent association between age and botanical 
supplements use with prevalence peaking in the 45-64 age groups, but the peak has been found to be 
later among Hispanics/Latinos [145].  Because the relationship between age and botanical supplement 
use was non-linear, it was categorized according to age groups defined in NHANES. 
Education and income have been consistently associated with supplement use in the general 
population [122, 146], but the associations within Hispanic populations have been less consistent.  
Education was derived from reported years of schooling and categorized as less than a high school 
graduate, high school graduate or equivalent, and post-secondary education.   
Income was derived from the midpoint of the reported family income categories, expressed as 
a percent of the published poverty threshold based on the family size and year of the field center clinic 
visit.  Because supplement use is known to vary by geographic location within the US [122], field center 
location was also be examined. 
Health behaviors 
 Positive health behaviors have been associated with dietary supplement use, including 
abstaining from cigarette smoking, getting physical activity, and adopting healthy dietary patterns 
[147, 148].   In addition, botanical supplement users are less likely to smoke than those not using 
botanicals [119].   In HCHS/SOL, cigarette smoking was ascertained via self-report.  Participants were 
asked, “Have you ever smoked at least 100 cigarettes in your entire life?”  If they answered yes, they 
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were asked if they are current smokers.  The variable is categorized as current smokers, former 
smokers, and never smokers.  For most analyses, current nonsmokers were identified. 
Physical activity assessment was based on variables from the global physical activity 
questionnaire as developed by the World Health Organization.  Participants were asked how often and 
how long they engage in moderate and vigorous physical activity at work, for transportation (e.g., 
cycling, walking), and recreational activity.  For the purposes of this analysis, physical activity was 
dichotomized as meeting or not meeting the 2008 physical activity recommendations of the Centers for 
Disease Control and Prevention [149].   The guidelines call for 150 minutes of moderate physical 
activity and/or 75 minutes of vigorous physical activity per week.   
Eating patterns were summarized with the Alternative Healthy Eating Index-2010 (AHEI-2010).  
The AHEI was developed to update prior healthy eating indices based on US Dietary Guidelines with 
recommendations derived from scientific studies of diet and health outcomes [150, 151].  The AHEI 
assigns values for consumption of vegetables, fruit, whole grains, sugar-sweetened beverages, 
nuts/legumes, red/processed meats, trans fat, long-chain n-3 fatty acids, total polyunsaturated fatty 
acids, sodium, and alcohol intake  with a maximum value of 110 [151].  In the Women’s Health 
Initiative, the mean AHEI was 38.2;  the mean for Hispanics was slightly lower at 34.5 [152].  In 
contrast, the mean AHEI in the Nurses’ Health Study was 50.6. 
TABLE 4.5. Additional variables  
 
4.5 Analysis Procedures for Specific Aim 1 
  After construction of the dietary supplement data files, they were examined for frequencies, 
missing data, and uncoded responses.   Uncoded responses were classified as delineated above.  Just 
over 100 products required additional identification by José Rivera, PharmD, an expert in botanical 
medicine among Hispanics/Latinos.  Twenty-nine products from the medication inventory could not be 
identified; 57 from the dietary supplement inventory.    
Covariate HCHS/SOL 
questionnaire 
Item  Potential categories 
Gender Personal Information Gender Male, Female 
Geographic area  Field Center location Miami, Bronx, Chicago, San Diego 
Season of the year Exploratory Date of visit Spring, summer, fall, winter 
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Once all potential botanical supplements were identified, they were classified as belonging or 
not belonging to the dietary supplement classifications: botanical dietary supplement by each 
definition and by each assessment instrument (medication inventory, dietary supplement interview 
with and without dietary recall data, either the medication inventory or the dietary supplement 
interview).  Each HCHS/SOL participant was classified as a botanical supplement user, based on his or 
her use of any botanical supplement over the past 30 days by the various definitions (TABLE 4.3). 
Prevalence estimates were calculated separately for dietary supplement and botanical supplement use 
under each definition and by each assessment instrument.  All prevalence estimates were adjusted 
with HCHS/SOL-provided sample and nonresponse weights and standardized to the age distribution of 
the 2010 US Census.   
 
Compare prevalence estimates of botanical supplement use between the medication inventory 
and the dietary supplement interview across categories of supplements  
An important assumption was required for the analysis.  Despite the fact that the dietary 
supplement interviewers had access to the medication inventory data, we presumed that, as per 
protocol, the dietary recall interviewers asked each participant about their supplement use, regardless 
of any botanical supplements reported with the medication inventory, and that they refrained from 
prompting if negative responses are contradicted by the medication inventory.  This enabled us to 
compare the medication inventory prevalence estimates with the dietary recall estimates and assess 
the concordance of the two with a Cohen’s kappa statistic.   Please see Chapter 6 for analysis details.   
 
4.6 Analysis of Specific Aim 2:  Estimate population characteristics and use patterns associated with 
botanical supplement use among Hispanics/Latinos with particular attention to: 
a. Hispanic/Latino background, as defined by country of origin (Cuba, Puerto Rico/Dominican 
Republic, Mexico, Central/South America;  
b. Acculturation (language preference, years in US, born in US);  
c. Access to healthcare (insurance status, perceived lack of access);  
d. Health indicators (medication use and perceived health):  
e. Health behaviors(smoking, physical activity, healthy eating pattern); 
f. Demographics (age, gender, education, income, geographic area):  
g. Season of the year and area of the US 
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FIGURE 4.1. Schematic of research plan for Aim 2 
  
 
4.6 Analysis Procedures for Specific Aim 2  
The goal of the analysis was to characterize botanical supplement users across definitions 
(botanical supplement product use, botanical supplement products with teas, and botanical 
supplement products with other NVNM supplements) with particular attention to Hispanic/Latino 
background.  Other than the 2007 NHIS report for the use of “biologically-based Complementary and 
Alternative Medicine” [122], distributions of botanical supplement use across Hispanic/Latino 
background groups has not been reported.  No published manuscripts have examined the distributions 
of characteristics of botanical supplement users across Hispanic/Latino background.   
For this analysis, all variables were examined for distributions across Hispanic/Latino 
background.  Stratification of variables by age, gender, acculturation, and Hispanic/Latino background 
was investigated to examine the potential for effect modification. Based on these exploratory analyses 
along with examination of the impact of interaction terms in the models, decisions were made 
regarding including the need to present stratified analyses.  Sample size considerations necessitated 
collapsing categories and presenting non-stratified results.  All analyses were conducted in Stata 13 
(StataCorp, LP, College Station, TX) with survey analysis commands applying sample and non-response 
weights.  Additionally, bivariate distribution analyses were standardized to the age distribution of the 
US 2010 Census.   
Aim 1: Botanical prevalence  
estimation 
Combined HCHS/SOL 
botanical prevalence 
i  
Demographics 
Age, gender, Hispanic-Latino 
background 
 
Confounding/Modifying 
variables 
(Demographics, including 
Hispanic/Latino background) 
 
 
 
Medication Inventory 
Botanical assessments 
   
 
   
   
  
 
Health indicators: Medication use 
Perceived health 
 
Insurance, Perceived Access to Care 
Dietary Supplement 
Interview Assessment 
   
 
   
   
  
 
Economic factors:  percent of poverty 
Aim 2: Assess factors associated with 
botanical use among Hispanics 
24-hour Dietary Recall 
Assessment 
   
 
  
  
  
  
 
Health behaviors: Smoking, dietary 
behaviors, physical activity 
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Multivariate binomial regression  
After examining relationships among the variables, binomial regression analyses were used to 
examine the characteristics of botanical supplement users in HCHS/SOL.  Definitions of botanical 
supplement use included botanical products (including fiber products), botanical products plus 
botanical teas, and all NVNM supplements.  Each of these definitions relied on defining a supplement 
user as one who reported use either by the medication inventory or the dietary supplement interview.  
The sample was restricted to individuals with complete data for all variables of interest (see Chapter 7) 
utilizing Stata survey subpopulation commands to ensure appropriate adjustment of standard errors.   
Two types of models were constructed.  The first employed logistic regression to identify 
variables independently associated with botanical supplement use across the three definitions.    
Models including age, Hispanic/Latino background and gender were examined for odds ratio 
modification by including interaction terms.  Interaction terms were dropped from the model if they 
were jointly not significant at the p=0.05 level using a partial F test.  Additional stratified models were 
then examined, but only those that had an impact on the interpretation were retained.  Otherwise, 
only summary models were reported.  After interactions between age, gender, and background were 
assessed, all other variables were added to the model.  Variables that did not contribute significantly 
to the model (partial F test) were dropped.  Because field center location was expected to be an 
influential variable and was too collinear with Hispanic/Latino background to include in models, the 
variable cross-classifying field center and Hispanic/Latino background was substituted into models.   
Most model evaluations employed survey procedures.  However, because survey procedures do 
not support model comparison statistics, goodness of fit (Hosmer-Lemeshow) and discrimination (area 
under the receiver operating curve) statistics were checked without the survey commands.   
The second modeling strategy was designed to examine the relationship between each of the 
sample characteristics and botanical supplement use.  Here, log binomial models were created 
adjusting only for those variables identified as confounders in a directed acyclic graph. Non-
confounders, e.g. variables within the causal pathway between the variable of interest and botanical 
supplement use, were not included in models [153].  For example, models for this Hispanic/Latino 
background were controlled for age and gender.  Each model was examined for prevalence ratio 
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modification through the inclusion of interaction terms of all other variables in the model with the 
primary exposure term for the model.  The significance of these terms was tested jointly with a partial 
F test.  Retained interaction terms followed the same strategy as reported for the logistic models. 
Model adjustment strategies 
Minimally-sufficient adjustment sets were determined for the variables of interest.  
Particularly of interest was Hispanic/Latino background.  Based on published literature, the following 
assumptions were made in drawing up a directed acyclic graph (DAG)[154] (FIGURE 4.2): 
1) Hispanic/Latino background varies by age and gender; 
2) Age varies  by gender; 
3) Geographic location in the US is a function of Hispanic/Latino background and age; 
4) Acculturation, defined by the SASH scale, US birthplace and years in the US, is a function of 
age, gender, and field center location.   
5) Education is a function of Hispanic/Latino background (e.g., Cuban populations have 
greater education than Mexican) and is also influenced by age (older individuals acquired 
less education), gender, and acculturation (born in the US); 
6) Perceived health is a function of age, gender, and education; 
7) Positive health behaviors (non-smoking, healthy eating habits, physical activity) have been 
associated with increasing age, female gender, higher education, higher income, better 
perceived health, lower acculturation, and area of the country (western US)[147]; 
8) Income is a function of age, gender, education, and area of the US.  It may also be a 
function of Hispanic/Latino background, but that is likely to be secondary to differences in 
education, age, and area of the US [155]; 
9) Insurance coverage is a function of age,  income,  and area of the US [155]; 
10) Perceived access to care is a function of age, insurance coverage, and area of the US; 
11) Medication use is a function of age, insurance coverage, and area of the US. 
Given assumptions about the relationships of the variables, the web-based graphical tool, 
DAGitty, version 2.0, was used to verify minimally-sufficient adjustment sets (TABLE 4.6)[156].  Where 
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multiple adjustment sets were possible, the set without both Field Center and Hispanic/Latino 
background (highly collinear) was chosen. 
Table 4.6.  Minimally-sufficient adjustment set for key variables 
Exposure variables Minimally-sufficient Adjustment Sets 
Hispanic/Latino background Age, gender 
Age Hispanic/Latino background, Gender 
Health Behaviors Age, Gender, panic/Latino Background, Income, Insurance, Medication Use, 
Perceived Access to Care 
Perceived Health Acculturation, Age, Education, Gender 
Acculturation Field Center, age, Gender 
Education Acculturation, Age, Gender, Hispanic/Latino Background 
Field Center Age, Hispanic/Latino Background 
Income Age, Education, Field Center, Gender 
Insurance coverage Acculturation, Age, Field Center, Income 
Perceived healthcare access 
Acculturation, Age, Education, Gender, Hispanic/Latino Background, Income, 
Insurance, Medication Use (or Field Center, Insurance) 
Medication Use 
Age, Gender, Health Behavior, Hispanic/Latino Background, Income, 
Insurance, Perceived Access to Care 
 
 
Power estimation 
  The HCHS/SOL cohort enrolled 16,414 participants, 16,060 of whom could be included in the 
analysis of Aim1 and 13,786 in Aim 2.  With an expected prevalence of botanical supplements use 
between 0.15 and 0.25,   a 2-sided alpha of 0.05 and a complete case analysis, power was estimated to 
be adequate for the planned analyses (TABLE 4.6).   
 
TABLE 4.7.  Power estimates for analysis of characteristics of botanical supplement users 
Variable N total Measurement Ref. level Baseline  Difference  POR Power 
Background group 7680 Discrete groups Mexican 0.06 to 0.30 0.03-0.20 1.15 - 4.16 89-99+% 
Acculturation 7680 Quartiles 
More 
acculturated 0.1 to 0.25 0.025-0.15 1.14 - 3.00 89-99+% 
Insurance status 15360 None, any insurance 0.1 to 0.20 0.03 – 0.20 1.34 – 3.86 79-99+% 
Medication use 7680 0, 1+ No meds 0.10 to 0.20 0.03 – 0.30 1.34 – 6.00 79-99+% 
Perceived Health 15360 
Excellent/good 
vs. fair/poor 
Good to 
excellent 0.15 to 0.25 0.03 - 0.15 1.24 – 2.43 71-99+% 
 
 
 
 
 
FIGURE 4.2 Directed Acyclic Graph depicting variable relationships associated with botanical supplement use in HCHS/SOL
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CHAPTER 5:  EXPLORATORY AND SENSITIVITY ANALYSES 
5.1 Exploration of the Medication Inventory and Dietary Supplement Interview Data 
Medication inventory data 
The medication inventory data, first to be available for coding, utilized a database developed 
for medications—both prescription and over-the-counter—that categorizes substances by their primary 
indication.   Vitamins, minerals, and fatty acids were largely recorded as nutritional products, but 
botanical supplements showed up in several categories including nutritional products, bulk chemicals, 
gastrointestinal agents, lipid-lowering agents, alternative medicines, and miscellaneous natural 
products.  Identifying the botanicals required review of all of these files.  Approximately 1500 
substances were not identified by the medications database; many of these were found to be dietary 
supplement products (with and without botanicals). Of the 1500, twenty-nine could not be identified.  
An additional 1640 products could not be coded due to insufficient information (entered as “Nutritional 
Supplement” or “Misc. Natural Product” or “unknown”) resulting in an unknown status for <400 
individuals.  Because the medications database mixed botanicals into several classification categories, 
it was not possible to ascertain if these products contained botanicals. 
Ultimately, a dataset comprised of >10,000 entries was merged with the dietary supplement 
interview data and the file with derived variables.  Frequencies were calculated for total dietary 
supplement use by participant along with prevalence of use of multiple supplements, non-vitamin, non-
mineral supplements (including botanicals), and botanical products.   
Dietary supplement interview data 
A similar process was employed for the dietary data, released in December 2012.  The dietary 
supplements from the 30-day supplement interview were recorded in the dietary supplements module 
(DSAM) of the NDSR.   Released data included detailed supplement product names and/or descriptions, 
allowing for refined product coding using the Langual-based coding scheme.  Although the goal of this 
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project is distinguishing botanicals from non-botanicals, additional data on product constituents from 
the DSAM were considered potentially useful.  The coding scheme was reviewed and revised based on 
newly available data with increased granularity.  All but 57 of the78 unknown products were identified 
by Dr. Rivera resulting in an unknown status for 18 individuals.  The medication data was reexamined 
to ensure that the coding and product identification was consistent across the datasets.   
We found that the dietary supplement interview files did not record botanical teas.  Because 
we saw botanical teas in the medication inventory data, we requested the opportunity to review the 
food level files from the 24-hour recall data.  After gaining access to these files in June, we extracted 
multiple variables, including botanical teas (chamomile, hibiscus, herbal) and liquid dietary 
supplement products containing protein supplements, aloe, or nopal.  Individuals were counted as a 
supplement user if they consumed one of the products on either day.  We created datasets including 
and excluding green tea (Camilla sinensis) and nopal (whole fruit) as botanicals for this analysis. Liquid 
supplement products with nopal were included in both datasets.   
The dietary data contains approximately 2,700 different products representing > 15,000 
entries.  We estimated the prevalence of use of any dietary supplement, 3 or more dietary 
supplements, non-vitamin, non-mineral supplements, and botanical supplements based on the 30-day 
supplement files alone.  We repeated the analysis including botanical teas and other liquid 
supplements as captured from the food file data.  All estimates were adjusted with sample and 
nonresponse weights to reflect the Hispanic/Latino population in the four target areas, namely the 
Bronx, Miami, Chicago, and San Diego.  Prevalence estimates across different assumptions on what is 
counted and not counted as a dietary supplement, a non-vitamin, non-mineral supplement, and a 
botanical supplement were calculated (TABLE 5.3). 
Ingredient files 
 Ingredient files for the dietary supplement data also became available in June 2013.  The file 
contained 41, 096 entries for individual ingredients of reported dietary supplement products and 
classified them with the same schema used in NHANES (vitamins, minerals, botanicals, amino acids, 
and other).  There were differences in classification as compared with the Langual-based scheme (and, 
 
 
43 
 
possibly some misclassification).  However, it was useful for classifying individuals as users of 
supplements with various ingredients to identify the prevalence of specific botanical and other NVNM 
ingredients.  Because it was not possible to identify the components of the medication inventory data 
with the same level of granularity, the Langual-based categorization scheme was used for comparison 
of the medication inventory and dietary supplement interview. 
5.2 Comparison of Prevalence across Botanical Supplement Definitions 
 Preliminary exploratory analyses compared prevalence estimates across supplement 
definitions.  These preliminary comparisons were not restricted to individuals with data for  both the 
medication inventory and the dietary supplement interview, nor were they standardized to the age 
distribution of the US population (TABLE 5.1).This resulted in some differences as compared with 
tables in the following chapters.   
 The medication inventory alone captured fewer dietary supplements of any kind—about   25% 
compared with a prevalence of 38% from the dietary supplement interview.  Combining the two, i.e., 
counting as supplement users anyone who reported taking a supplement by either method, increased 
the prevalence of any supplement to about 42%.  Larger proportional increases were noted in other 
supplement categories.  For example, supplements with NVNM components by the dietary supplement 
interview were nearly double that of the medication inventory.  Adding botanical teas and other liquid 
supplements from the 24-hour dietary recalls (food files) tripled the estimates for botanical 
supplement use.   Similar patterns were present with comparisons of the users of 3 or more dietary 
supplements and 2 or more NVNM or botanical products.  More multi-supplement users were identified 
in the dietary supplement interview and these increased slightly with identification of a user by either 
instrument.  Not surprisingly, because the dietary recalls capture food-based supplements, not 
captured well by the other assessments, the prevalence of multi-botanical users increases more than 4-
fold with the addition of botanical teas.  Interestingly, there were fewer liquid supplements reported 
with the dietary supplement interview than with the medication inventory.  Many of these types of 
products were seen with the dietary recall files.  Contrary to expectation, very few raw botanicals 
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(e.g., bulk herbs) were captured in either the dietary supplement interview or the medication 
inventory.  Only scanning the food files for nopal increased those estimates.   
                 
 
 
 
 
 
TABLE 5.1 Prevalence of non-vitamin, non-mineral and botanical supplement use in the HCHS/SOL Cohort across datasets 
 
  
Medication 
Inventory 
 
Dietary 
Supplement 
Interview 
(no teas) 
 
Dietary 
Supplement 
Interview   
 With Dietary 
Recall data 
(excluding 
nopal/green tea) 
 
Dietary 
Supplement 
Interview   
 With Dietary 
Recall data (with 
teas- including 
nopal/green tea) 
Medication 
Inventory 
or 
Dietary 
Supplement 
Interview 
 
Medication 
Inventory or 
Dietary 
Supplement 
Interview plus 
Dietary Recall 
(with herbal teas, 
no nopal) 
Medication 
Inventory or 
Dietary 
Supplement 
Interview plus 
Dietary Recall 
 (with nopal & 
herbal/green tea) 
 Variable % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) 
 Any dietary 
supplement (DS) 24.7 (23.5, 26.0) 38.5 (37.1, 39.9) 42.3 (40.8, 43.8) 44.3 (42.8, 45.8) 42.5 (41.1, 43.9) 45.7 (44.2, 47.2) 47.4 (45.9, 48.9) 
 DS with any NVNM 
component 12.2 (11.5, 13.0) 23.7 (22.4, 30.0) 29.0 (27.6, 30.4) 31.8 (30.4, 33.3) 26.7 (25.4, 27.9) 31.6 (30.2, 33.0) 34.1 (32.7, 35.9) 
 DS primarily  
NVNM 10.6 (10.0, 11.4) 18.3 (17.2, 19.4) 24.3 (23.0, 25.6) 27.5 (26.1, 28.9) 20.9 (19.8, 22.1) 26.5 (25.2, 27.8) 29.5 (28.1, 31.0) 
 DS with any 
botanical 
component 
4.3 (3.9, 4.7) 8.9 (8.2, 9.7) 15.1 (14.1, 16.2) 19.1 (17.9, 20.4) 11.1 (10.3, 11.9) 17.0 (15.9, 18.1) 20.8 (19.6, 22.1) 
 Primarily botanical 
products 3.3 (3.0, 3.6) 5.6 (5.1, 6.2) 12.2 (11.3, 13.1) 16.6 (15.5, 17.7) 7.3 (6.7, 7.9) 13.6 (12.7, 14.6) 17.9 (16.8, 19.1) 
         
 Use of 3+ DS 6.2 (5.6,6.8) 9.4 (8.7, 10.2) 8.8 (8.7, 11.1) 12.1 (11.3, 13.1) 10.9 (10.2, 11.8) 8.7 (8.6, 8.8) 13.4 (12.5, 14.3) 
 Use of 2+ NVNM  3.1 (2.8, 3.5) 5.1 (4.6, 5.8) 9.1 (8.3, 9.9) 9.8 (9.0, 10.7 6.3 (5.7, 6.9) 9.9 (9.1, 10.7) 10.6 (9.8, 11.5) 
 Use of 2+ DS with 
botanicals 0.9 (0.8, 1.1) 2.1 (1.9, 2.4) 5.1 (4.6, 5.7) 5.6 (5.0, 6.2) 2.6 (2.3, 2.9) 5.5 (5.0, 6.1) 6.0 (5.4, 6.6) 
 Use of 2+ botanical 
products 0.7 (0.6, 0.8) 1.2 (1.0, 1.4) 4.1 (3.6, 4.5) 4.2 (3.7, 4.7) 1.6 (1.4, 1.8) 4.4 (4.0, 4.9) 4.5 (4.1, 5.0) 
         
 Liquids/Teas* 3.4 (2.7, 4.2) 1.1 (0.7, 1.7) 19.1 (17.6, 20.6) 24.6 (23.1, 26.2) 2.9 (2.4, 3.6) 19.0 (17.6, 20.4) 24.1 (22.7, 25.6) 
 Powders* 25.7 (26.7, 27.8) 30.7 (28.9, 32.6) 31.0 (29.8, 33.2) 30.8 (29.2, 32.6) 33.0 (31.2 , 34.8) 33.6 (31.9, 35.3) 33.0 (31.3, 34.7) 
 Tablets, capsules* 88.5 (86.7, 89.9) 89.9 (88.7, 91.1) 82.4 (81.0, 83.7) 78.8 (77.4, 80.3) 90.4 (89.2, 91.5) 84.5 (83.2, 85.7) 81.5 (80.1, 82.7) 
 Other form (e.g., 
raw herb) 1.4 (0.9, 2.2) 0.1 (0.04, 0.3) 0.1 (0.05, 0.3) 5.6 (4.8, 6.7) 0.9 (0.6, 1.4) 0.9 (0.6, 1.3) 6.0 (5.1, 7.0) 
Abbreviations::  DS—dietary supplements; NVNM—non-vitamin, non-mineral products, including botanicals. 
†Proportions are adjusted by sample and nonresponse weights. * reflects proportion of supplement users who reported us e of at least one product in this category.  
Note:  estimates in this table were not corrected with new information and were not restricted to comparisons of individuals who had data for both measures.
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5.3 Sensitivity Analyses:  Assignment of Unclassifiable Supplements to NVNM and botanical 
categories 
Incomplete product identification in the medication inventory data limited the ability to make 
the datasets entirely comparable.  To assess the impact of products that could not be compared (set to 
missing in all but total dietary supplement analysis), additional analyses were completed assigning 
random samples of those products to supplements with NVNM and botanical ingredients.    
Statistical analysis 
First, the 1640 uncoded products were identified.  Second, the proportion of the total 
supplements belonging to each category of NVNM and botanical supplement was defined.  Third, a 
random sample corresponding to 33% of those uncoded supplements was assigned to the category of 
products with NVNM ingredients.  Correspondingly, 25% of supplements were assigned to the category 
of a primarily NVNM supplement, 17% were assigned to a category of supplements containing a 
botanical ingredient, and 12.5% were assigned to the category of a primarily botanical supplement.    
Additional samples increased the percentages of supplements assigned to each category as follows:  1) 
67-100% was assigned as products containing a NVNM; 2) 50-75% of products were assigned as a 
primarily NVNM product; 3) 17-50% of products were assigned as containing a botanical; and 4) 12.5-
37.5% of products were assigned as primarily botanical products.  The dataset was then restructured to 
identify supplement users rather than individual supplements.  Prevalence and kappa statistics were 
recalculated for each of the new datasets.  This process was repeated with 5 additional random 
samples.  All comparisons were restricted to participants who had data for both the medication 
inventory and the dietary supplement interview. 
Results and interpretation 
Assignment of random samples of those supplements that could not be coded to botanical 
reduced the discrepancy between the prevalence as assessed by the dietary supplement interview and 
that of the medication history.  For example, if half of the uncoded supplements actually had a 
botanical ingredient, the prevalence of supplements with a botanical as ascertained by the medication 
inventory increased to 7.0-7.5% as compared with 9.4% by the dietary supplement interview (TABLE 
5.2).  If 37.5% of those supplements were actually primarily botanical products, their prevalence in the 
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medication inventory might exceed their prevalence in the dietary supplement interview (5.9-6.4 vs. 
5.9%).  Similar reductions in the discrepancies were seen for supplements with NVNM ingredients and 
primarily NVNM supplements.  The discrepancy between the two assessments remained fairly large 
(16% vs. 25%), even if all of the uncoded supplements were assigned to the category of supplements 
with NVNM ingredients. Interestingly, concordance statistics improved slightly, but remained in the fair 
to moderate range (κ: 0.34-0.59).  Results suggest that the unclassifiable supplements did not have a 
major influence on the interpretation of the comparison between the medication inventory and dietary 
recall.  
TABLE 5.2. Sensitivity Analysis:  Comparison of 30-day NVNM and botanical assessments 
through the medication history and dietary supplement questionnaire in the HCHS/SOL Cohort*  
  
Medication  
Inventory 
Dietary 
Supplement 
Interview 
 
Kappa 
 
Variable % (95% CI) % (95% CI) (95% CI) 
DS with any NVNM component 12.9  24.6  0.50  
   33% of missing set to NVNM 14.2 – 14.3  0.42 - 0.45 
   67% of missing set to NVNM 15.1 – 15.3  0.46 – 0.47 
   100% of missing set to NVNM 16.0   0.47 
DS primarily  NVNM 11.3  19.0  0.49  
   25% of missing set to NVNM 12.3 – 12.4  0.50 
   50% of missing set to NVNM 13.7 - 13.8  0.50 -0.51 
   75% of missing set to NVNM 13.7 – 14.5  0.51  
DS with any botanical component 4.4  9.4  0.30  
   17% of missing set to botanical 5.5 – 5.7  0.32 – 0.34 
   33% of missing set to botanical 6.4 – 6.6  0.34 – 0.36 
   50% of missing set to botanical 7.0 – 7.5  0.35 – 0.37 
Primarily botanical products 3.5 5.9  0.32  
   13% of missing set to botanical 4.1 - 4.4  0.34 – 0.37 
   25% of missing set to botanical 4.8 – 5.1  0.37 – 0.39 
   38% of missing set to botanical 5.9 – 6.4  0.38 – 0.40 
Abbreviations:  DS—dietary supplements; NVNM—non-vitamin, non-mineral products, including botanicals; MH—medication 
history; DS—dietary recall 
†Proportions are adjusted by sample and nonresponse weights and are age-standardized to the 2010 Census distribution for 
Hispanics/Latinos 
*Analysis is restricted to subjects with data for both the medication inventory and the dietary supplement interview.  Estimates 
are based the range across six random samples.  Ideally, 1000 samples would be examined.   
 
 
 
 
48 
 
5.4 Bivariate Analyses 
Defining supplement users by their reported use in either the medication inventory or the 
dietary supplement interview, bivariable patterns were explored across a number of variables 
associated with dietary supplement use as reported in the literature.  These included demographic 
(Hispanic/Latino background, age, gender, education), acculturation (years of US residence, immigrant 
generation (born in US), language preference), economic (income), access to health care (insurance, 
perceived lack of access), health indicators (medication use, chronic illness, perceived health), and 
health behaviors (smoking, physical activity, healthy eating pattern).  Also examined were patterns of 
supplement use by marital status, season and location of the field center.  Prevalence estimates were 
calculated for use of any dietary supplement, for use of a primarily NVNM supplement (includes 
botanicals) and for use of a primarily botanical supplement (without fiber products) (TABLE 4.3).  
Sample and nonresponse weights were applied; analysis was restricted to participants with data for 
both the medication inventory and dietary supplement interview. 
 For this analysis, the study population consisted of 15,772 participants who provided summary 
medication inventory data and the dietary supplement interview (TABLE 5.3) Adjusting for sampling 
probabilities and nonresponse, 26% of the population was seen in the Bronx, 16% in Chicago, 30% in 
Miami, and 27% in San Diego.  Individuals with a Mexican background were the most numerous (38%), 
followed by Cubans (21%), Puerto Ricans (15%), Dominicans (9%), Central Americans (7%), South 
Americans (5%), and Other (mixed heritage)(4%).  Forty-eight percent of the participants were less than 
forty, with a mean age of 41.  Forty-eight percent were male.  Participants had lived in the US for a 
mean of 20 years and 72% had lived in the US ≥10 years.  Only 22% of the population was born in the US 
and only 25% preferred to use English rather than Spanish for communication.  Thirty-two percent of 
the population had less than a high school education and 39% had post-secondary education.  About 64% 
reported family incomes at 200% of the poverty threshold or less; 65% had an income of < $30,000 per 
year.   About half were uninsured and half were living with a partner.  With regard to health behaviors, 
79% were nonsmokers and 66% met the CDC 2008 physical activity guidelines: 75 minutes of vigorous or 
150 minutes of moderate physical activity per week through work, transportation, or leisure activities.  
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The mean score for the 2010 Alternative Healthy Eating Index, based on US Dietary Guidelines and 
scientific studies of diet and health outcomes [150, 151], was 47.5.       
In unadjusted analyses, differences in total supplement use across Hispanic/Latino background 
were relatively small.    Larger differences were seen when comparing botanical supplement use.  
Mexicans, Central, and South Americans reported greater use than other groups.  Females reported 
more use than males and use of all supplement types increased with age.  Prevalence of use of any 
dietary supplement, NVNM supplements, and botanical supplements increased with age.   
Small differences were seen across acculturation variables; considering botanicals, greater 
prevalence (8 vs. 5%) was present for those who prefer to speak Spanish and with first generation (born 
outside the US) vs. second generation (born in the US) immigrants, but use increased with length of 
residence in the US (not adjusted for age).  Prevalence also increased with a post-secondary education 
and with an income of at least $30,000 per year.  Income adjusted for family size (poverty status) also 
indicates greater prevalence with greater family income.  NVNM supplement use varied substantially by 
field center location; participants in San Diego (27%) and Miami (24%) reported greater use than 
Chicago (17%) and the Bronx (15%).    
Dietary supplement use was associated with positive health behaviors.  Prevalence of use of 
any dietary supplement, NVNM supplements, and botanicals increased with greater adherence to a 
healthy eating pattern, as measured with the 2010 AHEI.  For example, the highest quintile of the 
AHEI, corresponding to a mean value of 60.0 (95% CI: 59.8, 60.2), was associated with a prevalence of 
botanical supplement use of 14% whereas the lowest quintile (mean 38.7; 95% CI: 38.5, 38.8) was 
associated with a prevalence of 4%.  Prevalence of dietary supplement use (any, NVNM, or botanical) 
was about the same for those who adhered to physical activity guidelines as those who did not.  
Smokers were much less likely to take supplements of any kind.  For example, prevalence of NVNM use 
among smokers was 14% and increased to 23% among nonsmokers.   
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TABLE 5.3 Prevalence of dietary supplement use over 30 days defined by either the medication 
inventory or dietary supplement interview  
  
Use of any dietary 
supplements 
Use of any primarily NVNM 
supplements  
Use of any primarily 
botanical supplements 
 N* n* % (95% CI) † n % (95% CI) n % (95% CI) 
Overall  15,722 7455 42.8 (41.3, 44.3) 3,854 21.2 (20.1, 22.4) 1,449 7.6 (6.9, 8.2) 
Hispanic/Latino background      
 Dominican 1,469   617 41.0 (36.9, 45.1)   255 15.2( 12.8, 17.6) 70 4.5 (3.0, 6.0) 
 Central Amer. 1,151   805 43.3 (39.8, 46.9)   451 23.5 (20.8, 26.2) 170 9.6 (7.7, 11.6) 
 Cuban 3,240 1,005 42.1(39.2, 45.1)   573 23.4 (21.2, 25.6) 141 6.2 (4.9, 7.4) 
 Mexican 6,006 3,176 44.5 (41.9, 47.0) 1,705 22.4 (20.4, 24.3) 773 9.8 (8.7, 10.8) 
 Puerto Rican 2,383 1,112 40.5 (37.5, 43.6)   452 17.4 (14.7, 20.0) 131 4.5 (3.5, 5.6) 
 South Amer.    796   534 48.3 (44.0, 52.6)   307 25.1 (21.5, 28.9) 124 9.0 (6.9, 11.0) 
 Other Hisp.‡ 669   206 36.2 (29.8, 42.7)   111 18.4 (13.2, 23.5)   40 6.7 (3.9, 9.5) 
Gender        
 Male 6,258 2,537 38.1 (36.3, 40.0) 1,277 18.5 (17.0, 20.0)    446 6.0  (5.2, 6.7) 
 Female 9,415 4,918 47.1 (45.3, 48.9) 2,577 23.7 (22.2, 25.1) 1,003 9.0 (8.2, 9.9) 
Age       
 18 - 29 4,295 676 26.9 (24.5, 29.4)    146 8.9 (7.2, 10.7) 110 4.4 (3.3, 5.5) 
 30 - 39 3,302 879 38.0 (35.0, 41.0)    313 14.7 (12.7, 16.8) 205 8.1 (6.6, 9.5) 
 40 - 49 3,444 1,913 46.6 (44.3, 48.9)    612 20.5 (18.3, 22.8) 400 8.0 (6.9, 9.1) 
 50 - 59 2,511 2,336 54.6 (52.6, 57.0) 1,331 26.2 (24.3, 28.0) 449 9.7 (8.4, 11.0) 
 60 - 69 1,655 1,317 59.4 (56.1, 62.7) 1,142 30.5 (28.2, 33.0) 233 9.4 (7.5, 11.3) 
 70 - 74 509 330 70.4 (65.3, 75.5)    443 35.3 (31.0, 39.6)    52 11.6 (7.7, 15.6) 
Education        
 < HS 4,946 2,670 40.0 (38.1, 42.0) 1,282 17.9 (16.5, 19.4)   469 5.9 (5.2, 6.7) 
 HS graduate 4,409 1,713 37.9 (35.4, 40.3)    826 17.2 (15.5, 18.8)   311 5.8 (4.9, 6.7) 
 Some college 6,071 2,908 48.4 (46.0, 50.8) 1,653 26.4 (24.4, 28.3)   635 10.0 (8.8, 11.2) 
Marital status      
 Single 5,376 1,662 34.1 (31.9, 36.2)    738 14.6 (13.0, 16.1)   255 4.9 (40.1, 5.8) 
 Partnered 7,737 3,993 45.6 (43.5, 47.7) 2,170 23.6 (22.0, 25.2)   862 9.0 (8.1, 9.9) 
 Widowed or divorced 
2,582 1,787 52.9 (50.1, 55.6)    939 27.8 (25.5, 30.1)   329 8.7 (7.4, 10.0) 
Language preference      
 Spanish 11,841 6,398 44.3 (42.6, 46.0) 3,263 22.3 (21.0, 23.5) 1,234 7.9 (7.2, 8.6)) 
 English   3,881 1,048 38.4 (35.4,  41.4)    591 17.9 (15.6, 20.2)    215 6.6 (5.3, 7.9) 
Born in US        
 No 12,179 6,493 45.1 (43.5, 46.6) 3,370 22.8 (21.6, 24.1) 1,279 8.2 (7.5, 9.0) 
 Yes   3,532 1,244 35.9 (33.0, 38.9)    479 15.5 (13.5, 17.6)   167 5.2 (4.0, 6.3) 
Years in US       
 < 5   2,168   722 36.5 (33.5, 39.5)    361 17.0 (14.6, 19.4)    130 5.2 (4.0, 6.3) 
 5 -9   2,233   848 39.1 (36.0, 42.2)    446 20.6 (20.9, 23.5)    168 7.8 (6.1, 9.5) 
 10+ 11,262 5,858 44.8 (43.2, 46.5) 3,037 22.2 (20.9, 23.5) 1,147 8.0 (7.3, 8.7) 
Insurance status        
 None 7,776 3,467 39.6 (37.7, 41.4) 1,881 20.9 (19.5, 22.3)   772 8.1 (7.2, 8.9) 
 Any 7,655 3,885 46.2 (44.3, 48.2) 1,930 21.8 (20.1, 23.4)   664 7.1 (6.2, 8.1) 
Income (income_c2)**       
 < $30,000 9,259 4,546 41.6 (40.0, 43.2) 2,289 19.7 (18.5, 21.0)   840 6.8 (6.2, 7.5) 
 $30,000+ 5,030 2,342 47.4 (45.0, 49.8) 1,310 25.4 (23.1, 27.7)   519 9.5 (8.2, 10.7) 
Percent of poverty      
 <100% 5,639 2,584 39.2 (37.2, 41.2) 1,231 17.5 (16.1, 19.0)    439 6.0 (5.2, 6.8) 
 100-<200% 5,010 2,577 43.7 (41.6, 45.8) 1,398 22.0 (20.4, 23.7)    551 8.4 (7.5, 9.4) 
 200-<300% 1,986   977 46.9 (43.0, 50.8)    538 24.8 (21.6, 28.1)    207 8.0 (6.5, 9.5) 
 300% or more 1,646   745 54.6 (50.2, 59.0)    430 31.5 (27.7, 35.3)    160 11.5 (9.1, 13.9) 
Prevalence estimates include medication history estimates updated by the dietary assessment.  *N = overall frequencies are adjusted, but n=raw 
sample frequencies. Percentages reflect sample and nonresponse weights. All estimates are standardized to the age distribution of the 2010 
census †Percent of use with 95% confidence interval s based on sample and nonresponse weights. ‡Other Hispanic/Latino includes those 
reporting mixed backgrounds. **Missing  9.1% of data for the income variable 
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TABLE 5.4   Prevalence of dietary supplement use over 30 days defined by either the medication 
inventory or dietary supplement interview across additional covariates 
Prevalence estimates include medication history estimates updated by the dietary assessment.  *N = overall frequencies are 
adjusted, but n=raw sample frequencies. Percentages reflect sample and nonresponse weights. All estimates are standardized to 
the age distribution of the 2010 census †Percent of use with 95% confidence interval s based on sample and nonresponse weights. 
†Medication use was based on use of any of the following classes of medications: anti-anginal, anti-arrhythmic, anticoagulant, anti-
platelet, anti-diabetic, antihypertensive, cardiac glycoside, chemotherapy, lipid-lowering agent, or non-steroidal anti-inflammatory. 
Variable does not include use of oral contraceptives, fertility agents, or hormone replacement therapy.   ‡Exploratory variable--
Chronic illness score assigns one point each to asthma, COPD, diabetes, dyslipidemia, hypertension, stroke, cerebrovascular 
disease, and chronic kidney disease.  End stage renal disease is given a score of 2.   
 
Both use of chronic medications and presence of a chronic health condition was associated a 
higher prevalence of botanical and NVNM use.  For example, the prevalence of NVNM use was 27% 
among those with 2 or more conditions compared with 16% among participants with no chronic 
conditions.  Of the two variables, the medication use variable was more strongly related to supplement 
use and thus was chosen for inclusion in models.   
  Use of any dietary 
supplements 
Use of any NVNM 
supplements  
Use of  any botanical 
supplements 
 N* n* % (95% CI) † n % (95% CI) n % (95% CI) 
Alternative Healthy Eating Index Quintiles      
 Q1:  mean 39 3,929 1,098 33.0 (30.3, 35.6)    487 13.8  (12.0, 15.5)    149 4.3 (3.3, 5.3) 
 Q2: mean 44 3,534 1,336 39.4 (37.0, 41.9)    645 18.7 (16.7,  20.8)    223 5.7 (4.7, 6.7) 
 Q3: mean 49 3,150 1,482 43.6 (41.0, 46.1)    763 20.5 (18.7, 22.3)    268 7.3 (6.0, 8.6) 
 Q4: mean 53 2,688 1,617 49.0 (46.0, 52.0)    879 26.5 (23.8, 29.2)    351 9.9 (8.3, 11.5) 
 Q5: mean 60 2,277 1,875 57.4 (54.2, 60.6) 1,064 33.1 (29.5, 36.6)    452 13.8 (12.1, 15.6) 
Meets 2008 Physical Activity Guidelines      
 Yes 10,469 4,717 42.6 (40.7, 44.5) 2,472 21.3 (19.9, 22.8)    949 7.6 (6.8, 8.3) 
 No   5,170 2,714 43.3 (41.3, 45.3) 1,373 21.1 (19.5, 22.7)    497 7.6 (6.8, 8.4) 
Cigarette use       
 Never smoked   9,617 4,685 44.0 (42.3, 45.8) 2,409 21.7 (20.5, 23.0)    926 7.8 (7.0, 8.5) 
 Former Smoker   2,726 1,662 50.1 (47.4, 52.9)    941 27.8 (25.5, 30.1)    360 11.0 (9.5, 12.4) 
 Current smoker   3,339 1,094 33.2 (30.5, 35.8)    500 14.3 (12.3, 16.3)    120 4.3 (3.2, 5.4) 
Chronic medication use†       
 Yes   4,977 3,493 53.8 (51.6, 56.0) 1,864 29.1 (27.5, 30.8)    638 9.3 (8.3, 10.4) 
 No 10,746 3,962 37.8 (36.0, 39.5) 1,990 17.5 (27.5, 30.8)    811 6.7 (6.0, 7.5) 
Chronic illness score‡       
 0 4,249 1,385 36.0 (33.5, 38.6)    664 15.9 (14.2, 17.6)    299 7.0 (5.9, 8.2) 
 1 5,322 2,319 40.1 (38.0, 42.1) 1,200 19.0 (17.4, 20.6)    468 7.0 (6.0, 7.9) 
 2 or more 6,151 3,751 49.9 (47.9, 52.0) 1,990 26.7 (25.0, 28.5)    682 8.4 (7.5, 9.4) 
Perceived Health       
 Very good to excellent   4,437 1,728 41.8 (39.2, 44.3)    933 21.2 (19.0, 23.4)    352 7.5 (6.3, 8.7) 
 Good   7,238 3,394 41.8 (39.9, 43.7) 1,758 20.7 (19.3, 22.2)   683 7.7 (6.8, 8.5) 
 Fair to poor   4,615 2,314 46.1 (43.6, 48.6) 1,156 22.2 (20.5, 24.0)    410 7.4 (6.4, 8.5) 
Season       
 Winter   3,339  1,539 42.7 (39.9, 45.5)    793 21.4(19.0, 23.8) 597 7.5 (6.1, 8.8) 
 Spring   4,262 2,225 45.9 (43.1, 48.6) 1,194 23.8 (21.8, 25.9) 836 8.1 (6.8, 9.4) 
 Summer   4,296 1,911 41.0 (38.5, 43.4)    923 18.0 (16.1, 19.8) 617 6.3 (5.4, 7.2) 
 Fall   3,825 1,780 41.6 (38.7, 44.5)    944 21.7 (19.7, 23.7) 630 8.4 (7.0, 9.7) 
Field center location        
 Bronx 4,180 1,574 38.7 (36.2, 41.2)    613 14.6 (12.9, 16.3) 162 4.0 (3.1, 4.8) 
 Chicago 2,565 1,770 36.6 (34.4, 38.7)    862 17.0 (15.2, 18.7) 365 7.3 (6.0, 8.5) 
 Miami 4,766 1,847 43.4 (40.9, 46.0) 1,069 24.0 (22.2, 25.9) 343 7.6 (6.5, 8.7) 
 San Diego 4,212 2,264 50.2 (46.7, 53.7) 1,310 27.1 (24.2, 30.0) 579 11.3 (9.8, 12.7) 
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CHAPTER 6:  
COMPARISON OF A MEDICATION INVENTORY AND A DIETARY SUPPLEMENT INTERVIEW IN ASSESSING 
DIETARY SUPPLEMENT USE  
IN THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL) 
 
6.1 Introduction 
Growth in the number of dietary supplements on the market has been marked, increasing from 
4,000 products in 1994 to 55, 000 in 2009 [157].  Dietary supplements result in > $20 billion in sales 
each year with growth of about 6% per year [158] and prevalence of dietary supplement use is common 
in the United States (US) general public [122, 147].  In national studies,  among Hispanics/Latinos, the 
reported prevalence of any dietary supplement use (34%) in the past 30 days was lower as compared 
with Non-Hispanic whites (59%) [147].  National studies of botanical and non-vitamin, nonmineral 
supplement use in the prior year also report lower prevalence among Hispanics/Latinos, 12% compared 
with 23% [122],  but other studies conducted within Hispanic/Latino populations have resulted in much 
higher estimates: >60% in past twelve months [50, 113], leading to questions about the comparability 
of study designs. 
Assessment of supplement use is challenging in any population, but is particularly difficult 
among ethnic minorities and with regard to botanical and other non-vitamin, non-mineral (NVNM) 
supplements.  Most observational studies rely on self-completed questionnaires [61-64] or telephone 
surveys [65] to collect dietary supplement data, asking participants to choose from a list of 
supplements that may or may not be consistent with cultural traditions.  Product examination is 
considered a criterion standard for supplement assessment [66], but, if not assessed in the home, could 
miss supplements individuals forget to bring in to the study visit.  A more systematic approach to 
supplement assessment is clearly indicated.   
The current study utilizes the baseline data of the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL).   HCHS/SOL is unique in its supplement assessments in two ways.  The study 
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collected supplement data in a sample of US Hispanics/Latinos using both a dietary interview method 
and medication-based (product examination inventory) method to assess supplement use over 30 days.  
In addition, dietary supplement use was also captured in the 24-hour recall data, reflecting immediate 
use.  This analysis measured the prevalence of dietary supplement use among Hispanics/Latinos of 
diverse Hispanic backgrounds by a medication inventory and a dietary supplement interview and 
compared the two with concordance statistics. Prevalence selected supplement ingredients was also 
calculated. 
6.2 Methods 
Data source 
  The HCHS/SOL is a prospective cohort study designed to identify risk factors and disease 
prevalence among Hispanic/Latino residents of four communities in the United States (Miami, Bronx, 
Chicago, and San Diego). To achieve a representative sample of the target population, a two-stage area 
household probability design was employed [136, 137]. HCHS/SOL investigators chose communities to 
achieve a balanced recruitment of Hispanics/Latinos from across countries of origin and geographic 
areas of the US [137]. Within communities, census tracts were selected based on their proximity to the 
field center clinics and demographics;  study plans called for cross-stratifying by high vs. low 
concentration of Hispanic/Latino residents and high vs. low SES [136].  This report is based on cross-
sectional data from the baseline data collection, 2008-2011. 
Study population 
 The study enrolled 16,415 non-institutionalized adults who self-identified their background as 
Cuban, Dominican, Puerto Rican, Mexican, Central American, South American or other Hispanic/Latino.   
Individuals within sampled households were screened for eligibility (living in the household, age 18-74, 
able to attend a clinic visit, and not planning to move within 6 months) [136].  Enrolled individuals 
attended a comprehensive examination visit at the study field center where they reviewed/signed 
consent documents and participated in study assessments, including demographic, medical, nutrition, 
and physical activity assessments.  Study procedures were approved by the institutional review boards 
at the participating institutions.  The current analysis, based on de-identified data, was exempted. 
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Categorization of outcome data 
 Dietary supplement use was captured from product name files within the medication 
inventory, the dietary supplement interview, and the two 24-hour dietary recalls.  Dietary supplement 
products were categorized using an adapted form of the Langual categorization system for dietary 
supplements proposed by Saldanha, Dwyer et al. (2012) [138].  The Langual system involves coding 
multiple facets of a product, from the general, to the specific.  For this study, coded facets included 
product type (Facet A), physical form (Facet E, with collapsed categories), and ingredients (Facet H).    
Medication inventory 
 Participants in the HCHS/SOL were asked to bring all medications, dietary supplements, and 
herbal remedies taken in the 4 weeks prior to their baseline visit. The medication inventory was 
designed to therapeutically classify all prescription and over-the-counter medications and 
supplements, including vitamins, minerals, herbals, and supplements used by participants during the 
four weeks preceding examination.  The inventory involved scanning any Universal Product Code (UPC) 
bar code symbols on medication packaging, pill imprint searches using Facts & Comparisons® Drug 
Identifier and Ident-A-Drug Reference© when necessary, and automated therapeutic classification of > 
99% of products based on their generic/brand name using a Master Drug Data Base (Medispan MDDB®) 
supplemented with Spanish-language brand and generic name equivalents from Lexi-Comp Online™ and 
OVID© Martindale.  For the remaining 1% of products, manual coding was performed by healthcare 
professionals with expertise in medication and supplement identification.    Approximately 10,000 
products were identified as dietary supplements.   Over 1,600 products could not be coded beyond 
identification as a dietary supplement due to insufficient information, resulting in missing NVNM data 
for 630 individuals (4%). 
Dietary supplement interview 
 At the time of the field center clinic visit, immediately following the 24-hour dietary recall, 
technicians interviewed participants extensively (in Spanish or English, according to their preference) 
about their recalled dietary supplement use in the 30 days prior to the study visit.  The dietary 
supplements from the 30-day supplement interview were recorded in the Dietary Supplement 
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Assessment Module (DSAM) of the Nutrition Data System for Research database (NDSR).  Information for 
supplements that did not match in the DSAM were updated from the product label (obtained from the 
manufacturer when possible) and validated against outside resources.  DSAM-based product name files 
were recorded with greater detail than the medication inventory files, enabling refined product 
coding, a process that was extended to the medication data to ensure that the coding and product 
identification was consistent across the datasets.  The dietary supplement interview data consisted of 
approximately 2,700 different products representing ~15,000 entries.  Calculations of the prevalence of 
individual botanicals within dietary supplement products depended on the DSAM ingredient-level 
dataset.  Botanical supplement reports were limited to those most common—those with a prevalence of 
at least 0.2%.   
Dietary recall 
 The 30-day dietary supplement interview files recorded few botanical teas.  However, 
botanical teas were documented in the two 24-hour dietary recalls, along with other liquid dietary 
supplement products containing protein supplements, aloe, or nopal.  Three additional estimates were 
calculated: 1) estimates of supplement use including botanical teas without green or black tea 
(Camellia sinensis) and nopal (whole fruit); 2) estimates including green tea and nopal; and 3) 
estimates considering all fiber products as botanical (otherwise coded as NVNM products to supplement 
the diet).  
Statistical analysis 
 The distribution of key variables was examined across dietary supplement users, NVNM 
supplement users, and botanical supplement users, including demographics (age, gender, education, 
percent of poverty for family size and year), healthcare access (percent of poverty, insurance status, 
self-reported lack of access to care), health behaviors (cigarette smoking, diet quality, physical 
activity), and acculturation measures (language preference, years of residence in the US, born in US).   
All variables were examined for univariate distributions and missing data; analyses were based on 
16,060 individuals who had data for both the medication inventory and dietary supplement interview.  
Prevalence estimates defined  supplement users across multiple supplement types: 1) users of any 
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dietary supplements; 2) users of supplements containing any NVNM (including botanicals); 3) users of 
supplements consisting of primarily NVNM ingredients (including botanicals); 4) users of supplements 
containing any botanical ingredients; 5) users of supplements primarily botanical; 6) users of 3 or more 
supplements; 7) users of 2 or more NVNM supplements; 8) users of 2 or more botanical supplements; 9) 
users of liquid (including teas) vs. tablet/capsule vs. powdered supplement products.  Definitions of 
dietary supplements have not yet been standardized.  Based on the available product information, 
combination products that contained ≥50% of the recommended daily allowance (RDA) of a vitamin or 
mineral, but also contained a botanical or other non-vitamin, non-mineral (NVNM) ingredient were 
classified as a dietary supplement with NVNM.  Those that contained <50% RDA of a vitamin or mineral 
were classified as a primarily NVNM product.  Botanicals were similarly classified. NVNM products 
included botanicals, but botanical products excluded other NVNM (e.g., glucosamine, co-enzyme Q10, 
omega-3 and omega-6 fatty acids, fiber products, enzymes, probiotics, amino acids, and protein 
supplements) (FIGURE 6.1). 
Because neither the dietary supplement interview nor the medication inventory could be 
considered a gold standard measure, comparison of the two was limited to calculation of Cohen’s 
Kappa statistics with positive and negative agreements [159, 160] and prevalence and bias-corrected 
kappa (PABAK) [161].  Kappa statistics were interpreted following established criteria [162]. In 
addition, to look at the sensitivity of dietary supplement prevalence estimates to various assumptions, 
estimates were calculated based on: 1) the dietary supplement interview  updated with botanical teas 
from the dietary recall; 2) the dietary supplement interview with 24-hour recall data including nopal 
and green tea; and 3) the combined dietary supplement interview, medication inventory, and dietary 
recall.   
6.3 Results 
Characteristics of the study population 
 Distributions of key characteristics of the study population are presented, classifying 
participants as users of any dietary supplement (n= 7,658), users of NVNM supplements (including 
botanicals) (n=3,916), users of botanical supplements (n=1,433), and users of no supplements (n=8,402) 
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based on their reported use in either the dietary supplement interview or the medication inventory 
(TABLE 6.1).  Supplement use categories are nested (FIGURE 6.1). Users of supplements that included 
NVNM ingredients were older (mean age of 47 vs. 38 years among non-users), had lived in the US longer 
(21.0 vs. 18.6 years), and were more likely to be living in Miami.  Users of botanical supplements only 
had a higher education and greater adherence to a higher quality diet as measured by the 2010 
Alternative Healthy Eating Index.  They were more likely to be of Mexican background and living in San 
Diego; they were less likely to have insurance or to have been born in the US. 
Concordance of the medication inventory and dietary supplement interview 
 Prevalence of supplement use as measured by the dietary supplement interview was higher 
than that for the medication inventory, even for overall dietary supplement use (39.6% vs. 26.0%) 
(TABLE 6.2).  The absolute differences were smaller, but the proportional difference was greater for 
NVNM or botanical products.  Prevalence estimates of products with any NVNM or any botanical 
components in the dietary supplement interview were about twice that of the medication inventory.  
Positive agreement and overall Kappa statistics were consistent with moderate agreement for most 
comparisons (κ: 0.44-0.57).  Kappa for botanical products was only fair (κ: 0.28-0.33), but negative 
agreement was high, as was prevalence and bias-adjusted kappa (PABAK: 0.79-0.86).  Kappa statistics 
for liquid or powdered products (κ: 0.11-0.13) were low, but negative agreement for these products 
were high at 0.96-0.98 (PABAK: 0.85-0.95).  Over 90% of products were described as tablets or capsules 
(including chew tablets) or powders.  Concordance for tablet products was also moderate (0.52).  
Negative agreement was high across all categories of supplements (κ: 0.82-0.99).  In sensitivity 
analyses, categorizing products likely to be NVNM or botanical supplements, based on their similarity to 
products that were definitely classified as such, reduced the disparity between the two assessments 
(TABLE 6.2). 
Sensitivity of the prevalence estimates to ascertainment strategy 
 NVNM and botanical prevalence estimates were sensitive to inclusion of botanical teas and 
other liquid supplements captured in the dietary recalls (FIGURE 6.2). Estimates were also sensitive to 
inclusion of dietary fiber as a botanical (otherwise coded as a non-botanical NVNM).  The use of 
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botanical teas (excluding green tea) was relatively common:  6.6% (95% CI: 5.9, 7.3) reported drinking 
a botanical tea on either of the recall visits.   The prevalence of use of any nopal was 3.2% (95% CI: 
2.7, 3.6) and the prevalence of the use of dietary green tea was 3.6% (95% CI: 3.1, 4.1).  If teas, liquid 
nopal, and other liquid supplements were included in the estimates as primarily botanical  
supplements, prevalence increased by 131% in women and 105% in men.  Additionally counting brewed 
green tea and nopal as botanical supplements increased the prevalence of botanical supplements 
substantially, by 32% in women and 34% in men.  Additionally, counting all fiber products as botanicals 
increased the prevalence of botanical use by another 9% in women and 11% in men to 22.5% and 14.7%, 
respectively.  The combined dietary and medication information resulted in a prevalence of 43.8% (95% 
CI:  42.4, 45.2) for any dietary supplement, 27.7% (95% CI:  26.4, 28.9) for supplements with NVNM, 
and 11.7% (95% CI: 10.9, 12.5) for supplements with botanical components.   
Individual supplement ingredients 
NVNM ingredients included fish oil, glucosamine or related products, lutein-containing 
products; prevalence of these substances and individual botanical ingredients were calculated from the 
ingredient files (TABLE 6.3).  Among the NVNM supplements, omega-3 fatty acids, lutein, and lycopene 
were the most common, occurring with a prevalence of about 10%.  Omega-3 fatty acids were most 
often consumed as single supplements, while lutein and lycopene were often added to multivitamin 
products.  Other common combination products included those containing glucosamine (3.5%) and 
lipotropic agents (primarily lecithin and inositol—3.4%).  These, too, were most often consumed as 
combination products. 
Many combination products containing vegetable or fruit extracts were counted as botanicals.  
Over 2 percent of study participants consumed a supplement with at least one vegetable extract and 
over 4% consumed a product containing a fruit extract.  Culinary herbs, such as parsley, sage, and 
oregano were occasional constituents of combination products.   
Ginkgo and ginseng were the most commonly reported botanicals (2.6%), followed by green tea 
extracts and garlic (1.7%). Licorice was also a component of botanical products among about 1% of 
participants. Chamomile at 0.23% and nopal at 0.13% were less common constituents of dietary 
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supplement products—almost 2% of participants reported consuming chamomile tea in the dietary 
recall (1.9%; 95% CI: 1.6, 2.3). 
6.4 Discussion 
  Depending on the assessment (medication inventory and/or dietary supplement interview +/- 
dietary recall data), HCHS/SOL estimated that 4.5-21.6% of participants reported taking botanical 
supplements and 12.5-35.2% reported use of NVNM supplements, including botanicals.  Results of this 
study demonstrate the challenges of accurate dietary supplement assessments, particularly with regard 
to the botanical and other NVNM products.  Estimates based on the medication inventory alone differed 
substantially from those based on the dietary supplement interview and neither assessment appears to 
have captured use completely.  Some products were reported only with the medication inventory and 
others only with the dietary supplement interview.  Botanical estimates in particular were markedly 
sensitive to varying assumptions about what constitutes a botanical product—including all fiber 
products as botanicals, a reasonable, but not universal assumption, substantially increased estimates, 
as did the inclusion of botanical teas and other liquid dietary supplements ascertained in the 24-hour 
dietary recall files.   
  The importance of accurate measurement of dietary supplement use cannot be overstated.  
Although dietary supplements have biologic activity with the potential for adverse reactions and 
interactions with drugs [10, 163], dietary supplements are not regulated with the same level of scrutiny 
as drugs [10].  The limited regulation also precludes adequate surveillance of use—estimates of 
interactions and harmful reactions rely on adverse event reporting from individual users and their 
health care providers, many of which will go unrecognized [157, 164].  Unlike prescription drugs, 
tracking use via pharmacy charges is not possible, and supplement recording via medical records is 
poor, particularly among ethnic minorities [39].  
Comparability of assessment comparisons with other studies 
 The most accurate self-report measure of dietary supplement use is considered to be a 
detailed interview with label capture and transcriptions, conducted in the home [66].  Other studies 
have used a label capture system conducted in the clinic for supplement assessment, similar to the 
 
 
60 
 
medication inventory in HCHS/SOL [165, 166].  In these studies, participants completed a dietary 
supplement questionnaire at home prior to the in-person interview, perhaps prompting improved 
supplement recall.    
Kappa statistics in studies comparing questionnaires with label capture have been variable, 
ranging from 0.46 to 0.92 [66, 166].  Agreement of supplement use as measured by a telephone 
interview compared to a label capture was somewhat lower—with a kappa as low as 0.14 [165].   A 
fourth study compared vitamin and mineral supplement assessment via a self-completed health 
questionnaire and two types of dietary assessments, a food frequency questionnaire and a 7-day food 
diary [167].  Agreement in these studies comparing the three instruments was substantial (κ: 0.72 – 
0.81).   
In contrast, our agreement statistics are somewhat lower, especially for botanical products.  
Although every effort was made to classify dietary supplement products in the two datasets, some 
misclassification was likely, given the amount of missing information in the medication inventory data 
that prevented complete product characterization.     In addition, a kappa statistic is less reliable in a 
setting of low prevalence, as seen with botanical supplements [168] and with imbalances in the 
marginal totals as was seen in both the botanical and NVNM data [160].  However, moderate agreement 
was seen with the comparisons of overall dietary supplement use and with comparisons of NVNM 
supplements and negative agreement statistics were uniformly high.  Unfortunately, more 
sophisticated techniques for correcting misclassification were not possible, given the absence of a gold 
standard or a validation sample. 
Low agreement was not surprising, given the very different databases employed for the 
medication inventory as compared with the dietary supplement interview.  In the former, supplements 
were added to a database designed for medications—many NVNM supplements were recorded with 
insufficient detail to completely assess their ingredients.  In contrast, the dietary supplement interview 
used the Dietary Supplement Assessment Module (DSAM), a database designed specifically for capture 
of dietary supplement data.  The DSAM data was much more detailed, in most cases listing full product 
names and ingredients. 
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In addition to the superiority of the DSAM, a clinic-based review of medications may be more 
likely to underestimate dietary supplement use.  In clinical situations, accurate capture of dietary 
supplement use is uncommon:  33% of individuals with chronic disease reported that they disclosed 
supplement use to their conventional health care provider and disclosure rates were lower among 
Hispanics (22%) [39]. When asked why they did not disclose their supplement use, patients reported 
that they did not think that it was important for their providers to know [169].  A similar mechanism 
may be driving the lower prevalence in the medication inventory data in this study. 
Some concern has been expressed about the independence of the medication inventory and 
dietary supplement interview data—original plans called for dietary interviewers to have access to the 
medication inventory files.  However, the data was usually entered electronically and, because the two 
assessment systems were incompatible, electronic data was not shared.  Study staff for both the 
medication inventory and dietary supplement interview may have had access to either the bag of 
products brought in for analysis or to a list of the products, but the dietary supplement interview 
protocol called for asking each participant a series of questions about dietary supplement use.  
Assessments were completed on the same day in a flexible manner and it is likely that the dietary 
recall was more often completed second. Improved recall for supplements may have occurred when 
participants were asked a second time.  In addition, the supplement interview followed a 24-hour 
recall; possibly bringing to mind supplements not previously remembered or brought in to the field 
center clinic. 
Comparability of HCHS/SOL dietary supplement prevalence estimates 
 HCHS/SOL estimates are consistent with comparable studies (probability sample, capturing 
supplement use in  ≤ 30 days) of botanical dietary supplement use among Hispanic/Latinos with 
prevalence estimates for botanicals ranging from 4 to 9%, depending on the instrument, increasing to 
15% with the addition of data from the dietary recall (botanical teas and other liquid supplements also 
consumed as foods).  Commonly-reported supplements are consistent with patterns in the general US 
public, rather than those reportedly common among Hispanics/Latinos such as mint, chamomile, and 
linden [170].   
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  Comparable studies were limited to four; most targeted an older population.  In a home-based 
interview of dietary supplement use in the past 2 weeks with label capture among individuals 77 or 
older in Texas, about 38% of Hispanics reported using vitamin or mineral supplements and 5% reported 
using botanicals, most commonly garlic, ginkgo, and saw palmetto [171].  Another study employed a 
similar strategy (home-based interviews, use in past 2 weeks) among Mexican Americans ≥65 across the 
US-Mexican Border States and reported botanical medicine use was about 10% [59].  In this study, 
investigators specifically inquired about the use of herbal teas.  Most common botanical supplements 
were consistent with previously reported favorites among Hispanics/Latinos:  chamomile, mint, and 
aloe [59].  In a telephone interview of supplement and medication use in the past 7 days [73] in the 
general US public, the prevalence of NVNM use was 12% among Hispanics; the most common 
supplements were lutein, ginkgo, garlic, and glucosamine [73], similar to those reported in HCHS/SOL.  
Another telephone interview (subjects ≥ 52), reported Hispanic/Latino use of any supplement at 45% 
and botanicals at 12%.   
Limitations and Strengths 
  All participants were recruited from urban centers; the dietary supplement habits of 
Hispanics/Latinos in rural areas may be very different. However, although the target population is 
limited to the four cities, HCHS/SOL’s design, using probability sampling within diverse regions, is 
superior to the convenience samples typical of many dietary supplement studies in these populations. 
Dietary supplement assessment suffers from the same limitations as other data largely 
dependent on self-report or inventory methods conducted outside the home.  It is unclear whether or 
not either the medication inventory or the dietary supplement interview adequately captured 
supplement use.  Limitations of the medication inventory are enumerated above.   In addition, because 
supplements were spread across the files, instead of receiving a designation as a supplement, some 
supplements could have been missed, artificially reducing the prevalence estimates resulting from 
these data.  The dietary supplement interview assessment was limited by the use of prompts for 
supplements common in the general population (Echinacea, ginseng, ginkgo, St. John’s Wort), rather 
than those common among Hispanics/Latinos (e.g., chamomile, mint, and aloe).   However, the dietary 
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supplement interview data, using the DSAM, achieved much greater detail than has been reported in 
prior studies and the ability to add botanical teas from the 24-hour recall data filled in some of the 
missing information from the dietary supplement interview alone.   
Areas for future research 
 The reported prevalence of types of dietary supplements (botanical, NVNM) has been variable 
among Hispanics/Latinos.  Some of this variability is related to sampling design (probability vs. 
convenience), but, based on the findings in this report, it is likely that some of the variability reflects 
the non-standardized definitions of what constitutes a botanical or even a dietary supplement.  Studies 
that include only purchased dietary supplement products are not counting home remedies such as 
botanical teas.  Because raw botanicals and teas are part of the health practices of many ethnic 
minority populations, including Hispanics/Latinos, excluding them from estimates may lead to 
measurement error. 
Accurate measurement depends on many factors, only some of which are under the control of 
the investigator.  If, in the planning stages of a study, the investigator includes prompts for dietary 
supplements consistent with cultural use patterns, under-measurement of those supplements is less 
likely.  Measurement will be enhanced by utilizing a study database specific for dietary supplements, 
such as the DSAM along with a detailed interview process and a supplement inventory with label 
capture.  Because rules for classifying supplements as botanical or NVNM are not yet universal, 
reporting results of sensitivity analyses will improve understanding of how the estimates were 
obtained.  Similarly, greater detail in reporting product classifications will enable improved 
comparisons of results across studies.  
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FIGURE 6.1.  Dietary supplement assessment protocol schematic. Sample is restricted to participants 
with data for both the medication inventory and the dietary supplement interview. 
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TABLE 6.1. Distribution of sample population characteristics by use of supplement typesa in 
HCHS/SOL 
  
Users of any 
supplements 
N=7,658 
Users of any 
NVNM 
supplements 
N= 3,916 
Users of  any 
botanical 
supplements 
N=1,433 
Nonusers of 
dietary 
supplements 
N=8,402 
 Nb Mean or % (95% CI) c 
Mean or % 
(95% CI) c 
Mean or % 
(95% CI) c 
Mean or % 
(95% CI) c 
      
Mean age 16, 060 45.5 (44.8, 46.1) 47.0 (46.2, 47.8) 45.0 (43.7, 46.3) 37.7 (37.1, 38.2) 
% Female 9,643 56.6 (54.8, 58.4) 56.9 (54.4, 59.5) 62.5(58.5, 66.4) 48.3 (46.8, 49.8) 
Mean % poverty threshold 14,669 169 (160, 178) 186 (173, 199) 181 (166, 196) 142 (137, 147) 
Hispanic/Latino Background (%)     
 Dominican 1,443 9.8 (8.3, 11.7)      7.7  (6.2, 8.1) 6.0 (4.3, 8.4) 9.8 (8.4, 11.3) 
 Central American 1,693 7.6 (6.5, 9.0) 8.4 (7.0, 10.2) 9.5 (7.4, 12.1) 7.0 (6.0, 8.2) 
 Cuban 2,305 18.6 (16.0, 21.7) 20.4 (17.4, 23.9) 16.6 (13.3, 20.4) 22.8 (19.2, 26.9) 
 Mexican 6,397 40.0 (36.5, 43.6) 41.1 (37.1, 44.3) 49.6 (44.9, 54.4) 35.0 (31.7, 38.4) 
 Puerto Rican 2,646 14.6 (13.0, 16.4) 12.4 (10.4, 14.7) 8.7 (6.7, 11.3) 16.8(15.0, 18.7) 
 South American 1,063 5.6 (4.8, 6.6) 5.9 (4.8, 7.1) 5.6 (4.2, 7.4) 4.6 (4.0, 5.3) 
 Other 513 3.7 (3.0, 4.6) 4.0 (2.9, 5.5) 3.9 (2.5, 6.0) 4.1 (3.5, 4.8) 
Preference for Spanish 16,060 74.8 (72.6, 76.8) 74.8 (72.6, 76.8) 74.6 (71.8, 77.2) 76.8 (74.6, 78.9) 
Born in US (%) 2,863 21.5 (19.6, 23.5) 21.2 (19.1, 23.5) 18.1 (15.0, 21.7) 21.2 (19.7, 22.9) 
Mean years in US 15,994 21.2 (20.5, 22.0) 21.0 (20.2, 21.9) 21.1 (20.1, 22.1) 19.9 (19.0, 20.7) 
Education (%)      
 < HS 5,988 28.4 (26.4, 30.5) 25.2 (22.6, 27.9) 24.7 (21.0, 28.8) 36.2 (34.5, 38.1) 
 HS graduate   4,076 26.4 (24.7, 28.2) 25.0 (22.5, 27.7) 23.0 (19.8, 26.6) 29.2 (27.8, 30.6) 
  At least some college 5,674 45.2 (42.8, 47.7) 49.9 (46.5, 53.2) 52.3 (47.5, 57.1) 34.6 (32.9, 36.3) 
% with no insurance  7,814 47.2 (44.8, 49.6) 51.5 (49.3, 53.0) 55.2 (50.6, 59.8) 50.8 (48.7, 52.9) 
% unable to get needed 
healthcare 2,665 15.1 (13.7, 16.6) 15.8  (13.8, 17.9) 17.0 (14.3, 20.0) 15.6 (14.4, 16.8) 
% Meeting physical activity 
guidelinesd 10,198 68.7 (66.9, 70.5) 70.4 (67.8, 72.9) 68.2 (63.7, 72.3) 64.5 (62.9, 66.0) 
Mean AHEIe 16,060 48.3 (47.9, 48.7) 49.0 (48.4, 49.5) 50.0 (49.3, 50.8) 47.1 (46.7, 47.5) 
Cigarette use (%)     
 Never smoked 9,760 64.6 (62.8, 66.4) 64.8 (62.2, 67.4) 64.5 (60.4, 68.3) 57.8 (56.1, 59.7) 
 Former Smoker 3,180 18.7 (17.3, 20.1) 20.1 (18.3, 22.0) 23.4 (20.3, 26.8) 17.6 (16.6, 18.8) 
 Current smoker 3,090 16.7 (15.1, 18.5) 15.1 (12.9, 17.5) 12.1(9.6, 15.2) 24.5(23.1, 26.0) 
Self-reported health (%)      
 Fair-poor 4,750 25.5 (23.6, 27.4) 23.7 (21.6, 26.1) 29.8 (26.1, 28.6) 26.3 (24.9, 27.8) 
 Good 7,405 45.0 (43.0, 47.0) 44.5 (41.7, 47.4) 46.6 (42.6, 50.6) 47.1 (45.5, 48.7) 
 Very good - excellent 3,852 29.5 (27.6, 31.5) 31.7 (28.8, 34.8) 28.2 (24.6, 32.0) 26.6 (25.2, 28.1) 
Geographic area (US) (%)     
 Bronx 3,969 25.8 (22.9, 29.0) 20.4 (17.6, 23.5) 15.0 (12.0, 18.6) 29.6 (26.5, 33.0) 
 Chicago 4,075 14.2 (12.3, 16.4) 13.6 (11.3, 16.2) 16.2 (13.0, 20.0) 17.0 (14.9, 19.3) 
 Miami 3,997 28.8 (24.9, 32.9) 31.6 (27.3, 36.2) 29.6 (24.8, 34.8) 31.5 (27.0, 36.4) 
 San Diego 4,019 31.2(27.0, 35.6) 34.5 (29.4, 39.9) 39.2 (33.2, 45.5) 21.9  (18.9, 25.2) 
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Abbreviations:  AHEI = alternative healthy eating index.  a. Supplement users were defined as users by either the 
medication inventory or the dietary supplement interview.  Categories presented for comparison of distributions 
include only users of any dietary supplement, users of primarily NVNM products (including botanicals) and users of 
botanical supplements.  b. N = number of participants in sample, rather than the representative population.  c. Means 
and percents reflect sample weights. d. Physical activity data was summarized as meeting or not meeting CDC 2008 
guidelines for physical activity. e. Nutritional data was summarized with the Alternative Healthy Eating Index-2010 
(AHEI-2010).  The AHEI was developed to update prior healthy eating indices based on US Dietary Guidelines with 
recommendations derived from scientific studies of diet and health outcomes [150, 151].  The AHEI assigns values 
for consumption of vegetables, fruit, whole grains, sugar-sweetened beverages, nuts/legumes, red/processed meats, 
trans fat, long-chain n-3 fatty acids, total polyunsaturated fatty acids, sodium, and alcohol intake  with a maximum 
value of 110 [151].  Healthy individuals aged 55-80 in the Nurses’ Health Study had a mean AHEI-2010 of 53.2 [150].  
 
 
 
 
TABLE 6.2. Comparison of 30-day dietary supplement use assessed through the medication inventory and dietary supplement interview in HCHS/SOLa 
Abbreviations:  DS—dietary supplements; NVNM—non-vitamin, non-mineral products, including botanicals; MV—medication inventory; DS—dietary 
supplement interview. Agreement statistics were calculated with DAG_Stat, an Excel-based program for calculation of agreement statistics [172].  a. Analysis 
is restricted to subjects with data for both the medication inventory and the dietary supplement interview (n = 16,060). An additional 639 (4%) of participants 
took only supplements for which insufficient detail was available for coding.  b. Proportions are adjusted by sample and nonresponse weights and are age-
standardized to the 2010 Census distribution for Hispanics/Latinos. c. The prevalence and bias-adjusted Kappa (PABAK) adjusts not only for the prevalence 
effect (the difference between the positive and negative agreements), but also for differences in the marginal probability of supplement use between the 
assessments.   d. Sensitivity analysis reflects coding supplements with insufficient information, but likely to be NVNM and botanical (based on similar or 
nearby products). 
 
  
Medication  
Inventory (MV) 
 
Dietary 
Supplement 
Interview (DI) 
 
MV+ 
DI+ 
MV+ 
 DI- 
MV- 
DI+ 
MV– 
DI- 
Positive 
agreement 
Negative 
agreement 
 
Cohen’s 
Kappa 
 
Prevalence- 
and Bias- 
Adjusted 
Kappac 
 Variable % (95% CI)b % (95% CI)b n n n n (95% CI) (95% CI) (95% CI)  
 Any dietary 
supplement (DS) 26.0 (24.7, 27.3) 39.6 (38.3, 41.0) 4053 728 2877 8402 0.69 (0.68, 0.70) 0.82 (0.82, 0.83) 0.52 (0.51, 0.54) 0.55 
 DS with any NVNM 
component 12.5 (11.7, 13.3) 24.6 (23.4, 25.9) 1733 560 2285 10,843 0.55 (0.53, 0.56) 0.88 (0.88, 0.89) 0.44 (0.43, 0.46) 0.63 
 
DS primarily  NVNM 10.9 (10.2, 11.6) 19.0 (17.9, 20.1) 1465 529 1594 11,833 0.58 (0.56, 0.60) 0.92 (0.91, 0.92) 0.50 (0.48, 0.52) 0.72 
 
DS with any botanical  4.5 (4.1, 4.9) 9.3 (8.5, 10.1) 417 458 1205 13,544 0.33 (0.31, 0.36) 0.94 (0.94, 0.94) 0.28 (0.26, 0.31) 0.79 
 Primarily botanical 
products 3.3 (3.0, 3.7) 5.8 (5.2, 6.3) 327 548 563 13,983 0.37 (0.34, 0.40) 0.96 (0.96, 0.96) 0.33 (0.30, 0.36) 0.86 
 
Use of 3+ DS 6.7 (6.1, 7.4) 9.9 (9.2. 10.7) 912 335 863 13,950 0.60 (0.58, 0.62) 0.96 (0.96, 0.96) 0.56 (0.54, 0.59) 0.85 
  Use of 2+ primarily 
NVNM products 3.2 (2.8, 3.7) 5.4 (4.7, 6.0) 363 221 480 14,357 0.52 (0.48, 0.55) 0.98 (0.98, 0.98) 0.49 (0.46, 0.53) 0.91 
 Use of 2+ primarily 
botanical products 0.7 (0.6, 0.9) 1.2 (1.0, 1.4) 71 145 124 15,081 0.35 (0.29, 0.40) 0.99 (0.99, 0.99) 0.34 (0.28, 0.40) 0.97 
 Liquids/Teas 1.7 (1.4, 2.0) 0.9 (0.7, 1.1) 34 260 138 15,590 0.15 (0.10, 0.19) 0.98 (0.98, 0.98) 0.13 (0.09, 0.18) 0.95 
 Powders 5.6 (5.0, 6.2) 2.7 (2.3, 3.2) 102 885 337 14,698 0.15 (0.12, 0.17) 0.96 (0.96, 0.96) 0.11 (0.09, 0.14) 0.85 
 Tablets, capsules 23.9 (22.7, 25.1) 38.3 (37.0, 39.6) 3765 633 2932 8692 0.68 (0.67, 0.69) 0.83 (0.82, 0.84) 0.52 (0.51, 0.53) 0.56 
 Sensitivity Analysis          
 DS with NVNMd  15.5 (14.4, 16.5) 24.7 (23.5, 25.9) 2133 778 2248 10,817 0.58 (0.57, 0.60) 0.88 (0.87, 0.88) 0.47 (0.45, 0.48) 0.62 
 DS with botanicald 5.1 (4.6, 5.6) 9.4 (8.6, 10.2) 486 525 993 13,520 0.39 (0.37, 0.41) 0.95 (0.94, 0.95) 0.34 (0.31, 0.36) 0.80 
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FIGURE 6.2. Prevalence of non-vitamin, non-mineral supplements considering the addition of supplements captured in the dietary 
recalls.  
Prevalence estimates are standardized to the 2010 US Census and weighted with sample and non-response weights and stratified by gender 
DI no recall no nopal references the dietary supplement interview data without dietary recall data 
DI with recall no nopal references the dietary supplement interview data with addition of dietary recall data, but excluding raw nopal and green tea 
DI with recall with nopal references the dietary supplement interview data with dietary recall data including raw/cooked nopal and green tea 
Only nopal ingested outside recipes was included in these estimates. 
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TABLE 6.3.  Prevalence of Selected Supplement Ingredients in the 30-Day Dietary Supplement 
Interview  
Supplement 
ingredient N Prevalence 
 Supplement           
ingredient N Prevalence 
Vitamins 5,763 32.8 (31.6, 34.1)  Botanicals   
Minerals 5,577 31.8 (30.5, 33.1)     Garlic 336 1.7 (1.4, 2.1) 
NVNM       Ginger 111 0.66 (0.47, 0.85) 
   Amino acids 568 3.2 (2.8, 3.6)     Ginkgo 461 2.6 (2.2, 3.0) 
   Chondroitin 356 2.0 (1.6, 2.3)     Ginseng 442 2.6 (2.2, 3.0) 
   Coenzyme Q10 173 1.0 (0.72, 1.3)     Graine 273 1.5 (1.2, 1.8) 
   Collagen 181 0.91 (0.70, 1.1)     Grape seed 180 0.94 (0.72, 1.1) 
   Enzyme 55 0.26 (0.16, 0.35)     Green tea 280 1.7 (1.4, 2.0) 
   Fiber 249 4.2 (3.7, 4.7)     Guarana 54 0.30 (0.19, 0.40) 
   Glucosamine 672 3.5 (3.0, 4.0)     Hawthorn 43 0.21 (0.11, 0.32) 
   Lipotropica 677 3.5 (3.1, 3.8)     Holy basil 30 0.22 (0.09, 0.35) 
   Lutein 1,606   9.6 (8.8, 10.4)     Horseradish 54 0.38 (0.21, 0.55) 
   Lycopene 1,688  10.5 (9.7, 11.4)     Horsetail 163 0.72 (0.54, 0.90) 
   MSM 273 1.4 (1.1, 1.7)     Licorice 236 0.96 (0.77, 1.2) 
   Omega-3 b 1,794 9.7 (8.9, 10.4)     Milk thistle 72 0.52 (0.25, 0.79) 
   Omega-6c 193 1.1 (0.81, 1.5)     Mint 54 0.27 (0.17, 0.36) 
   Omega-9 d 146 0.89 (0.58, 1.2)     Mushroom 102 0.44 (0.28, 0.61) 
   Probiotics 121 0.57 (0.41, 0.73)     Nettle 45 0.35 (014, 0.57) 
   Protein 362 2.2 (1.8, 2.6)     Olive leaf 40 0.21(0.11, 0.30) 
Botanicals       Parsley 155 0.89 (0.67, 1.1) 
   Aloe 128 0.60 (0.43, 0.76)     Pepper (black) 43 0.24 (0.11, 0.37) 
   Astragalus 48 0.30 (0.16, 0.45)     Pine bark 93 0.41 (0.28, 0.53) 
   Bioflavonoids 37 0.29 (0.15, 0.44)     Pumpkin seed 59 0.47 (0.27, 0.67) 
   Black cohosh 80 0.31 (0.22, 0.39)     Rhodiola 89 0.42 (0.28, 0.55) 
   Boswellia 82 0.28 (0.19, 0.37)     Rose hips 76 0.30 (0.21, 0.40) 
   Cascara/ Senna 96 0.41 (0.31, 0.55)     Rosemary 95 0.59 (0.41, 0.77) 
   Cayenne 96 0.42 (0.30, 0.54)     Sage 39 0.24 (0.12, 0.36) 
   Cinnamon 103 0.52 (0.37, 0.67)     Saw palmetto 107 0.86 (0.61, 1.1) 
   Chamomile 55 0.24 (0.16, 0.32)     Schisandra 59 0.36 (0.23, 0.49) 
   Dandelion 76 0.39 (0.26, 0.52)     Seaweed 216 1.0 (0.80, 1.3) 
   Dong quai 54 0.25 (0.15, 0.35)     Soy 103 0.50 (0.36, 0.64) 
   Echinacea 101 0.69 (0.49, 0.89)     Spirulina 158 0.87 (0.66, 1.1) 
   Elderberry 53 0.34 (0.18, 0.49)     Turmeric 80 0.38 (0.24, 0.52) 
   Eleuthero 105 0.57 (0.35, 0.79)     Uva Ursi 45 0.20 (0.12, 0.28) 
   Fennel 54 0.29 (0.19, 0.40)     Valerian 46 0.22 (0.14, 0.31) 
   Fo-ti 58 0.22 (0.14, 0.30)     Vegetable extract 438 2.3 (2.0, 2.7) 
   Fruit extracts 810 4.2 (3.7, 4.6)     Yerba Mate 42 0.26 (0.16, 0.36) 
a. Lipotropic:  lecithin, inositol.   
b. Omega-3:  fish oils, flaxseed oil; 
c. Omega-6:  linoleic acid, borage, evening primrose oils; 
d. Omega-9:  olive oil,  oleic acid; 
e. Grain: oats, wheat, corn, quinoa, alfalfa; 
Note:  Chamomile, Green tea, and Nopal are also commonly consumed as foods—no included in these estimates 
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CHAPTER 7: 
CHARACTERISTICS OF BOTANICAL SUPPLEMENT USERS IN THE HISPANIC COMMUNITY HEALTH 
STUDY/STUDY OF LATINOS 
 
7.1 Introduction 
Hispanics/Latinos are the largest minority groups in United States (US). Currently, Mexicans 
make up the majority of the Hispanics living in the US, but the number of immigrants from other 
countries is growing rapidly [173]. Hispanics/Latinos increasingly encompass individuals from varied 
cultural traditions with differences in dialects, primary language, and traditions [22] as well as 
different experiences within the US. Shared health belief have been posited [174], but the extent to 
which these belief systems influence commonalities across Hispanic/Latino background groups in the 
use of botanical supplements is less clear. Studies that have reported botanical supplement use 
patterns among Hispanics/Latinos largely have largely focused on a single region (e.g., Mexican 
Americans in Texas and/or southwestern US)[50, 59] making comparisons of the unique characteristics 
across subgroups more challenging and potentially leading to stereotypes and misconceptions about the 
use of botanical supplements among different groups of Spanish-speaking patients.  In addition, 
characteristics of botanical supplement users across Hispanic/Latino subgroups have been poorly 
characterized due to the lack of a large enough sample of Hispanics/Latinos of different backgrounds. 
Unlike in the general population, factors related to botanical supplement use among 
Hispanics/Latinos are incompletely understood.  Education appears either to play a limited role or to 
vary across categories of acculturation [50, 51]. Moreover, the operational definition of acculturation 
itself is variable  Most studies including acculturation as a covariate limit its definition to length of 
residence in the US and/or primary language [57, 135], the latter possibly conflated with employment 
opportunity and income rather than Hispanic/Latino identity [40].  Other studies include acculturation 
scales, such as the Short  Acculturation Scale for Hispanics/Latinos [140], to assess the degree to which 
individuals are oriented to the new vs. the initial culture.   Some studies report higher botanical 
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supplement prevalence estimates among recent immigrants [5, 29, 59, 175], but others find no 
association between length of residence and the prevalence of botanical supplement use [33, 40, 60, 
135].  Moreover, a closer examination of the studies suggests that overall prevalence may not differ 
much by acculturation, regardless of its measurement, but by the types of botanicals used.   In one 
study, botanical use patterns among those with higher US acculturation scores were more similar to 
that of the non-Hispanic white (NHW) sample than to less acculturated Hispanics/Latinos [29].  
Similarly, in a small study of middle-aged Mexican American women, those who used botanical 
supplements common among Hispanics/Latinos scored higher on the Mexican orientation of an 
acculturation scale as compared with women who used botanical supplements popular in the US 
population [46]. 
Because the definition of botanical supplements varies across studies, comparisons of patterns 
of use across studies are challenging.  Some studies of botanical supplement use may count teas, 
extracts, tinctures and raw botanicals with or without non-botanical components [6, 59] while others 
may be limited to commercially-available products [122].   Often, botanical supplements are 
categorized with other non-vitamin, non-mineral (NVNM) supplement products, such as glucosamine 
and probiotics [78, 108].   
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) provides a unique 
opportunity to address some of the challenges inherent in measuring botanical supplement intakes 
among diverse groups of Hispanics/Latinos.  The sampling strategy of HCHS/SOL, ensuring 
representation of all Hispanic/Latino background groups, provides the basis for estimating patterns of 
use particular to Hispanics/Latinos.  This report examines botanical usage patterns by Hispanic/Latino 
background across different botanical supplement definitions and explores reported reasons for use.    
7.2 Methods 
Study Population 
HCHS/SOL, a prospective cohort study, examines prevalence of disease among Hispanic/Latino 
residents in four US communities:  Miami, Bronx, Chicago, and San Diego. The study employed a two-
stage area household probability design utilizing census tracts [136, 137] to achieve a balanced 
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recruitment of Hispanics/Latinos from across countries of origin,   income diversity, and neighborhood 
Hispanic/Latino concentration  [137]. Sampled  individuals within households were screened for 
eligibility (living in the household, age 18-74, ability to attend a clinic visit)[136].  From 2008-2011, 
enrolled subjects attended a comprehensive baseline visit at the study field center including 
demographic, medical, nutrition, and physical activity assessments.  This report utilizes baseline cross-
sectional data from 13,789 individuals with complete data for all variables of interest of the 16,415 
non-institutionalized adults, self-identified as Hispanic/Latino.  
Botanical supplement assessments and definitions  
Botanical supplement use was assessed via a past 4-week medication inventory and a detailed 
past 30-day dietary supplement interview.  Consumption of other botanicals was derived from two 24-
hour dietary recalls, assessing intakes of foods as well as botanical teas, traditional medicinal foods, 
and other dietary supplements.  Outcomes in this report are based on defining a supplement user as a 
person reporting use by either the medication inventory or dietary supplement interview with or 
without the addition of botanical supplements captured in the 24-hour food recall. This study employed 
three overlapping definitions of botanical supplements: 1) products with botanical ingredients; 2) 
products with botanical ingredients plus other NVNM ingredients, such as probiotics and  glucosamine; 
and 3) products with botanical ingredients plus raw plants (dried or fresh) often used as medicinal 
substances according to available literature (e.g., botanical teas, nopal, aloe)[170].   
Reasons for botanical use 
In the dietary supplement interview, participants reported reasons for taking each supplement 
and these were recorded verbatim.  Text files were reviewed and grouped into categories.  Because 
multiple reasons were given for use of some supplements, categories are not mutually exclusive.   
Population characteristics of interest 
Self-reported Hispanic/Latino background was of interest.   Background groups included:  
Dominican, Cuban, Puerto Rican, Mexican, Central American, South American, and “other 
Hispanic/Latino”.  The latter classification included individuals reporting more than one background 
group.  Variables associated with botanical supplement use in other population-based studies were also 
 
 
73 
 
of interest.  These included:   1) age (18-24, 25-34, 35-44, 45-54, 55-64, 65-76); 2) gender; 3) 
education (< high school, high school graduate, post high school; 4) wealth (percent of poverty for 
household size in the intake year as defined by the US Census in 4 categories:  ≤100% , 101-200%, 201-
300%, and >300%)); 5) insurance status (no insurance vs. any ); 6) perceived lack of access to care 
(“Were you unable to get healthcare when you needed it?”--no lack of access) 7) cigarette smoking 
(nonsmoker vs. smoker); 8) physical activity—adequate activity as defined by 2008 guidelines from the 
Center for Disease Control and Prevention; 9) use of prescription medications (vs. no medication use)); 
11) perceived health as measured by the Rand short form, (“Compared with a year ago, how would you 
rate your current health”, categorized as very good to excellent, good ),and fair to poor; and 12) 
location of the HCHS/SOL field center (Bronx).  In addition, acculturation was measured via the Short 
Acculturation Scale for Hispanics (SASH)[141].  SASH measures orientation to Spanish language and 
preferences for Hispanic/Latino media and social interactions [52].  Finally, dietary patterns as defined 
by the Alternative Healthy Eating Index (AHEI) based on US Dietary Guidelines and scientific studies of 
diet and health outcomes [150, 151].  A maximum value of 110 is related to consumption of  
red/processed meats, sugar-sweetened beverages, trans fat,  vegetables, fruit, whole grains, 
nuts/legumes, long-chain n-3 fatty acids, total polyunsaturated fatty acids, sodium, and alcohol [151].   
 Statistical analysis 
All variables were examined for distributions and missing data—only the income variable was 
missing more than 5% of values (8%).    Because of the complex sampling design, sampling and 
nonresponse weights were applied, completed with Stata 13 (StataCorp LP, College Station, TX) survey 
commands. Sample characteristics were estimated across Hispanic/Latino background, standardized to 
the age distribution of the 2010 US census.  
Logistic models were constructed to identify the set of variables independently associated with 
botanical supplement use.  Backward elimination strategies defined significant associations.    Log 
binomial models—reporting prevalence ratios and predicted prevalence—were constructed to assess the 
association between variables of interest and botanical use, controlling for potential confounding 
variables.  Confounding variables were determined through a graphical process, a directed acyclic 
graph, that enables definition of a minimally-sufficient adjustment set of confounders for each 
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exposure-outcome association.[156]  Each model was examined for prevalence ratio modification.  
Partial F tests including all potential interactions with the variable of interest tested statistical 
significance of potential modifiers.  Summary prevalence ratios are reported; modifiers with consistent 
impacts on the estimates are discussed.   
7.3 Results 
Differences in variables reportedly associated with botanical use were noted across 
Hispanic/Latino background (TABLE 7.1).  Notably, Cubans tended to be better educated and incomes 
were higher among Puerto Ricans, who were also more likely to have lived in the US 10 years or longer.  
Central and South Americans were least likely to have been born in the US.   
Independent associations 
The following variables were independently associated with botanical supplement use:  
Hispanic/Latino background, age, female gender, wealth, education, having no insurance, healthy 
dietary pattern, physical activity, nonsmoking, medication use.  Perceived health and perceived lack of 
healthcare access and acculturation were not independently associated with botanical supplement. 
Model discrimination was 0.66.  Field center location was too collinear with Hispanic/Latino 
background to include both in most models.  When it was entered instead of Hispanic/Latino 
background, field center location was significantly associated with botanical supplement use. 
Because of the increased prevalence when NVNM supplements were added to the botanicals, 
cross-classification of site and background could be included in the model.  Models of NVNM 
supplement use were independently associated with field center by Hispanic/Latino background, age, 
gender, wealth, education, and positive lifestyle behaviors, but not insurance.  Botanical teas and 
nopal (prickly pear cactus fruit) added to botanical supplements were independently associated with 
the same variables.  There was a suggestion of heterogeneity by acculturation, which was explored in 
detail in additional models. 
Patterns of botanical supplement use by population characteristics 
Controlling for age and gender, the prevalence of botanical use varied substantially across 
Hispanic/Latino background (TABLE 7.2, FIGURE 7.1). Mexicans reported the greatest prevalence of 
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botanical products at 17% (95% CI:  15-19%); prevalence estimates for Central and South Americans 
were similar (14 and 16%, respectively).  Individuals with a Puerto Rican, Cuban, or Dominican 
background reported taking products with botanical ingredients with almost half the prevalence as did 
individuals with Mexican backgrounds (TABLE 7.2).   
Variations across botanical supplement definitions were less marked.  Adding other NVNM 
products to botanicals attenuated the differences among background groups. Conversely, adding 
botanical teas from the 24-hour dietary food recalls to the definition of a botanical supplement tended 
to exaggerate the differences among background groups with prevalence ratios ≤0.50 for individuals 
from Puerto Rico or Cuba compared with those from Mexico. 
Botanical use increased with age, income, and education across all definitions, though with 
evidence of heterogeneity (FIGURE 7.2).  With high acculturation (SASH score = 4), individuals with a 
post-secondary education were 2.7 times as likely to use botanical supplements (with teas) as those 
with less than a high school education.  With low acculturation (SASH score = 1), individuals with high 
acculturation were only 1.1 times as likely to take botanical supplements.   
Women were more likely to take botanical supplements than men, but differences were small 
at higher incomes (38% for both genders at an income 301% of the poverty threshold or more, compared 
with 24 vs. 20 % at <100% of the poverty threshold).   Increases in use with age was more evident for 
NVNM products—compared with individuals 18-24 years old, those 65-76 were 3 1/2 times as likely to 
take NVNM products.   
Across all definitions, botanical use increased with positive health behaviors (healthy dietary 
pattern, physical activity, non-smoking).  For example, for each 5 point increase in the AHEI, the 
probability of supplement use increased by 12-20%.  Active individuals were about 1.2 times as likely to 
be botanical users as inactive ones.  Again, some heterogeneity was noted: nonsmokers from Caribbean 
backgrounds were 1.5 times as likely to take NVNM supplements as smokers, but non-smokers from 
continental Latin America were not significantly more likely to take NVNM supplements. Individuals 
who considered themselves in very good to excellent health were more likely to report botanical use 
than those who reported fair to poor health.  Prescription medication use was more common among 
botanical supplement users.   
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Substantial differences were present in prevalence by HCHS/SOL field center location.  
Individuals in San Diego were more than twice as likely to consume botanical products as individuals in 
the Bronx (PR 2.20; 95% CI 1.82, 2.68).   Prevalence of NVNM supplement use in San Diego and Miami 
was similar (31% and 33%, respectively), bur lower in Chicago (24%) and the Bronx (21%).   Compared 
with Dominicans in the Bronx, continental Latin Americans, and Puerto Ricans were about as likely to 
take botanical supplements.  However, in Chicago, continental Latin Americans were more likely to 
take botanical supplements than Puerto Ricans (TABLE 7.3). 
Motivations for botanical supplement use 
Individuals reported taking botanical and other NVNM supplements for a number of reasons 
(FIGURE 7.3) , including for: 1)  physical health conditions (e.g., anemia, cancer, diabetes, eye health, 
heart or lung disease, kidney disease, lipid control, pain, prostate care, poor appetite); 2) mental 
health (stress, mental clarity); 3) illness prevention (general health,  detoxification, immunity, bone 
health); 4) digestion/ bowel health; 5) to improve training and energy; and 6) to improve appearance 
(hair, skin, nails, weight loss).  Another 34% of botanical users reported taking the product to 
supplement or compensate for an inadequate diet.  Almost 10% of botanical users gave nonspecific 
reasons for use or were not sure why they were taking supplements.  Ten percent reported that their 
botanical supplement had been recommended by their health care provider while 5.7% reported that a 
friend or family member had recommended the product.   Reasons given for botanical use varied less 
across Hispanic/Latino background (TABLE 7.4).  A statistically significant difference emerged in the 
use of botanicals to increase energy, particularly for NVNM:  controlling for age, Cuban and South 
Americans reported that they used 15% of supplements for energy, compared to about 20 % of 
Mexicans, Dominicans and Central Americans, and 33% of Other Hispanics/Latinos.  Puerto Ricans and 
Dominicans were less than half as likely to report botanical supplement use for pain as Cubans and 
Mexicans.   
7.4 Discussion  
Differences in the prevalence of botanical supplement use in Hispanic/Latino background 
groups were marked.  Individuals with a self-reported Dominican, Cuban, or Puerto Rican background 
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were much less likely to report taking botanical supplements than individuals with a Mexican, Central 
or South American background.  Differences were greater with the addition of botanical teas and were 
less evident when including other NVNM supplements.  
In general, in HCHS/SOL, patterns of supplement use were similar across Hispanic/Latino 
background groups and these patterns were similar to those reported in the general US public.  
Botanical supplement use increased with age, female gender, education, income, and adherence to 
healthy lifestyle behaviors.  However, some heterogeneity was noted across education categories:  
more educated individuals were markedly more likely to take botanical supplements with increasing 
acculturation, but this pattern was not present among less educated individuals, especially when 
botanical teas were added.   
In the 2007 NHIS, prevalence of botanical supplements (including NVNM and special diets) was 
greatest among Puerto Ricans and differences across Hispanic/Latino background were small [122].  
Otherwise, characteristics of supplement users in the overall US population were similar to those 
described in HCHS/SOL:  increasing prevalence with age (to age 69), education, and income [122].  In 
multivariate logistic regression models in the  2002 NHIS, botanical supplement use was associated with 
female gender, living in the northeast or west, having no medical insurance, perceived poor to fair 
health, and taking medication [176].  In contrast, in HCHS/SOL, botanical use was least common in the 
northeast (Bronx) and health perceived as very good or excellent was associated with greater use.  In 
both the 2002 NHIS and the 1998 MEPS survey, individuals with perceived lack of access to healthcare 
were more likely to use botanical supplements [177, 178]; in HCHS/SOL, neither having insurance nor 
perceived access to care appeared to be strongly associated with botanical use.  In the Vitamins and 
Lifestyle study, botanical use was associated with a healthier lifestyle, including greater physical 
activity, non-smoking, and greater intakes of fruits/vegetables [127].  Similar patterns were seen in 
HCHS/SOL:  nonsmokers had about 1.4 times the probability of botanical use compared with smokers. 
The association of botanical use with healthy dietary patterns (AHEI 2010) was particularly strong:  
prevalence of botanical use was 18 % (95% CI: 16, 21) in the top quintile of AHEI compared with 8% (95% 
CI: 8, 10) in the lowest quintile.   
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In previous studies among Hispanics/Latinos, patterns have been more mixed, particularly with 
regard to acculturation variables.  In a study of patients in New Mexico (2000-2001), low acculturation 
as measured with the SASH scale, was associated with greater use of botanicals [29].  In contrast, in 
the 2002 NHIS, acculturation, defined as nativity plus years of residence in the US, was not predictive 
of botanical use [56].  In HCHS/SOL, greater acculturation (SASH scale) was associated with a higher 
probability of botanical and NVNM product use, but did not predict the use of botanical supplements 
when botanical teas were included—in fact the trend was in the opposite direction.  Two studies have 
reported that more acculturated Hispanics/Latinos use botanical supplements similar to the general US 
public and the less acculturated use botanical home remedies [29, 50]. 
Motivations for botanical supplement use closely corresponded to those reported in the 2007-
2010 NHANES, with slightly greater emphasis in HCHS/SOL on supplements for weight loss, energy, and 
mental health. 
Limitations 
This study was limited in that specific prompts for supplements historically prominent in some 
Hispanic/Latino populations were not included in assessments [170].  However, addition of botanical 
teas and other traditional products from the food-based dietary recall mitigated that deficiency.  In 
addition, the current analysis defined botanical supplement use broadly to lessen any impacts of under-
assessment.   
The necessity of excluding individuals with data missing for any of the variables possibly 
resulted in selection bias.  Although both sampling and nonresponse weights were applied, the extent 
of the missing data could have had an impact on the results, especially in that the analysis dataset was 
enriched with individuals more likely to take botanical supplements.  A sensitivity analysis based on 
multiple imputation is underway, but imputation itself is sensitive to model misspecification and may 
be less reliable in complex survey data [179]. 
Importance for prevention 
 In this study, botanical supplement use was strongly associated with positive lifestyle 
behaviors.  Moreover, reasons for supplement use indicated interest in self-care and prevention. 
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Unfortunately, although individuals are choosing to take botanical supplements to improve their 
health, the potential for harm associated with their use is real. Botanical supplements are often taken 
with medications, increasing concerns botanical-medication interactions [9, 180].    Product 
contamination, either intentional (e.g., addition of undeclared drugs)[181] or accidental (e.g., plant 
misidentification) is problematic [163] and may be more common in imported products [14].  Up to 30% 
of Mexican Americans obtain botanical supplements from Mexico [6, 12, 13], increasing worries about 
product safety.  In spite of the potential risks, rates of disclosure of botanical supplement use to 
physicians are low;  only about a third of supplement users report their use to healthcare providers and 
rates are often lower among Hispanics/Latinos [7, 31, 39].  In both provider-patient interactions and 
public health messaging, culturally-sensitive and respectful communication is in order, encouraging 
disclosure by asking about and honoring what individuals choose to improve their health and sharing 
what is known about the safety and effectiveness of botanical supplements.  Urgently needed is more 
research in botanical safety and effectiveness, better education of healthcare providers (including 
pharmacists, physicians, extenders, and nurses), and better surveillance of supplement use and 
products. 
Conclusions  
Botanical supplement use in HCHS/SOL varied greatly by Hispanic/Latino background, but overall, 
characteristics of botanical supplement users and motivations for use indicate an interest in health 
improvement.  Improving botanical supplement disclosure will require considerate, culturally-sensitive 
communication.    
 
 
 
 
TABLE 7.1 HCHS/SOL Study population characteristics by Hispanic/Latino background and botanical supplement use 
   Dominican 
N = 1,206 
Central American 
N=1,427 
Cuban 
N=1,890 
Mexican 
N=5,642 
Puerto Rican 
N=2,273 
South American 
N = 930   
   mean  or 
% (se)a 
mean  
or % 
(se) 
mean  or 
% (se) 
mean  
or % 
(se) 
mean  or 
% (se) 
mean  
or % 
(se) 
mean  or 
% (se) 
mean  
or % 
(se) 
mean  or 
% (se) 
mean  
or % 
(se) 
mean  or 
% (se) 
mean  
or % 
(se) 
    Non-
users Users 
Non-
users Users 
 Non-
users Users 
 Non-
users Users 
 Non-
users Users 
 Non-
users Users 
 Mean age Nb 39 (0.8) 43 (1.8) 39 (0.5) 44 (1.3) 47 (0.5) 49 (1.5) 38 (0.4) 42 (0.7) 43 (0.6) 44 (1.5) 43 (0.8) 43 (1.8) 
 % Female 13,789 60 (2) 69 (5) 51 (2) 55 (5) 44 (1) 52 (4) 51 (1) 61 (3) 49 (2) 52 (5) 54 (2) 61 (6) 
 Mean SASH score 11,020 39 (0.8) 43 (2) 39 (0.5) 44 (1) 47 (0.5) 49 (2) 38 (0.4) 42 (0.7) 43 (0.6) 44 (1) 43 (0.8) 43 (2) 
 % in US 10+ years 10,732 76 (2) 80 (4) 67 (2) 66 (5) 51 (2) 64 (5) 78 (1) 78 (2) 93 (1) 93 (3) 58 (3) 69 (4) 
 Education (%)              
  < HS 5,038 38 (2) 27 (5) 39 (2) 30 (4) 19 (1) 12 (2) 40 (2) 30 (2) 35 (2) 19 (3) 23 (2) 19 (3) 
  HS graduate 3,595 24 (2) 21 (4) 28 (2) 19 (4) 32 (2) 33 (5) 29 (1) 23 (2) 29 (2) 14 (3) 29 (2) 14 (3) 
  Post-secondary 5,156 38 (2) 53 (5) 33 (2) 51 (5) 50 (5) 55 (5) 32 (2) 47 (3) 36 (2) 56 (5) 48 (3) 67 (5) 
 Percent of poverty threshold (%)             
  0 – 100% 5,623 49 (2) 40 (5) 50 (2) 32 (3) 39 (2) 27 (4) 40 (2) 31 (2) 38 (2) 28 (4) 38 (3) 27 (4) 
  101 – 200% 5,002 35 (2) 36 (5) 34 (2) 39 (4) 37 (1) 44 (5) 35 (1) 39 (2) 30 (2) 29 (4) 39 (2) 42 (5) 
  201 – 300% 1,834 11 (1) 8 (3) 11 (1) 13 (3) 13 (1) 19 (4) 13 (1) 14 (1) 16 (2) 18 (4) 13 (2) 13 (3) 
  300% or more 1,330 5 (1) 16 (5) 5 (1) 16 (4) 10 (1) 10 (3) 11 (1) 16 (3) 16 (1) 25 (4) 11 (2) 19 (3) 
 % with insurance 7,012 71 (2) 76 (4) 34 (2) 34 (4) 39 (2) 35 (5) 45 (1) 45 (3) 79 (1) 69 (4) 43 (3) 40 (5) 
 % lacking HC access 2,323 14 (1) 17 (4) 20 (2) 24 (4) 19 (1) 23 (4) 12 (1) 13 (2) 15 (1) 15 (4) 18 (2) 17 (4) 
 % physically active d 8,874 66 (2) 67 (5) 69 (2) 77 (3) 57 (2) 62 (4) 68 (1) 74 (2) 68 (2) 76 (3) 68 (2) 80 (3) 
 Mean AHEI 13,789 49 (0.2) 50 (0.5) 48 (0.2) 48 (0.4) 43 (0.1) 44 (0.4) 53 (0.2) 54 (0.3) 41 (0.2) 42 (0.5) 46 (0.3) 47 (0.6) 
 % Nonsmokers 9,516 88 (2) 92 (2) 86 (1) 86 (3) 72 (2) 87 (3) 82 (1) 86 (2) 66 (2) 78 (4) 88 (1) 88 (4) 
 % taking medicatione 7,291 35 (2) 40 (4) 31 (2) 40 (4) 37 (1) 39 (4) 34 (1) 39 (2) 36 (1) 44 (4) 28 (2) 29 (2) 
 Perceived health (%)              
  Fair to poor 4,022 26 (2) 34 (5) 29 (2) 30 (5) 31 (2) 35 (5) 27 (1) 29 (3) 27 (2) 32 (50 31 (2) 38 (5) 
  Good 6,434 39 (2) 37 (5) 46 (2) 50 (5) 46 (2) 40 (4) 51 (1) 50 (2) 41 (2) 39 (5) 51 (2) 44 (5) 
  Very good -excellent 3,333 35 (2) 30 (4) 24 (2) 21 (3) 23 (1) 25 (3) 22 (1) 21 (2) 32 (2) 29 (4) 19 (2) 18 (3) 
Abbreviations:  SASH= Short Acculturation Score for Hispanics; HS = high school; HC = health care; AHEI = alternative healthy eating index.   a. All estimates (except age) are 
standardized to the age distribution of the US 2010 census with application of sampling and non-response weights.  b. N = number of respondents in sample, not representative 
sample.  c. Percents reflect sample weights. d. Physical activity data was summarized as meeting or not meeting CDC 2008 guidelines for physical activity. e. category counts 
prescription medication 
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     TABLE 7.2 Adjusted prevalence ratios of botanical supplement use in HCHS/SOL 
  
Users of products with 
NVNM ingredients 
N= 4,873 
Users of   
products with botanical 
ingredients 
N=2,246 
Users of  botanical 
supplements 
including teas 
N=3,479 
  
N 
Prevalence Ratio 
(95% CI) c 
Prevalence Ratio 
 (95% CI) c 
Prevalence Ratio 
 (95% CI) c 
Hispanic/Latino background     
 Dominican 1,206 0.72 (0.62, 0.84) 0.54 (0.43, 0.69) 0.57 (0.49, 0.67) 
 Central American 1,432 1.05 (0.93, 0.1.18) 0.94 (0.78, 1.12) 0.71 (0.62, 0.82) 
 Cuban 1,890 0.87 (0.78, 0.98) 0.62 (0.51, 0.75) 0.47 (0.40, 0.54) 
 Mexican 5,642 1 1 1 
 Puerto Rican 2,273 0.75 (0.66, 0.85) 0.58 (0.47, 0.70) 0.45 (0.38, 0.54) 
 South American 932 1.07 (0.94, 1.23) 0.85 (0.67, 1.07) 0.99 (0.86, 1.14) 
 Other 414 0.99 (0.79, 1.25) 0.73 (0.51, 1.04) 0.68 (0.50, 0.93) 
Age   (18-24 referent) 1,254 1 1 1 
 25-34 1,788 1.56 (1.25, 1.94) 1.73 (1.30, 2.31) 1.51 (1.20, 1.90) 
 35-44 2,593   2.14 (1.75, 2.63) 1.87 (1.41, 2.46) 1.90 (1.53, 2.35) 
 45-54 4,232   2.71 (2.24, 3.28) 2.02 (1.55, 2.64) 2.00 (1.62, 2.45) 
 55-64 2,894 2.99 (2.43, 3.67) 1.93 (1.45, 2.57) 2.00 (1.60, 2.50) 
 65-76 2,894 3.56 (2.87, 4.40) 2.12 (1.53, 2.95) 2.14 (1.67, 2.74) 
Female gender (male ref.) 8,158 1.16 (1.07, 1.26) 1.30 (1.14, 1.47) 1.46 (1.32, 1.62) 
SASH scale (per  1 point increase) 2,408 1.13 (1.07, 1.19) 1.13 (1.05, 1.22) 0.96 (0.90, 1.02) 
Education (< HS , < 10 years in US) 5,038 1 1 1 
 HS graduate,  < 10 years in US 3,595 1.04 (0.84, 1.30) 0.92 (0.69, 1.23) 0.93 (0.75, 1.15) 
  >HS,  < 10 years in US 5,156 1.39 (1.12, 1.71) 1.25 (0.93, 1.66) 0.98 (0.79, 1.22) 
 HS graduate, 10+ years in US  1.18 (1.06, 1.31) 1.20 (1.01, 1.42) 1.13 (0.99, 1.28) 
  >HS, 10+ years in US  1.68 (1.54, 1.85) 2.04 (1.76, 2.36) 1.59 (1.42, 1.77) 
Percent of poverty (0 – 100% ref.) 5,623 1 1 1 
    101 – 200% 5,002 1.21 (1.11, 1.31) 1.35 (1.18, 1.53) 1.20 (1.09, 1.33) 
    201 – 300% 1,834 1.37 (1.22, 1.54) 1.47 (1.02, 1.46) 1.23 (1.04, 1.45) 
    300% or more 1,330 1.50 (1.35, 1.68) 1.65 (1.37, 1.98) 1.38 (1.20, 1.59) 
Insurance (uninsured ref.) 7,012 0.99 (0.91, 1.08) 0.89 (0.79, 1.03) 0.96 (0.86, 1.06) 
Lacking healthcare access  2,323 1.02 (0.93, 1.12) 1.12 (0.96, 1.30) 1.08 (0.95, 1.23) 
Physical activity (low activity ref.) 8,874 1.21 (1.12, 1.29) 1.36 (1.17, 1.59) 1.11 (1.02, 1.22) 
AHEI (per 5 points) 13,789 1.12 (1.08, 1.15) 1.17 (1.11, 1.22) 1.20 (1.16, 1.23) 
Nonsmoker (smoker ref.)* 9,516 1.38 (1.24, 1.55) 1.31 (1.08, 1.58) 1.47 (1.28, 1.68) 
Prescription Medication use 7,291 1.18 (1.09, 1.28) 1.21 (1.07, 1.36) 1.09 (0.95, 1.25) 
Perceived health ( fair to poor ref.) 4,022 1 1 1 
 Good 6,434   1.01 (0.93, 1.10) 1.07 (0.92, 1.24) 1.11 (0.99, 1.25) 
 Very good to excellent 3,333   1.16 (1.05, 1.28) 1.21 (1.03, 1.43) 1.21 (1.07, 1.37) 
 
Abbreviations:  AHEI = alternative healthy eating index.  a. Supplement users were defined as users by either the 
medication history or the dietary supplement interview +/- data from the dietary recalls. All estimates (except age) are 
standardized to the age distribution of the US 2010 census.  Models presented here are summary models.  Control 
variables in models are as follows:  Hispanic/Latino background – age and gender; age –gender ; education—
acculturation  variables, age, gender, and Hispanic/Latino background; poverty—age , gender, education, field center 
location; insurance—acculturation, age, field center location, percent of poverty;  perceived healthcare access—
acculturation, age, gender, Hispanic/Latino background, percent of poverty, insurance, medication use; acculturation—
age, gender, field center location; health behaviors—age, gender, Hispanic/Latino background, percent of poverty, 
insurance coverage, perceived access to care; perceived health—age, gender, education, acculturation..  *indicates 
statistically significant prevalence ratio modification: See Supplemental Table 1.    
 
 
 
 
 
FIGURE 7.1.  Comparison of model-predicted prevalence of use of botanicals in the past 30 days by various definitions across 
Hispanic/Latino background 
Estimates are based on model-predicted marginal means with 95% confidence intervals.  Botanicals include any product with a botanical ingredient, botanicals with teas also 
include botanical teas from the 24-hour dietary recall files, NVNM products include botanicals and other non-vitamin, non-mineral ingredients (e.g., fish oil, glucosamine).  All 
estimates are weighted (sample, non-response). 
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FIGURE 7.2.  Heterogeneity in the association of education and years of residence in the US with botanical supplement use 
Estimates are based on model-predicted marginal means with 95% confidence intervals.  Botanical products include any product with a botanical ingredient, botanicals with teas 
also include botanical teas from the 24-hour dietary recall files, NVNM products include botanicals and other non-vitamin, non-mineral ingredients (e.g., fish oil, glucosamine).<Hs 
= less than high school education,  HS = high school graduate , >HS =post-secondary education.  <10  and 10+ years indicates years of  residence in the US.  All estimates are 
weighted (sample, non-response). 
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FIGURE 7.3.  Comparison of selected reasons for use of botanicals and NVNM across Hispanic/Latino background 
Individuals reported reasons for use of each supplement in the 30-day dietary supplement interview.  Percentage is reported with sample and non-response weights yielding 95% 
confidence intervals. Botanicals are commercial supplements with botanical ingredients; NVNM are supplements with botanical and other non-vitamin, non-mineral ingredients 
(e.g., glucosamine, fish oil). 
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TABLE 7.3.  Botanical supplement use across Background and Site in the Hispanic Community Health Study/Study of Latinos 
    Users of products with NVNM 
ingredients 
N= 4,873 
Users of   
products with botanical ingredients 
N=2,246 
Users of  botanical supplements 
including teas 
N=4,108 
 
 Background Site N n % (95% CI)  n % (95% CI) n % (95% CI)  
           
 Dominican Bronx 1,221 289 20.2 (17.5, 23.2) 116 8.7 (6.8, 10.9) 222 16.2 (13.9, 18.8)  
 Central American Bronx 171 51 26.1 (19.4, 34.1) 16 10.5 (5.9, 18.0) 30 16.2 (10.8, 23.6)  
 Mexican Bronx 190 34 17.4 (11.7, 25.1) 20 9.5 (5.6, 15.8) 39 19.4 (13.2, 27.6)  
 Puerto Rican Bronx 1,538 354 20.4 (17.6, 23.5) 118 7.2 (5.8, 9.0) 203 12.8 (10.4, 15.7)  
 South American Bronx 165 39 20.6 (14.8, 27.9) 20 11.5 (6.9, 18.5) 44 28.0 (20.3, 37.2)  
 Other Bronx 222 44 28.4 (22.0, 35.7) 16 7.7 (3.9, 14.8) 34 13.3 ( 8.1, 20.8)  
 Central American Chicago 411 140 31.4 (26.5, 36.7) 60 10.4 (7.6, 14.3) 128 28.3 (23.0, 34.2)  
 Mexican Chicago 2,384 634 24.4 (22.0, 27.0) 329 12.9 (10.9, 15.1) 721 27.2 (25.0, 29.6)  
 Puerto Rican Chicago 761 218 23.1 (19.6, 27.1) 84 9.7 (7.2, 12.8) 126 15.7 (12.8, 19.2)  
 South American Chicago 371 127 29.0 (22.4, 36.7) 70 15.1 (10.9, 20.5) 127 28.5 (23.0, 34.8)  
 Other Chicago 150 39 27.8 (14.9, 45.7) 21 14.4 (8.6, 23.1) 33 24.1 (16.1, 34.6)  
 Central American Miami 1,023 349 31.8 (28.7, 35.1) 166 16.4 (13.9, 19.2) 239 22.1 (19.4, 25.0)  
 Cuban Miami 2,248 665 25.4 (23.3, 27.6) 234 9.7 (8.2, 11.5) 353 15.1 (13.0, 17.5)  
 South American Miami 464 195 37.8 (32.9 (42.9) 85 15.6 (12.1, 19.9) 162 33.5 (28.5, 39.0)  
 Other Miami 295 105 32.6 (26.6, 39.1) 52 17.9 (13.1, 24.1) 78 26.8 (21.0, 33.6)  
 Mexican San Diego 3,781 1,480 34.8 (32.0, 37.7) 789 17.9 (16.1, 19.9) 1,477 35.0 (32.4, 37.8)  
 Other San Diego 243 102 39.7 (30.6, 49.6) 47 17.2 (11.3, 25.2) 85 36.5 (27.9, 46.0)  
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TABLE 7.4.  Reasons for botanical /NVNM supplement use in HCHS/SOL 
    
Overall   
% (n)* Dominican 
% (n) 
Central 
American 
% (n) 
Cuban 
% (n) 
Mexican 
% (n) 
Puerto 
Rican 
% (n) 
South 
American 
% (n) 
Other 
Hispanic-
Latino 
% (n) 
 
 Conditions Anemia 3.4 (150) 5.2 (17) 2.7 (14) 2.5 (15) 2.7 (52) 5.0 (31) 3.7 (13) 6.5 (8)  
  Increase appetite 0.9 (38) 1.8 (6) 1.5 (8) 1.2 (7) 0.3 (6) 1.4 (9) 0.3 (1) 0.8 (1)  
  Cancer 1.0 (45) 1.5 (5) 1.0 (5) 1.2 (7) 1.0 (19) 0.3 (2) 1.4 (5) 1.6 (2)  
  Diabetes 1.6 (70) 0.6 (2) 0.8 (4) 1.2 (7) 2.2 (42) 1.0 (6) 1.7 (6) 2.4 (3)  
  Eye/Ear health 2.7 (119) 2.1 (7) 2.5 (13) 2.0 (12) 2.9 (56) 2.6 (16) 3.4 (12) 2.4 (3)  
  Indigestion 1.3 (56) 0.6 (2) 0.8 (4) 0.3 (2) 1.7 (33) 1.1 (7) 1.4 (5) 2.4 (3)  
  Gynecological 5.0 (221) 7.0 (23) 4.4 (23) 4.1 (24) 5.5 (105) 3.6 (22) 5.4 (19) 4.1 (5)  
  Heart/Lipid health 12.8 (568) 18.5 (61) 11.4 (59) 9.7 (57) 11.0 (210) 18.4 (113) 13.1 (46) 17.9 (22)  
  Kidney disease 0.8 (36) 1.2 (4) 0.4 (2) 0.7 (4) 1.0 (18) 0.3 (2) 1.1 (4) 1.6 (2)  
  Joint health 13.0 (716) 5.5 (18) 15.2 (79) 14.0 (82) 19.6 (374) 11.7 (72) 21.4 (75) 13.0 (16)  
  Liver health 1.5 (65) 0.6 (2) 2.1 (11) 1.5 (9) 1.3 (24) 1.9 (12) 1.4 (5) 1.6 (2)  
  Lung disease 1.6 (70) 3.3 (11) 2.1 (11) 2.0 (12) 0.9 (18) 2.3 (14) 1.1 (4) 0  
  Pain 10.7 (474) 7.3 (24) 10.6 (55) 11.1 (65) 11.6 (221) 7.6 (47) 14.3 (50) 9.8 (12)  
  Prostate/ Sexual  1.9 (86) 1.5 (5) 1.7 (9) 3.6 (21) 1.6 (30) 1.8 (9) 2.0 (7) 2.4 (3)  
  Other conditions 1.2 (55) 0.9 (3) 0.6 (3) 1.5 (9) 1.3 (24) 1.6 (1.6) 1.4 (5) 0.8 (1)  
 Nutrition Supplement diet 28.6 (1,268) 20.4 (67) 26.8 (139) 24.3 (143) 31.0 (593) 30.4 (187) 27.4 (96) 35.0 (43)  
 Prevention Healthy aging 2.1 (95) 2.4 (8) 1.9 (10) 0.7 (4) 2.5 (47) 2.4 (15) 2.9 (10) 0.8 (1)  
  Bone health 22.8 (1,013) 27.7 (91) 21.4 (111) 11.9 (70) 23.7 (454) 27.3 (168) 25.7 (90) 23.6 (29)  
  Immune system 12.6 (561) 11.6 (38) 9.6 (50) 23.8 (140) 9.0 (173) 12.7 (78) 17.1 (60) 17.9(22)  
  General health 20.7 (68) 20.7 (68) 12.5 (65) 14.5 (85) 20.1 (384) 20.0 (123) 16.6 (58) 26.8 (33)  
 Bowel Bowel health 9.9 (440) 10.0 (33) 11.0 (57) 5.9 (35) 11.4 (218) 8.3 (51) 7.4 (26) 16.3 (20)  
  Digestion 4.1 (182) 3.7 (12) 3.3 (17) 0.7 (4) 5.6 (107) 2.8 (17) 5.1 (18) 5.7 (7)  
 Mental Stress 5.0 (223) 2.7 (9) 3.3 (17) 1.7 (10) 7.2 (138) 3.3 (20) 5.4 (19) 8.1 (10)  
  Mental clarity 6.4 (282) 5.5 (18)  7.9 (41) 3.9 (23) 6.9 (131) 5.8 (36) 6.9 (24) 7.3 (9)  
 Appearance Increase energy 19.1 (847) 20.7 (68) 22.2 (115) 13.4 (79) 21.0 (401) 17.2 (106) 13.4 (47) 25.2 (31)  
  Improve sport 3.0 (135) 4.0 (13) 1.7 (9) 1.4 (8) 3.0 (58) 4.4 (27) 3.7 (13) 5.7 (7)  
  Lose weight 6.6 (293) 5.5 (18) 4.8 (25) 4.6 (27) 8.3 (159) 4.4 (27) 7.7 (27) 8.1 (10)  
  Hair, skin, nails 9.7 (432) 10.6 (35) 11.9 (62) 8.7 (51)  7.8 (149) 11.2 (69) 15.4 (54) 9.8 (12)  
 Other Nonspecific 3.4 (150) 2.1 (7) 1.7 (9) 3.4 (20) 4.0 (76) 2.8 (17) 4.9 (17) 3.3 (4)  
  Unknown 5.0 (223) 2.7 (9) 3.5 (18) 3.9 (23) 6.7 (128) 4.6 (28) 4.0 (4) 2.4 (3)  
 Recommended Clinician 14.7 (654) 14.0 (46) 13.1 (68) 16.5 (97) 14.5 (277) 15.7 (97) 15.7 (55) 11.4 (14)  
  Friend/family 5.7 (251) 4.0 (13) 4.2 (22) 4.1 (24) 6.9 (132) 5.2 (32) 5.7 (20) 6.5 (8)  
  General  3.6 (156) 3.6 (12) 2.3 (12) 3.2 (19) 4.3 (83) 3.6 (22) 1.7 (6) 3.2 (4)  
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CHAPTER 8: DISCUSSION AND CONCLUSIONS 
 
8.1 Key Study Findings 
 
Prevalence of botanical supplement use  
 
 This study documents that the prevalence of botanical and other NVNM supplements among 
Hispanics/Latinos depends on the methodology of data collection and definition used First, differences 
in the method of ascertainment influenced results.  The prevalence of supplements consumed in the 
past 30 days containing a botanical was 4.4% as ascertained by the medication inventory and was 9.4% 
as ascertained in the dietary supplement interview, increasing to 11.6 % if defined by either the 
medication inventory or the dietary supplement interview.  Second, different definitions of botanical 
supplements greatly influenced prevalence estimates.  If all fiber products were considered botanicals, 
the prevalence of products with botanicals increased to 12.3% and if botanical teas from the dietary 
recall were added, the prevalence was 22.8%.  Many studies conflate botanical and other so-called 
“specialty supplements” (here labeled NVNM ingredients).  Prevalence of supplements with NVNM 
ingredients was 12.9% by the medication inventory, 24.6% by the dietary supplement interview, and 
27% when defined by either measurement instrument.   
 Due to differences in the assessment period and differences in the target population, no prior 
studies are entirely comparable to HCHS/SOL.  The expected prevalence of botanical supplement use 
was calculated prior to the analysis.  Based on median estimates from a systematic review of botanical 
supplement use among Hispanics/Latinos, the prevalence of botanical supplement use among 
Hispanics/Latinos, including botanical teas, in the past 12 months was between 30 and 45%.  Estimated 
use in the past 30 days, based on the 2007 NHIS data would be 70-75% of that in the past 12 months.  
Because many botanical supplements are consumed episodically, one would expect an additional 
reduction in the prevalence, perhaps by another 25%.  Hence, the expected prevalence of botanical 
supplements with teas was between 15 and 25%.  Applying the same logic to estimate the prevalence of 
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botanical supplement products only (without teas), the expected prevalence was 5-10%.  Study findings 
are consistent with these expectations.   
 The prevalence of individual supplement ingredients from the dietary supplement interview 
was also calculated.  Among dietary supplement users (about 40% of the population), 25% were taking a 
supplement with an essential fatty acid and almost 30% were taking a supplement with lutein or 
lycopene.  Another 11% were taking a supplement with an ingredient usually used for arthritis 
(glucosamine, MSM, chondroitin, collagen) and 10% reported taking a supplement for joint health.  
Popular botanicals among supplement users included ginkgo (6.5%), ginseng (6.7%), and garlic (4.4%).  
Licorice was also a relatively common ingredient (2.4%).  Aloe and chamomile were infrequent 
ingredients in dietary supplement products captured in the dietary supplement interview, but were 
seen more often in the 24-hour dietary recalls.   
Patterns of botanical supplement use among Hispanics/Latinos 
Characteristics of botanical supplement users in HCHS/SOL were similar to those seen in the 
general US population [122, 147].  Defining botanical and NVNM supplement users by their reported use 
in either the medication inventory or the dietary supplement interview, users were more likely to be 
better educated and have a higher income.  They were also more likely to be physically active, non-
smokers, with greater adherence to healthy diet recommendations.  HCHS/SOL participants who 
considered themselves in good health were more likely to use botanical supplements, but they were 
also more likely to take at least one chronic prescription medication.   
  In general, Hispanics/Latinos of Cuban, Dominican and Puerto Rican descent were less likely to 
take botanical supplements than individuals of Mexican, Central or South American descent.  
Individuals reporting a mixed Hispanic/Latino heritage were more likely than others to report use of 
botanicals.  However, this pattern did not hold across all study sites and all definitions of botanical 
supplement use.  For example, in the Bronx, with relatively more Puerto Ricans (n=1,538) and 
Dominicans (n=1,221), the prevalence of NVNM supplements in those groups (about 20%) exceeded the 
prevalence for Mexicans (17%).  In contrast, the prevalence of NVNM supplements among Mexicans in 
San Diego (n=3,781) was almost 35%.  For data including botanical teas, prevalence among Mexicans 
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was consistently higher than Puerto Ricans, Dominicans, and Cubans, but remained higher for Mexicans 
in San Diego (35%) as compared with Mexicans in Chicago (27%) and the Bronx (19%).    
Motivations for supplement use among Hispanics/Latinos 
 Individuals in HCHS/SOL reported a variety of reasons for taking supplements.  Among those 
who were taking supplements with NVNM ingredients, 21% (age-standardized) reported taking 
supplements for their general health and 13% were taking NVNM supplements for cardiovascular health 
(heart, blood pressure, lipid abnormalities).  Ten percent of NVNM users were taking supplements for 
stress or anxiety.  About 8% of NVNM users gave nonspecific reasons for use:  they had heard it was a 
good product or they were not sure why they were taking it.   
 Despite the fact that the dietary supplements reported in HCHS/SOL were similar to those 
reported in the general population, reported motivations for use (of any dietary supplement) were 
somewhat dissimilar.  For example, in HCHS/SOL, the reported use of supplements for weight loss was 
6% compared with 3% in NHANES 2007-2010 [147].  HCHS/SOL participants were also more likely to 
report taking supplements for energy (18 vs. 11%), mental health (7 vs. 4%), and bowel health (6 vs. 
5%) and to supplement the diet (29 vs. 22 %).  HCHS/SOL participants were less likely to report 
supplement use for heart health (14 vs. 15%), joint health (9 vs. 12%) or bone health (15 vs. 25%), but 
7% also reported taking supplements to treat pain conditions.  Motivation patterns are consistent with 
those previously reported:  use of supplements to treat self-limited or minor conditions [49] and to 
improve health [182]. 
8.2 Study Limitations 
 
Possible inconsistent coding 
Identifying and coding supplements as botanicals and other NVNM in HCHS/SOL was a difficult 
process.  Although guidance was sought from and given by the Office of Dietary Supplements, the 
author was unable to ensure that coding procedures were entirely consistent with other studies.  The 
investigator chose the Langual-based process, because it was more specific than the NHANES-based 
supplement coding process.  The latter was appropriate for and applied to the categorization of 
individual supplement ingredients in the dietary supplement data.  Because much of the medication-
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based data could not be coded at the ingredient level, ingredient-level coding was not appropriate for 
these data.  The Langual-based coding scheme was easily adapted to product-level data and enabled 
the capture of many individual ingredients and the assignment of supplements to both broad and 
narrow categories.  
Every effort was made to ensure consistent coding across the datasets and repeated data 
checks were performed.  However, inconsistencies undoubtedly occurred.  The medication-based and 
dietary-based data were very different in character.  The medication-based data encoded much 
product information in a numeric variable saved as a string, but this information did not include 
specific ingredients.  Where sufficient detail was available for the products, ingredients were obtained 
from online product labels and saved in an Excel spreadsheet, but only the most common ingredients 
were encoded, usually as classes of products such as protein, fiber or lipotropic agents.  Particularly 
common individual ingredients were coded separately, e.g., omega-3 and omega-6, glucosamine with 
related chondroitin, MSM, and collagen, and lipotropic agents.  Inconsistencies in coding could have 
influenced negatively the concordance statistics and resulted in biased estimates. An additional review 
of the coding of both the medication inventory and dietary supplement interview data would be 
desirable.   
Possible additional measurement error 
 Lower overall estimates in the Bronx are of some concern.  It is unclear whether botanical 
supplement use is just not as popular in the Bronx, or if there a systematic measurement error 
affecting those estimates.  However, in previous studies, the prevalence of NVNM therapies in the 
northeast (18%) was lower than that seen in the west (24%) [122]. 
No standardization for botanical supplement assessments 
A standard procedure for botanical supplement capture and assessing prevalence does not 
exist.  Some methods restrict prevalence estimates to supplements that are consumed at least once 
per week and others count any use.  Some studies ask about supplement use in the past week [73, 107] 
or two weeks [59, 171], others collect data on supplement use in the past year, e.g., [115, 119] or 
supplement use at any time in the participant’s life, e.g., [5, 183].  Some studies ask about use of 
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supplements for a particular indication.  For example, studies request information about the use of 
supplements for diabetes [102] or arthritis [184].  Others ask about supplement use by individuals with 
certain conditions (e.g., menopause [37]) or individuals who are taking medications [16].  These 
differences in study design can make a large difference in prevalence estimates.   
No studies have presented methods for correction for measurement error in dietary supplement 
studies.  As noted above, all prior studies have compared duplicate instruments across supplements 
with kappa and intra-class correlation statistics.  Calibration of botanical supplement use is hampered 
by the lack of a “gold standard”, an instrument with 100% sensitivity and specificity for defining the 
variable.  
In the nutritional epidemiology literature, a literature with similar measurement error 
challenges, several methods have been considered, all of which presume continuous exposure variables 
and utilize linear regression models.  The goal of these models is to approximate the “true” value of a 
dietary value given available measures.  They include:  1) validation with an instrument considered 
error-free (the “gold standard” or “criterion” measure) in a subsample with application of a correction 
to the entire sample [66, 165]; 2) repeated assessments in the same population with the same 
instrument[185]; and/or 3) assessments with one or more additional, but error-prone instruments with 
utilization of statistical methods to come closer to the “true” measure [186].  The latter approach is 
hampered by non-identifiability when multiple variables are unknown.  Non-identifiability can be 
solved by either making assumptions about the actual value of one of the variables and examining the 
sensitivity of the analysis to variations in the value [187] or by utilizing a Bayesian approach, making 
assumptions about the range and the shape of the distribution of unknown variables, based on prior 
literature and analyses [186, 188].   Other model-based procedures, e.g. regression calibration, correct 
measurement error in one variable by regressing it on an outcome, preferably one with little error.  In 
regression calibration, analysts substitute the expected value of a variable, based on one or more 
values measured with error.  The procedure requires setting one measure as the criterion, but uses all 
available information in setting up the equation. 
In the current study, neither of the assessment instruments could be considered a gold standard.  
The medication inventory, if done in the home, could have been a criterion measure.    But an 
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inventory completed at a study visit could miss supplements participants fail to bring to the visit [189].  
Alternatively, the dietary supplement interview, following the 24-hour dietary recall as it does, may be 
a better criterion measure, making the assumption that the dietary supplement interview is more 
sensitive than the medication inventory for the outcome.  In the current study, it may be possible to 
define a calibration coefficient for adjusting the probability of botanical supplement use as assessed by 
the medication inventory by regressing it on the probability of use as determined by the dietary 
supplement interview including probability of being a botanical user given covariates as assessed in Aim 
2.  However, attempts to run this calculation resulted in improbably large correction estimates.  
Additional work in this area is needed.   
  It could be possible to estimate the “true botanical supplement prevalence” based on the 
imperfectly measured medication-based and dietary-based estimates using a structural equation 
modeling approach [190].  Structural equation modeling (SEM) is an attractive method for situations in 
which observed variables, measured with error, are expressions of a latent variable.  In future, 
consultation with an expert in SEM may make the desired calculation possible.   
Missing data 
 Very little data was missing for the dietary supplement interview or for the medication 
inventory.  Moreover, even though more than 1600 products in the medication inventory could not be 
coded, because many individuals took multiple supplements, less than 4% of individuals were affected.  
Sensitivity analyses changed the interpretation of the comparisons between methods very little.   
More data was missing for the analysis of characteristics of botanical supplement users.  The 
analysis was restricted to individuals with complete data for all of the variables included in models.  
Data was missing for the medication inventory or dietary recall (355), education (386), physical activity 
(246), dietary quality (243), cigarette smoking (93), perceived health (238), birthplace (73), years of US 
residence (120), insurance status (323), and income (1488), resulting in a reduction in the analysis 
population from 16,415 to 13,735(16%).  Individuals included in the analysis differed from those 
excluded by:  1) background group (fewer Cubans, more Mexicans); 2) gender (fewer females); 3) 
education (fewer less educated, more highly educated); 3) physical activity (more active); 4) smoking 
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(fewer smokers); 5) AHEI score (slightly higher in analysis dataset); and 6) acculturation (slightly higher 
SASH score).  Hence the analysis dataset was enriched by individuals more likely to be supplement 
users.   In addition, modeling missing variable status revealed several variables predicted missing value 
status with regard to percent of poverty.  Attempts to correct for missing data with multiple 
imputation programs were unsuccessful due to the need to include survey design characteristics in the 
model. 
Lack of generalizability of study findings 
Although HCHS/SOL recruits Hispanics/Latinos from across the United States and across 
background groups, by design, all of the target areas/field centers are in urban areas.   Hence, the 
results of this study will not be generalizable to rural Hispanic/Latino populations, such as immigrants 
to small towns or migrant farmworkers. 
8.3 Importance to Public Health and Clinical Medicine 
Prevalence estimates use botanical supplements use in Hispanic/Latino populations are 
currently uncertain, partially due to differences in use botanical supplement definitions in the 
literature.  This effort examined botanical and NVNM supplement use by multiple definitions, some 
intentionally very broad (all NVNM products or any botanical, including fiber products and food-like 
botanical remedies captured from the 24-hour dietary recalls) and some very narrow (botanical 
products captured in the dietary supplement interview).  The many different prevalence estimates 
sheds light on how and why the differences have occurred across studies and may lead to a better 
understanding of botanical supplement use in Hispanic/Latino populations.   Moreover, this study 
estimated population characteristics of botanical supplements users using multiple definitions, yielding 
a greater capacity for comparisons across studies in the literature.    
Understanding characteristics of supplement users is important to defining the likely 
supplement user.  In addition, understanding drivers of botanical and NVNM supplement use are 
essential to communication with patients about their use.  Botanical supplements have biologic activity 
and may interact with medications.  For example, ginkgo, a relatively popular botanical supplement in 
HCHS/SOL, may result in serious bleeding including intracerebral hemorrhage [191] and bleeding risk 
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may be more prominent with the concomitant administration of aspirin [192].  Individuals who take 
medications are more likely to take botanical supplements than those who do not and this finding was 
confirmed within HCHS/SOL.   However, as seen in the US general public, botanical supplement users in 
HCHS/SOL were also more likely to exhibit evidence of health-seeking behaviors, such as healthy 
dietary patterns and avoidance of smoking.  Increasingly, healthcare professionals are recognizing the 
desirability of empowering patients to take an active interest in maintaining good health.  Honest 
communication with patients is critical, particularly with patients who choose dietary supplements 
[193].  Adherence to both healthy lifestyle choices and medication recommendations has been 
associated with positive health outcomes [194].  Adherence depends on a mutually respectful 
relationship between the healthcare professional and the patient as well as recognition of outcomes 
important to patients [194].  Botanical supplement use, serving as a marker for other health-seeking 
behaviors, should be part of the conversation with patients.   
A respectful conversation about botanical supplement use is doubly important with patients 
who are members of a minority group.  Hispanics/Latinos are less likely than non-Hispanic whites to 
disclose their supplement use to their healthcare professionals [134].  Patients, who encounter other 
barriers to health care due to language challenges, structural barriers, and discrimination, may be even 
less likely to bring up botanical supplement use spontaneously.  In addition, based on the results of this 
study, unless patients are asked specifically about taking various types of supplements, such as 
botanical teas or liquid aloe supplements, they may not even think about them.  Healthcare 
professionals find that they must inquire about botanical supplement use in several different ways to 
achieve a complete sense of what a patient is taking (Gardiner, personal communication). 
Overall, dietary supplement use is captured poorly in the US and this is especially true for 
botanical supplements.  Botanical supplements may have both positive and negative long term effects, 
but these effects are inadequately studied.  Thousands of supplement products are introduced to the 
marketplace each year [158].   Despite good manufacturing process rules, many botanical supplement 
products currently do not contain label-stated ingredients and may contain misidentified plants and 
intentional adulteration with pharmaceuticals [39, 195].  Some of the weight loss botanical products 
identified in HCHS/SOL were known to contain undeclared medications (e.g., Fruta Planta) that had 
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been recalled by the US FDA.  Other identified products from Latin America contained a mixture of 
prescription and OTC medications, vitamins, and NVNM ingredients (e.g., Reumofan Plus).   
8.4 Future directions 
Multiple opportunities exist for the improvement of botanical supplement capture.  Based on 
experience with HCHS/SOL, further collaboration with the Office of Dietary Supplements could refine 
the derived Langual-based coding scheme to make it broadly applicable to dietary supplement coding 
in other settings.  Capture of all dietary supplement ingredients, such as is possible through the DSAM, 
is clearly superior, but may not be possible in smaller studies with fewer resources or to clinicians, 
unless, the DSAM were broadly and freely available to both researchers and clinicians.   
 Improving botanical supplement capture within Hispanic/Latino populations depends on a 
thorough understanding of the patterns of botanical supplement use within Hispanic/Latino 
populations, including understanding differences among background groups.  In this study, differences 
were suggested by the increased disparity in botanical supplement prevalence between Mexicans and 
Dominicans with the addition of botanical teas.  In prior studies, botanical teas comprised a substantial 
component of supplement use among Mexican Americans [38, 59, 69].   That HCHS/SOL captured few 
botanical teas outside the dietary recall assessments raises questions about the adequacy of botanical 
supplement ascertainment strategies in the study.  A validation study would be indicated for these 
populations, involving home-based dietary supplement inventories with prompts for capture of raw 
botanical product use, either in product form (e.g., commercial teas) or in other raw forms (home-
grown herbs, nopal).  This type of study could also inform a dietary supplement questionnaire for 
future follow-up. 
Improving botanical supplement capture in general depends not only on better communication 
with healthcare professionals, but also on improved surveillance techniques.  Currently, even if a 
conversation takes place between clinicians and patients about botanical supplement use, the medical 
chart often does not reflect it [169, 196].  Adverse event reporting depends on spontaneous reports to 
poison control centers, supplement manufacturers, or the FDA adverse event reporting system.  It is 
estimated that <1% of dietary supplement adverse events are reported [197].  A better system would 
capture supplement use routinely for storage in a national database.  This would require a partnership 
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between dietary supplement vendors, community pharmacies, clinicians, and patients as well as 
database programmers.  With voluntary routine capture of dietary supplement use, a better 
understanding of both the value and perils or supplement use can be assessed.  
 
 97 
 
APPENDIX.  EXAMPLE OF DIRECTED ACYCLIC GRAPH WITH EXPOSURE HIGHLIGHTED 
 
 
 
 
 
 
 
Daggity software, through its color-coding (exposure antecedents in pink, green lines 
indicating variables in causal pathway), enables the identification of antecedents of a 
variable in its relationship with a designated outcome.  Adjustment sets are easily 
constructed. 
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